Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",A1BG,Alpha-1B-glycoprotein,18511,1612,1.96 [1.45-2.64],1.0418045457706468e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AAMDC,Mth938 domain-containing protein,17992,1559,0.96 [0.88-1.06],0.4131641569907487
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AARSD1,Alanyl-tRNA editing protein Aarsd1,21186,1853,1.08 [1.00-1.16],0.0400664506023811
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABCA2,ATP-binding cassette sub-family A member 2,17856,1551,1.18 [1.02-1.36],0.0246284528707163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABHD14B,Protein ABHD14B,21040,1844,1.01 [0.94-1.09],0.8053150061545828
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABL1,Tyrosine-protein kinase ABL1,21186,1853,1.08 [1.02-1.15],0.0084089706325302
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABO,Histo-blood group ABO system transferase,18509,1603,0.98 [0.95-1.01],0.2167871544616108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABRAXAS2,BRISC complex subunit Abraxas 2,17856,1551,1.03 [0.96-1.11],0.4391705402224326
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",20784,1814,1.20 [1.14-1.26],3.123962945323044e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",18165,1571,1.05 [0.99-1.12],0.0987505158003411
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",18494,1603,1.03 [0.98-1.09],0.2571764641866333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAN,Aggrecan core protein,21072,1842,0.92 [0.79-1.07],0.2680206229639122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE,Angiotensin-converting enzyme,18509,1603,1.26 [1.05-1.52],0.0124491469701007
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE2,Angiotensin-converting enzyme 2,20906,1832,1.33 [1.23-1.43],2.3147430135304766e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACHE,Acetylcholinesterase,18077,1558,1.08 [0.94-1.23],0.2791179844173256
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACOT13,Acyl-coenzyme A thioesterase 13,18435,1602,1.03 [0.99-1.07],0.2003032595098667
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,21289,1860,1.11 [1.02-1.20],0.010982891305069
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP1,Low molecular weight phosphotyrosine protein phosphatase,17944,1562,0.80 [0.72-0.90],8.867565893395803e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,21379,1864,1.48 [1.32-1.67],9.076164777272904e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP6,Lysophosphatidic acid phosphatase type 6,21448,1875,1.09 [1.02-1.16],0.0107290908357545
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACRBP,Acrosin-binding protein,18419,1587,0.97 [0.85-1.09],0.5817846083849014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACRV1,Acrosomal protein SP-10,17944,1562,1.04 [0.99-1.09],0.1111150896845963
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACSL1,Long-chain-fatty-acid--CoA ligase 1,17856,1551,1.15 [1.00-1.33],0.0555891951089412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTA2,"Actin, aortic smooth muscle",20906,1832,1.21 [1.11-1.32],1.0076542569705308e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTN2,Alpha-actinin-2,17856,1551,0.96 [0.89-1.04],0.3385393511853671
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTN4,Alpha-actinin-4,20914,1833,1.18 [1.04-1.35],0.0092909232138831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,21064,1844,2.02 [1.75-2.34],2.3684819650275854e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY1,Aminoacylase-1,21289,1860,1.24 [1.16-1.32],3.1558216846024776e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,17856,1551,1.15 [1.06-1.25],0.0011866074820154
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACYP1,Acylphosphatase-1,18017,1554,1.04 [0.97-1.12],0.2510531253436692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA,Adenosine deaminase,21543,1879,1.17 [1.05-1.30],0.0030681503982873
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA2,Adenosine deaminase 2,21179,1847,1.24 [1.13-1.37],1.1379649306487164e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,17944,1562,1.53 [1.34-1.73],5.1658756748244426e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,20906,1832,1.20 [1.05-1.37],0.0067961374085623
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,21104,1848,0.76 [0.69-0.85],1.1639210582921003e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,21543,1879,0.92 [0.82-1.03],0.1488998028672062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,21450,1874,1.39 [1.21-1.60],2.466053094854432e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,18435,1602,1.45 [1.23-1.70],8.406358599984638e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,17944,1562,1.17 [1.00-1.36],0.049629827541195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,21556,1882,0.68 [0.57-0.80],7.467223832690105e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,21186,1853,1.25 [1.13-1.38],2.262159746094844e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,20906,1832,1.05 [0.93-1.19],0.4280519476955888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,17944,1562,1.31 [1.16-1.48],2.4819241937815618e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,21352,1860,0.81 [0.74-0.89],6.4680187617462135e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,18498,1605,1.90 [1.68-2.15],4.01972361637824e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL4,ADAMTS-like protein 4,17992,1559,1.52 [1.24-1.87],6.35088998570289e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL5,ADAMTS-like protein 5,18494,1603,0.95 [0.85-1.07],0.3781151479227639
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,20784,1814,0.87 [0.76-0.99],0.0397652343379473
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADD1,Alpha-adducin,18077,1558,0.95 [0.89-1.02],0.1683468015461102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRB3,Adhesion G protein-coupled receptor B3,21064,1844,1.05 [0.93-1.19],0.4385896260743304
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,18077,1558,1.62 [1.46-1.79],6.888290629731606e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE1,Adhesion G protein-coupled receptor E1,18435,1602,1.02 [0.93-1.11],0.69469382181116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE2,Adhesion G protein-coupled receptor E2,21367,1868,0.84 [0.73-0.97],0.0163715502379725
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE5,Adhesion G protein-coupled receptor E5,21451,1873,0.82 [0.72-0.94],0.0042351212727878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRF5,Adhesion G protein-coupled receptor F5,18494,1603,1.21 [1.02-1.43],0.0282919297998953
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,21186,1853,1.10 [1.04-1.15],0.0002809355727989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG2,Adhesion G-protein coupled receptor G2,21289,1860,0.90 [0.77-1.04],0.1561611867504003
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRV1,Adhesion G-protein coupled receptor V1,17877,1545,1.06 [0.99-1.13],0.0973158691728967
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADH1B,All-trans-retinol dehydrogenase,18077,1558,1.04 [0.98-1.10],0.2390285248218579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,20906,1832,1.06 [1.01-1.12],0.0233375207391014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADIPOQ,Adiponectin,18511,1612,1.21 [1.13-1.29],6.950448691520471e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADM,Pro-adrenomedullin,21472,1876,2.73 [2.32-3.20],3.138194425393302e-34
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADRA2A,Alpha-2A adrenergic receptor,17856,1551,0.96 [0.89-1.04],0.3554583327576652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AFAP1,Actin filament-associated protein 1,18077,1558,0.99 [0.93-1.05],0.7142737112410323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AFM,Afamin,18511,1612,0.90 [0.71-1.13],0.3670088791601809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AFP,Alpha-fetoprotein,21027,1843,1.05 [0.98-1.12],0.1421061311224435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGBL2,Cytosolic carboxypeptidase 2,17877,1545,1.02 [0.97-1.08],0.4497692583824428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGER,Advanced glycosylation end product-specific receptor,21236,1857,0.84 [0.76-0.92],0.0004371736087263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR2,Anterior gradient protein 2 homolog,20683,1820,1.13 [1.09-1.18],9.150078293132504e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR3,Anterior gradient protein 3,20754,1812,1.07 [1.00-1.15],0.0494535924538038
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRN,Agrin,21367,1868,1.43 [1.27-1.60],2.072431438897286e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRP,Agouti-related protein,21543,1879,1.09 [1.01-1.18],0.0293492005387904
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGT,Angiotensinogen,18509,1603,1.24 [1.00-1.54],0.0523367287214926
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGXT,Serine--pyruvate aminotransferase,21289,1860,1.16 [1.10-1.23],2.60335210329976e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHCY,Adenosylhomocysteinase,21289,1860,1.04 [0.98-1.10],0.2322647848365919
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHNAK,Neuroblast differentiation-associated protein AHNAK,17992,1559,1.24 [1.08-1.41],0.0020037217618496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHNAK2,Protein AHNAK2,17992,1559,0.94 [0.80-1.10],0.4138430056213967
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,18419,1587,0.99 [0.93-1.07],0.8663891309449915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHSG,Alpha-2-HS-glycoprotein,18509,1603,1.04 [0.87-1.25],0.6428491587956553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHSP,Alpha-hemoglobin-stabilizing protein,21265,1862,1.02 [0.97-1.07],0.411270192011873
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIDA,"Axin interactor, dorsalization-associated protein",18001,1566,0.97 [0.90-1.03],0.3249322846799942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIF1,Allograft inflammatory factor 1,20784,1814,1.10 [1.02-1.19],0.0139911073125294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIF1L,Allograft inflammatory factor 1-like,17992,1559,1.08 [1.00-1.17],0.0608085779799475
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",21155,1849,1.09 [1.04-1.13],2.509615008677192e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AK1,Adenylate kinase isoenzyme 1,21289,1860,1.05 [0.98-1.12],0.1501787384695267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AK2,"Adenylate kinase 2, mitochondrial",18446,1599,1.03 [0.98-1.07],0.252208823149973
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKAP12,A-kinase anchor protein 12,18077,1558,0.80 [0.62-1.02],0.0698328655874543
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1B1,Aldo-keto reductase family 1 member B1,20784,1814,1.04 [0.98-1.11],0.1495574895528464
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1B10,Aldo-keto reductase family 1 member B10,18001,1566,1.15 [1.07-1.24],0.0001197476669619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1C4,Aldo-keto reductase family 1 member C4,20906,1832,1.14 [1.07-1.23],0.0001978371547728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR7L,Aflatoxin B1 aldehyde reductase member 4,17944,1562,1.11 [1.04-1.19],0.0034076363171822
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKT1S1,Proline-rich AKT1 substrate 1,20838,1837,1.03 [0.97-1.10],0.3852239705344805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKT2,RAC-beta serine/threonine-protein kinase,18454,1594,1.00 [0.96-1.04],0.959950923791486
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKT3,RAC-gamma serine/threonine-protein kinase,20683,1806,0.97 [0.91-1.05],0.4824537563736706
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALCAM,CD166 antigen,21556,1882,1.33 [1.08-1.65],0.0075272998278799
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH1A1,Retinal dehydrogenase 1,21302,1865,1.15 [1.07-1.24],0.0001458828423168
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH2,"Aldehyde dehydrogenase, mitochondrial",18419,1587,1.07 [0.98-1.17],0.1479014628336661
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",21245,1861,1.18 [1.12-1.25],2.7679149799066527e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",18454,1594,1.29 [1.17-1.43],2.410095846971856e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALMS1,Alstrom syndrome protein 1,18165,1571,1.08 [0.96-1.21],0.2047153490266796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPI,Intestinal-type alkaline phosphatase,17944,1562,0.99 [0.95-1.03],0.5590035718053334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPP,"Alkaline phosphatase, placental type",21186,1853,1.22 [1.17-1.27],3.299437490661569e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBN,Ameloblastin,20914,1833,0.92 [0.79-1.07],0.2802337704158044
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBP,Protein AMBP,21442,1872,1.66 [1.37-2.02],4.240980227603286e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,18498,1605,1.01 [0.84-1.21],0.923940953190568
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMFR,E3 ubiquitin-protein ligase AMFR,20838,1837,1.07 [1.00-1.14],0.0403911244144755
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMIGO1,Amphoterin-induced protein 1,18001,1566,0.97 [0.88-1.07],0.5101550754073545
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMIGO2,Amphoterin-induced protein 2,21186,1853,1.36 [1.14-1.62],0.0005991148145681
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMN,Protein amnionless,20914,1833,1.02 [0.94-1.11],0.5986823002301374
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMOT,Angiomotin,18077,1558,0.73 [0.64-0.83],2.075559224832605e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMOTL2,Angiomotin-like protein 2,18338,1580,1.01 [0.90-1.13],0.8456952244483071
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMPD3,AMP deaminase 3,18446,1599,1.01 [0.95-1.08],0.7177244978810366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,17383,1507,0.95 [0.86-1.05],0.3234984607991122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY2A,Pancreatic alpha-amylase,20503,1784,0.92 [0.84-1.00],0.0449232247163498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY2B,Alpha-amylase 2B,19850,1721,0.91 [0.84-0.99],0.0362967606509343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANG,Angiogenin,21250,1853,1.43 [1.27-1.62],7.40823613036622e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT1,Angiopoietin-1,21213,1855,1.04 [0.99-1.09],0.113264995920969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT2,Angiopoietin-2,21472,1876,1.71 [1.54-1.91],3.6876927756135547e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL1,Angiopoietin-related protein 1,20960,1825,1.42 [1.22-1.64],3.453100898271698e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL2,Angiopoietin-related protein 2,21291,1861,1.13 [1.02-1.25],0.0160806717513277
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL3,Angiopoietin-related protein 3,21325,1860,1.26 [1.12-1.43],0.0001524043368311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,21336,1865,1.45 [1.33-1.59],2.840948787874009e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,21472,1876,1.34 [1.21-1.48],2.6255073334855685e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANK2,Ankyrin-2,17856,1551,1.05 [0.98-1.12],0.1643994183042695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,17944,1562,1.03 [0.97-1.09],0.3726104238306184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANKRA2,Ankyrin repeat family A protein 2,17841,1543,0.95 [0.87-1.05],0.3255611021842798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANKRD54,Ankyrin repeat domain-containing protein 54,20784,1814,1.06 [0.99-1.13],0.1108072044783858
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,17992,1559,1.04 [0.90-1.19],0.628177423855713
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANPEP,Aminopeptidase N,21362,1861,1.57 [1.33-1.84],3.668369216129272e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA1,Annexin A1,17990,1552,1.09 [0.98-1.20],0.1182944345843072
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA10,Annexin A10,20838,1837,1.14 [1.08-1.20],4.801988668485044e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA11,Annexin A11,21246,1860,1.01 [0.95-1.08],0.7204278358010318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA2,Annexin A2,17730,1541,1.12 [1.06-1.20],0.0002144561415695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA3,Annexin A3,21450,1874,1.06 [1.00-1.13],0.0364631838582505
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA4,Annexin A4,21199,1852,1.03 [0.97-1.09],0.2875530601899966
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA5,Annexin A5,20769,1824,1.14 [0.98-1.32],0.092065245165572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AOC1,Amiloride-sensitive amine oxidase [copper-containing],20914,1833,0.99 [0.91-1.07],0.7493985666862317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AOC3,Membrane primary amine oxidase,21393,1864,1.55 [1.35-1.79],1.6901454097263114e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP1G2,AP-1 complex subunit gamma-like 2,18419,1587,1.08 [1.02-1.15],0.006189967029171
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP2B1,AP-2 complex subunit beta,18001,1566,0.97 [0.88-1.08],0.6223365890393646
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP3B1,AP-3 complex subunit beta-1,18435,1602,1.06 [1.00-1.13],0.0614323532586964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP3S2,AP-3 complex subunit sigma-2,18446,1599,1.06 [0.96-1.16],0.2543911267989997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,21186,1853,1.07 [0.98-1.17],0.1058152557244056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APCS,Serum amyloid P-component,18354,1597,1.32 [1.13-1.54],0.0004310633379914
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,21415,1872,1.13 [1.05-1.20],0.0006142883070437
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APLP1,Amyloid-like protein 1,21289,1860,0.78 [0.72-0.85],3.4291348850627316e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA1,Apolipoprotein A-I,18511,1612,1.20 [1.02-1.42],0.0301178395335636
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA2,Apolipoprotein A-II,18509,1603,1.18 [1.07-1.30],0.0005552100063616
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA4,Apolipoprotein A-IV,18511,1612,1.10 [0.96-1.26],0.1631821118079197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOB,Apolipoprotein B-100,18509,1603,1.03 [0.83-1.28],0.7724145694132821
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOBR,Apolipoprotein B receptor,17992,1559,0.94 [0.84-1.05],0.2640710342339233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOC1,Apolipoprotein C-I,18483,1611,1.22 [1.09-1.37],0.0008352108410527
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOD,Apolipoprotein D,17704,1531,1.13 [1.00-1.26],0.0468595261245039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOE,Apolipoprotein E,18511,1612,1.07 [1.00-1.14],0.0367821138645098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOF,Apolipoprotein F,18509,1603,0.96 [0.80-1.14],0.6144898713409631
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOH,Beta-2-glycoprotein 1,21302,1865,1.06 [0.95-1.18],0.3194162935607941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOL1,Apolipoprotein L1,18509,1603,1.00 [0.92-1.09],0.9857509052766738
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOM,Apolipoprotein M,21360,1861,1.19 [1.03-1.38],0.015357483224906
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APP,Amyloid-beta precursor protein,21268,1861,1.08 [1.01-1.15],0.0147572460434684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APPL2,DCC-interacting protein 13-beta,18077,1558,1.01 [0.97-1.05],0.668847351098654
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APRT,Adenine phosphoribosyltransferase,21067,1843,1.03 [0.94-1.12],0.5165690461041743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARAF,Serine/threonine-protein kinase A-Raf,18165,1571,1.05 [0.98-1.12],0.2084550737616818
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AREG,Amphiregulin,21186,1853,1.82 [1.65-2.00],4.6530930152885755e-34
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARF6,ADP-ribosylation factor 6,18435,1602,1.01 [0.97-1.06],0.5893931531337956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARFIP1,Arfaptin-1,18454,1594,1.02 [0.95-1.09],0.6167852287182476
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARG1,Arginase-1,21142,1838,0.96 [0.88-1.04],0.264421348357976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARG2,"Arginase-2, mitochondrial",18419,1587,0.93 [0.83-1.05],0.2690446423248441
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP1,Rho GTPase-activating protein 1,20784,1814,0.94 [0.86-1.03],0.1683492111162491
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP25,Rho GTPase-activating protein 25,20784,1814,1.00 [0.94-1.07],0.9815499724832708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP30,Rho GTPase-activating protein 30,18165,1571,0.83 [0.70-0.97],0.0228955708154234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP45,Rho GTPase-activating protein 45,18077,1558,1.01 [0.96-1.07],0.6828018937326625
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP5,Rho GTPase-activating protein 5,17841,1543,0.99 [0.92-1.06],0.6993121260377964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF1,Rho guanine nucleotide exchange factor 1,18446,1599,1.04 [0.98-1.09],0.1830853170315402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF10,Rho guanine nucleotide exchange factor 10,18454,1594,1.04 [0.99-1.10],0.091674930574329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF12,Rho guanine nucleotide exchange factor 12,21282,1863,1.00 [0.97-1.04],0.8283032283154141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF5,Rho guanine nucleotide exchange factor 5,17877,1545,1.10 [1.03-1.18],0.0055398326569989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARID3A,AT-rich interactive domain-containing protein 3A,17877,1545,1.09 [0.96-1.23],0.1718507378423085
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARID4B,AT-rich interactive domain-containing protein 4B,20838,1837,1.07 [0.98-1.18],0.1525955157253208
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARL13B,ADP-ribosylation factor-like protein 13B,17856,1551,1.10 [1.03-1.18],0.0046388116623049
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,17856,1551,0.99 [0.87-1.12],0.8473540671467629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARMCX2,Armadillo repeat-containing X-linked protein 2,17877,1545,1.03 [0.95-1.12],0.4847955211820701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARNT,Aryl hydrocarbon receptor nuclear translocator,20914,1833,0.90 [0.79-1.02],0.1050944482082961
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,17856,1551,1.06 [0.96-1.17],0.2719207359987187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARSA,Arylsulfatase A,21302,1865,1.17 [1.07-1.27],0.0005856685054888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARSB,Arylsulfatase B,21186,1853,1.11 [1.03-1.19],0.0064805224955931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ART3,Ecto-ADP-ribosyltransferase 3,21393,1864,0.85 [0.76-0.95],0.0057556615372216
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ART5,Ecto-ADP-ribosyltransferase 5,17877,1545,1.04 [0.96-1.13],0.3504783771291587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARTN,Artemin,20914,1833,1.02 [0.94-1.11],0.631824491920403
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASAH1,Acid ceramidase,18331,1596,1.22 [1.10-1.35],0.0001942418136137
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASAH2,Neutral ceramidase,21104,1848,0.92 [0.86-0.99],0.0268344873815003
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,21104,1848,1.83 [1.63-2.05],1.34401330292528e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,18509,1603,1.91 [1.59-2.29],4.2801122262928135e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASPN,Asporin,18494,1603,1.12 [0.95-1.32],0.1781287128676325
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASPSCR1,Tether containing UBX domain for GLUT4,18454,1594,0.99 [0.93-1.07],0.8815286456686082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASRGL1,Isoaspartyl peptidase/L-asparaginase,17992,1559,1.01 [0.96-1.06],0.7585035358094879
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASS1,Argininosuccinate synthase,17856,1551,1.02 [0.96-1.09],0.4608732136239163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATF2,Cyclic AMP-dependent transcription factor ATF-2,20838,1837,0.98 [0.93-1.04],0.5040761873787254
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATF4,Cyclic AMP-dependent transcription factor ATF-4,17841,1543,1.03 [0.89-1.19],0.7151801933453608
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATG16L1,Autophagy-related protein 16-1,18435,1602,1.06 [1.00-1.12],0.0367438916662185
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATG4A,Cysteine protease ATG4A,20784,1814,1.05 [0.99-1.13],0.126497728380223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATOX1,Copper transport protein ATOX1,21352,1860,1.08 [1.02-1.15],0.0060369340022106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,17856,1551,1.00 [0.90-1.10],0.9243187812545632
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,17856,1551,1.01 [0.86-1.19],0.914982862116797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,17856,1551,0.99 [0.88-1.12],0.923350395864547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B4,Protein ATP1B4,17841,1543,1.04 [0.93-1.17],0.4807987326391808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP2B4,Plasma membrane calcium-transporting ATPase 4,17856,1551,1.00 [0.91-1.10],0.984240928706098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP5F1D,"ATP synthase subunit delta, mitochondrial",17856,1551,1.03 [0.95-1.12],0.49030362230867
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP5IF1,"ATPase inhibitor, mitochondrial",21367,1868,1.03 [0.99-1.07],0.1335438899791155
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP5PO,"ATP synthase subunit O, mitochondrial",20838,1837,1.00 [0.91-1.10],0.9942028442918582
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6AP2,Renin receptor,20784,1814,1.09 [0.98-1.21],0.1185664638890733
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1D,V-type proton ATPase subunit D,21186,1853,0.86 [0.74-1.01],0.068079591114659
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1F,V-type proton ATPase subunit F,20809,1835,1.00 [0.94-1.07],0.8829741738569484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1G1,V-type proton ATPase subunit G 1,17992,1559,1.01 [0.94-1.07],0.8636074031265663
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1G2,V-type proton ATPase subunit G 2,17856,1551,1.02 [0.96-1.07],0.5859037275705294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATRAID,All-trans retinoic acid-induced differentiation factor,18435,1602,1.32 [1.14-1.53],0.00024148757636
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATRN,"Attractin, Isoform 2",18511,1612,1.21 [0.90-1.63],0.2112745707316418
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN10,Ataxin-10,20838,1837,0.98 [0.93-1.04],0.4998643444998705
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN2,Ataxin-2,17877,1545,1.02 [0.97-1.07],0.4895649741338556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN2L,Ataxin-2-like protein,18454,1594,1.01 [0.91-1.12],0.8349098852936958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN3,Ataxin-3,18446,1599,1.06 [0.97-1.14],0.1868347204004007
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AXIN1,Axin-1,21282,1863,1.02 [0.97-1.06],0.466387581620617
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AXL,Tyrosine-protein kinase receptor UFO,21393,1864,0.78 [0.67-0.91],0.0018034064088516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AZI2,5-azacytidine-induced protein 2,18454,1594,1.11 [1.02-1.21],0.0142022304015987
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AZU1,Azurocidin,20674,1799,1.11 [1.05-1.16],4.233192025043754e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B2M,Beta-2-microglobulin,18511,1612,1.50 [1.36-1.65],6.87375878651356e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,17856,1551,1.11 [0.86-1.43],0.4412698714084575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",17992,1559,1.36 [1.19-1.55],4.221196329673823e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",21367,1868,1.40 [1.21-1.61],4.255145335272606e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GAT1,"Beta-1,4-glucuronyltransferase 1",21302,1865,1.01 [0.85-1.20],0.8804401776842772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BABAM1,BRISC and BRCA1-A complex member 1,17944,1562,0.88 [0.74-1.05],0.1549990817349846
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BACH1,Transcription regulator protein BACH1,21282,1863,1.05 [0.99-1.11],0.1038700473317542
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAG3,BAG family molecular chaperone regulator 3,21064,1844,1.00 [0.90-1.10],0.9266923687125704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAG4,BAG family molecular chaperone regulator 4,17944,1562,1.09 [0.99-1.19],0.0731474441286892
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAG6,Large proline-rich protein BAG6,20906,1832,1.07 [0.96-1.20],0.208745563778694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,20784,1814,1.24 [1.16-1.32],1.8070495920122048e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAMBI,BMP and activin membrane-bound inhibitor homolog,20784,1814,1.24 [1.06-1.44],0.0055909164034606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BANK1,B-cell scaffold protein with ankyrin repeats,21282,1863,1.02 [0.98-1.06],0.4132266181032474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAP18,Chromatin complexes subunit BAP18,18446,1599,1.12 [1.05-1.19],0.000468880085616
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BATF,Basic leucine zipper transcriptional factor ATF-like,18001,1566,1.03 [0.97-1.10],0.3003344664861343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAX,Apoptosis regulator BAX,20803,1831,1.06 [1.01-1.11],0.0093840240282395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAM,Basal cell adhesion molecule,21302,1865,1.35 [1.14-1.61],0.0004672522392195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAN,Brevican core protein,21104,1848,0.60 [0.53-0.67],5.8269219093180464e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",18494,1603,1.27 [1.09-1.47],0.0016824992021509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",17877,1545,1.00 [0.91-1.10],0.9888166109099844
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCHE,Cholinesterase,18175,1574,0.90 [0.76-1.08],0.2714057668930046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2,Apoptosis regulator Bcl-2,18435,1602,1.11 [1.02-1.21],0.0136773558321582
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L1,Bcl-2-like protein 1,18446,1599,1.01 [0.96-1.06],0.7104689525398529
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",21282,1863,1.21 [1.09-1.34],0.0003264396560607
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L15,Bcl-2-like protein 15,17944,1562,1.09 [1.01-1.18],0.0244533971256022
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL7A,B-cell CLL/lymphoma 7 protein family member A,17841,1543,1.00 [0.93-1.08],0.9057717260921702
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL7B,B-cell CLL/lymphoma 7 protein family member B,18419,1587,0.91 [0.81-1.04],0.15883591393503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCR,Breakpoint cluster region protein,21282,1863,1.01 [0.96-1.05],0.7535076354601444
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BDNF,Brain-derived neurotrophic factor,18498,1605,1.08 [1.02-1.15],0.007320179275827
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BECN1,Beclin-1,17992,1559,1.05 [0.97-1.14],0.237792547241895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BEX3,Protein BEX3,17841,1543,0.96 [0.85-1.09],0.5320673227209907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BGLAP,Osteocalcin,18498,1605,1.03 [0.98-1.09],0.265706589938743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BGN,Biglycan,20754,1810,0.96 [0.93-1.00],0.0291201227933771
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BHLHE40,Class E basic helix-loop-helix protein 40,17877,1545,1.00 [0.93-1.07],0.9959513858438006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,17856,1551,0.93 [0.76-1.14],0.470415097164254
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BID,BH3-interacting domain death agonist,21282,1863,1.06 [1.00-1.12],0.0515278725464844
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BIN2,Bridging integrator 2,21302,1865,1.02 [0.98-1.07],0.3594158938030802
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BIRC2,Baculoviral IAP repeat-containing protein 2,20784,1814,1.00 [0.94-1.07],0.9868266912736252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLMH,Bleomycin hydrolase,21556,1882,0.90 [0.79-1.03],0.1156219022962562
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLNK,B-cell linker protein,17944,1562,1.10 [0.98-1.22],0.0951487987906451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,17877,1545,1.00 [0.94-1.07],0.9611685748902672
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,18446,1599,1.07 [0.95-1.19],0.2637911340513775
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLVRB,Flavin reductase,21302,1865,1.02 [0.96-1.08],0.566631306873429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP10,Bone morphogenetic protein 10,18077,1558,1.09 [0.91-1.30],0.3443847214291613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP4,Bone morphogenetic protein 4,21064,1844,0.97 [0.88-1.07],0.5288109858108982
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP6,Bone morphogenetic protein 6,20872,1829,1.04 [0.93-1.15],0.4975619640980188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMPER,BMP-binding endothelial regulator protein,18077,1558,1.75 [1.41-2.19],5.343664129017388e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,18494,1603,0.97 [0.84-1.11],0.6322188490379811
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,17944,1562,1.25 [1.12-1.39],3.849624232986798e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BOC,Brother of CDO,20906,1832,0.96 [0.81-1.15],0.6740159943007397
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BOLA1,BolA-like protein 1,17877,1545,1.07 [0.98-1.16],0.1211874577151088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BOLA2_BOLA2B,BolA-like protein 2,17992,1559,0.98 [0.89-1.07],0.6204724692321277
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFA2,BPI fold-containing family A member 2,17389,1508,0.96 [0.92-1.00],0.0772388407322157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB1,BPI fold-containing family B member 1,21257,1855,1.45 [1.36-1.54],3.2972043871775215e-30
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB2,BPI fold-containing family B member 2,18461,1600,1.03 [0.96-1.12],0.411882901548532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRAP,BRCA1-associated protein,18256,1584,1.02 [0.97-1.06],0.5091880510947687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRD1,Bromodomain-containing protein 1,18165,1571,0.91 [0.77-1.06],0.2245993298796072
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRD2,Bromodomain-containing protein 2,17877,1545,0.91 [0.77-1.07],0.2374054892008014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRD3,Bromodomain-containing protein 3,17856,1551,0.95 [0.86-1.06],0.3857410593337415
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRDT,Bromodomain testis-specific protein,17856,1551,1.03 [0.91-1.18],0.6039101185827819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRK1,Protein BRICK1,20838,1837,1.13 [1.03-1.24],0.0075825270686276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRME1,Break repair meiotic recombinase recruitment factor 1,17877,1545,1.03 [0.91-1.18],0.6186878460327324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRSK2,Serine/threonine-protein kinase BRSK2,18454,1594,1.01 [0.88-1.16],0.8479561388136786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSG,Basigin,21507,1876,2.35 [1.94-2.85],4.141774820888349e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSND,Barttin,17841,1543,0.94 [0.80-1.10],0.4530255291514021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,21484,1876,1.06 [0.97-1.16],0.226336144469755
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST2,Bone marrow stromal antigen 2,21484,1876,1.54 [1.44-1.65],1.977130926780645e-34
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTC,Probetacellulin,20784,1814,1.09 [1.03-1.15],0.001510623166988
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTD,Biotinidase,18511,1612,0.92 [0.74-1.16],0.4973411882955811
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTLA,B- and T-lymphocyte attenuator,17841,1543,0.97 [0.91-1.03],0.2586391518262677
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN1A1,Butyrophilin subfamily 1 member A1,18382,1585,0.87 [0.75-1.00],0.0552764589644555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN2A1,Butyrophilin subfamily 2 member A1,21367,1868,1.36 [1.17-1.59],7.512241956470324e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,21282,1863,1.30 [1.17-1.44],1.2810899006875658e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTNL10,Butyrophilin-like protein 10,17841,1543,0.97 [0.87-1.09],0.6489852664667658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C19orf12,Protein C19orf12,20838,1837,1.15 [1.09-1.22],1.2108982999373887e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1GALT1C1,C1GALT1-specific chaperone 1,17856,1551,0.99 [0.84-1.16],0.881789627578631
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QA,Complement C1q subcomponent subunit A,21435,1866,1.11 [0.92-1.32],0.2724818087491897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",18454,1594,1.01 [0.94-1.08],0.7531388461883342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QL2,Complement C1q-like protein 2,17944,1562,1.18 [1.06-1.31],0.0022312071639786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,21393,1864,1.32 [1.20-1.45],3.346860836105882e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,18077,1558,1.10 [0.96-1.26],0.1853108019378324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,18454,1594,1.08 [0.94-1.24],0.2609673900566772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,18048,1555,0.84 [0.77-0.93],0.0004474150634515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1R,Complement C1r subcomponent,18511,1612,1.54 [1.17-2.02],0.001777559016183
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1RL,Complement C1r subcomponent-like protein,18478,1609,1.05 [0.83-1.34],0.6888703418794726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1S,Complement C1s subcomponent,18511,1612,1.46 [1.16-1.83],0.0013223071465897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2,Complement C2,21360,1861,1.34 [1.09-1.65],0.0052372772904458
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2CD2L,Phospholipid transfer protein C2CD2L,20809,1835,1.21 [1.09-1.34],0.0002557125042082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2orf69,UPF0565 protein C2orf69,18001,1566,0.99 [0.91-1.08],0.8046549787541362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C3,Complement C3,17604,1535,1.18 [1.07-1.31],0.0016482145709156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C4BPB,C4b-binding protein beta chain,21352,1860,0.90 [0.81-0.99],0.0387137873077241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C5,Complement C5,18511,1612,1.44 [1.06-1.94],0.0187294970407278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7,Complement component C7,18066,1572,1.73 [1.49-2.01],1.1746575573131314e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7orf50,Uncharacterized protein C7orf50,18446,1599,1.26 [1.06-1.49],0.0083632857322352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C8B,Complement component C8 beta chain,18511,1612,1.26 [1.07-1.47],0.0045892678492339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C9,Complement component C9,18509,1603,1.05 [0.96-1.13],0.2764004060230534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C9orf40,Uncharacterized protein C9orf40,18435,1602,1.00 [0.94-1.06],0.9942412349029222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA1,Carbonic anhydrase 1,20855,1814,1.01 [0.94-1.09],0.7333146023498827
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA11,Carbonic anhydrase-related protein 11,20784,1814,1.14 [0.99-1.30],0.0618683459388537
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA12,Carbonic anhydrase 12,21186,1853,1.17 [1.03-1.32],0.0170918476992704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA13,Carbonic anhydrase 13,21043,1831,1.00 [0.96-1.04],0.9489452459681302
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA14,Carbonic anhydrase 14,21472,1876,0.73 [0.65-0.82],1.9789576215275853e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA2,Carbonic anhydrase 2,21237,1862,1.06 [1.00-1.13],0.0622657420049516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA3,Carbonic anhydrase 3,21523,1879,0.98 [0.91-1.05],0.5495843385593768
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA4,Carbonic anhydrase 4,21556,1882,1.56 [1.33-1.83],7.191385787843766e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA5A,"Carbonic anhydrase 5A, mitochondrial",20906,1832,1.13 [1.08-1.18],3.542801931835192e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA6,Carbonic anhydrase 6,21237,1860,0.80 [0.75-0.86],8.507789528294004e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA7,Carbonic anhydrase 7,18165,1571,0.96 [0.84-1.10],0.5736037285866196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA8,Carbonic anhydrase-related protein,17944,1562,0.78 [0.63-0.98],0.034675528050305
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA9,Carbonic anhydrase 9,21472,1876,1.23 [1.12-1.35],8.155378398979193e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CABP2,Calcium-binding protein 2,18001,1566,0.95 [0.88-1.03],0.2312637508867295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,17877,1545,1.03 [0.89-1.19],0.7055897477580511
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,17856,1551,0.92 [0.83-1.01],0.0702379259700615
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,17877,1545,1.01 [0.93-1.10],0.7336957562423736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,18454,1594,1.04 [0.98-1.10],0.1869682897098515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACYBP,Calcyclin-binding protein,18046,1554,1.03 [0.99-1.08],0.1803705606225347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CADPS,Calcium-dependent secretion activator 1,18001,1566,1.05 [0.91-1.21],0.5087851606321143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALB1,Calbindin,21186,1853,1.00 [0.91-1.10],0.9324731121317462
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALB2,Calretinin,20838,1837,1.14 [1.00-1.31],0.0513616764208742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCA,Calcitonin,21075,1846,1.12 [1.06-1.19],0.0001016143287439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCB,Calcitonin gene-related peptide 2,18446,1599,1.29 [1.14-1.46],5.29457162160305e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,21413,1870,1.02 [0.98-1.06],0.4551989378368529
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,17992,1559,1.03 [0.97-1.10],0.318675210701225
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALY,Neuron-specific vesicular protein calcyon,17856,1551,1.09 [0.96-1.22],0.1844295998810792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,20784,1814,1.10 [1.01-1.21],0.0379127496899744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,18001,1566,1.04 [0.96-1.14],0.328343684112622
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,18454,1594,1.06 [1.01-1.11],0.0122613125257436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CANT1,Soluble calcium-activated nucleotidase 1,21219,1849,1.38 [1.13-1.68],0.001844176213033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPG,Macrophage-capping protein,21139,1848,1.21 [1.13-1.29],8.321952774160932e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPN3,Calpain-3,18419,1587,0.94 [0.82-1.07],0.3363088960438801
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPS,Calcyphosin,18446,1599,1.00 [0.96-1.05],0.8899846240952467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CARHSP1,Calcium-regulated heat-stable protein 1,20838,1837,1.05 [0.96-1.14],0.2842737868349387
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASC3,Protein CASC3,18001,1566,1.05 [0.94-1.17],0.4276188036213328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP1,Caspase-1,20838,1837,1.06 [1.01-1.13],0.0276309298267038
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP10,Caspase-10,20838,1837,1.04 [0.99-1.11],0.1442154029178316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP2,Caspase-2,21282,1863,1.02 [0.97-1.09],0.4385486943317868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP3,Caspase-3,21556,1882,1.01 [0.97-1.06],0.6000621427936179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP4,Caspase-4,18165,1571,1.02 [0.99-1.05],0.1479781993394493
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP7,Caspase-7,18446,1599,1.01 [0.95-1.07],0.7492224070747551
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP8,Caspase-8,21418,1871,0.99 [0.93-1.06],0.8585973425596993
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP9,Caspase-9,17944,1562,0.97 [0.90-1.05],0.4520644181687266
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASQ2,Calsequestrin-2,17856,1551,1.02 [0.93-1.12],0.6887856641786034
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAT,Catalase,18247,1584,1.00 [0.91-1.10],0.9774682824523082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLIF,Cobalamin binding intrinsic factor,21260,1858,1.07 [1.01-1.13],0.0264905199900128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN1,Cerebellin-1,17877,1545,0.98 [0.92-1.03],0.371323212257305
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN4,Cerebellin-4,21472,1876,0.72 [0.63-0.81],2.9326122749190694e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBS,Cystathionine beta-synthase,17992,1559,1.14 [1.04-1.25],0.0040727332893243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBX2,Chromobox protein homolog 2,17856,1551,1.05 [0.93-1.19],0.4078376422442119
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,21104,1848,1.05 [1.00-1.11],0.0656813132467405
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCAR2,Cell cycle and apoptosis regulator protein 2,18446,1599,1.11 [1.03-1.20],0.0043234958658642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC134,Coiled-coil domain-containing protein 134,18419,1587,1.08 [0.98-1.19],0.1175407253049769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC28A,Coiled-coil domain-containing protein 28A,18001,1566,0.97 [0.83-1.13],0.6739985336860421
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC50,Coiled-coil domain-containing protein 50,18454,1594,1.03 [0.97-1.10],0.2685117272463899
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,21289,1860,1.53 [1.36-1.72],1.2490322628452688e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,17992,1559,0.86 [0.79-0.93],0.0001674814995169
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL11,Eotaxin,21543,1879,1.30 [1.17-1.45],2.029251739360424e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL13,C-C motif chemokine 13,21512,1876,1.02 [0.96-1.08],0.6251636754911414
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL14,C-C motif chemokine 14,21250,1853,1.22 [1.11-1.34],5.784144901393654e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL15,C-C motif chemokine 15,21556,1882,1.31 [1.20-1.43],1.518733798122927e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL16,C-C motif chemokine 16,21556,1882,1.23 [1.13-1.34],6.03087775610622e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL17,C-C motif chemokine 17,21218,1857,1.14 [1.09-1.18],4.378527449682512e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL18,C-C motif chemokine 18,21021,1836,1.13 [1.07-1.19],1.370629231624197e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL19,C-C motif chemokine 19,21484,1876,1.08 [1.05-1.11],1.6431450216605082e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL2,C-C motif chemokine 2,21064,1844,1.00 [0.92-1.08],0.9423388656208292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL20,C-C motif chemokine 20,21543,1879,1.22 [1.17-1.28],6.390314245826694e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL21,C-C motif chemokine 21,21367,1868,1.51 [1.40-1.62],4.950218137326337e-30
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL22,C-C motif chemokine 22,21047,1838,1.37 [1.27-1.48],9.791018864175656e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL23,C-C motif chemokine 23,21367,1868,1.26 [1.15-1.39],2.225322946250424e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL24,C-C motif chemokine 24,21336,1865,1.05 [1.00-1.10],0.0551981863583531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL25,C-C motif chemokine 25,21543,1879,1.22 [1.12-1.32],1.5045016956453951e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL26,C-C motif chemokine 26,21282,1863,1.01 [0.97-1.05],0.6720749911370665
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL27,C-C motif chemokine 27,21289,1860,1.17 [1.10-1.25],3.10074680947737e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL28,C-C motif chemokine 28,21214,1855,1.19 [1.12-1.27],2.2532811876481163e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL3,C-C motif chemokine 3,21282,1863,1.15 [1.09-1.20],9.518370925643845e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL4,C-C motif chemokine 4,21293,1862,1.04 [0.98-1.09],0.2099950894796921
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL5,C-C motif chemokine 5,21393,1864,1.09 [1.05-1.14],1.884146434255438e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL7,C-C motif chemokine 7,21282,1863,1.24 [1.17-1.32],4.286473146922877e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL8,C-C motif chemokine 8,21442,1872,1.08 [1.01-1.15],0.0191842498258189
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN1,CCN family member 1,21156,1849,1.13 [1.07-1.19],2.70998473957162e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN2,CCN family member 2,21266,1861,1.09 [1.02-1.17],0.0159932231403221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN3,CCN family member 3,21515,1875,1.30 [1.15-1.48],2.7686114454956108e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN4,CCN family member 4,21472,1876,1.27 [1.14-1.41],9.89938742742748e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN5,CCN family member 5,21302,1865,1.04 [0.93-1.16],0.5223461058083703
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCND2,G1/S-specific cyclin-D2,18165,1571,1.13 [1.00-1.29],0.0522937437599722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCNE1,G1/S-specific cyclin-E1,17944,1562,0.97 [0.90-1.04],0.408039567135414
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCS,Copper chaperone for superoxide dismutase,21104,1848,1.01 [0.92-1.10],0.8659638512608812
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCT5,T-complex protein 1 subunit epsilon,20784,1814,1.03 [0.93-1.13],0.6001202237225067
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD101,Immunoglobulin superfamily member 2,18435,1602,1.29 [1.14-1.45],2.44388288247504e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD109,CD109 antigen,21302,1865,1.01 [0.89-1.15],0.8540957649465393
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD14,Monocyte differentiation antigen CD14,20900,1824,1.61 [1.46-1.78],4.239575839073812e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD160,CD160 antigen,21543,1879,0.99 [0.91-1.08],0.8459108306735504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD163,Scavenger receptor cysteine-rich type 1 protein M130,21393,1864,1.33 [1.22-1.46],3.3524095118553357e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD164,Sialomucin core protein 24,21302,1865,1.10 [0.94-1.29],0.242310288693752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD164L2,CD164 sialomucin-like 2 protein,18001,1566,0.92 [0.80-1.05],0.223469919092713
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD177,CD177 antigen,21269,1862,1.05 [1.01-1.08],0.0078245896111585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD1C,T-cell surface glycoprotein CD1c,21352,1860,1.14 [0.97-1.35],0.105467138997106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD2,T-cell surface antigen CD2,17856,1551,1.09 [0.96-1.24],0.1844635627411837
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD200,OX-2 membrane glycoprotein,21282,1863,0.97 [0.83-1.12],0.6475573952712199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD200R1,Cell surface glycoprotein CD200 receptor 1,21207,1858,0.89 [0.79-1.00],0.0454676892017768
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD207,C-type lectin domain family 4 member K,20803,1824,1.16 [1.04-1.29],0.0065835085314191
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD209,CD209 antigen,21351,1859,1.03 [0.93-1.14],0.5243663494990787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD22,B-cell receptor CD22,21543,1879,0.93 [0.84-1.02],0.1299385579462579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD226,CD226 antigen,17944,1562,0.97 [0.87-1.09],0.6447874626672732
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD244,Natural killer cell receptor 2B4,21543,1879,0.91 [0.79-1.06],0.2140631579820896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD248,Endosialin,18498,1605,0.78 [0.70-0.87],7.339559685674736e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD27,CD27 antigen,21352,1860,1.51 [1.37-1.66],3.275283265475432e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD274,Programmed cell death 1 ligand 1,21104,1848,1.47 [1.30-1.67],1.1900066638151935e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD276,CD276 antigen,21262,1860,1.22 [1.08-1.37],0.0011382991314822
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD28,T-cell-specific surface glycoprotein CD28,20784,1814,1.05 [0.95-1.16],0.3726875367189114
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD2AP,CD2-associated protein,21289,1860,1.06 [1.00-1.13],0.0616743010535951
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300A,CMRF35-like molecule 8,18077,1558,1.36 [1.16-1.59],0.000196958924626
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300C,CMRF35-like molecule 6,21484,1876,1.45 [1.29-1.62],2.095715943286578e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300E,CMRF35-like molecule 2,21413,1871,1.45 [1.31-1.60],1.6834662119681358e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300LF,CMRF35-like molecule 1,21472,1876,1.21 [1.13-1.30],1.239775113234038e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300LG,CMRF35-like molecule 9,21302,1865,1.10 [0.98-1.22],0.1074705807399176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD302,CD302 antigen,21186,1853,1.67 [1.47-1.91],6.710480674587462e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD33,Myeloid cell surface antigen CD33,21352,1860,1.02 [0.97-1.07],0.5191671911877992
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD34,Hematopoietic progenitor cell antigen CD34,21417,1871,0.77 [0.64-0.92],0.0033001593927819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD36,Platelet glycoprotein 4,17944,1562,1.11 [1.00-1.23],0.0461069134118587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,21186,1853,0.93 [0.82-1.06],0.3049208472364069
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD3D,T-cell surface glycoprotein CD3 delta chain,17877,1545,0.96 [0.82-1.12],0.5746886912599098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD3E,T-cell surface glycoprotein CD3 epsilon chain,18165,1571,1.12 [0.99-1.28],0.0669336129534836
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD3G,T-cell surface glycoprotein CD3 gamma chain,17944,1562,0.99 [0.94-1.05],0.7475264864974578
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD4,T-cell surface glycoprotein CD4,21251,1857,1.52 [1.33-1.75],2.114858617958854e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,21262,1859,1.21 [1.12-1.31],3.557697478406411e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD40LG,CD40 ligand,21543,1879,1.07 [1.02-1.12],0.0098789079469516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD46,Membrane cofactor protein,21185,1845,1.18 [1.02-1.37],0.0271318861989231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD48,CD48 antigen,21336,1865,1.20 [1.04-1.37],0.0101514855374939
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5,T-cell surface glycoprotein CD5,21442,1872,1.23 [1.10-1.37],0.0002783799941375
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD55,Complement decay-accelerating factor,20561,1791,1.26 [1.06-1.49],0.0080683265451441
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD58,Lymphocyte function-associated antigen 3,21222,1856,0.95 [0.75-1.20],0.6484111537856124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD59,CD59 glycoprotein,20545,1789,1.52 [1.28-1.82],2.587344988479955e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5L,CD5 antigen-like,18425,1606,1.22 [1.10-1.34],0.0001142714848284
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD6,T-cell differentiation antigen CD6,21507,1876,1.03 [0.96-1.11],0.4128143540614137
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD63,CD63 antigen,21064,1844,1.09 [1.01-1.19],0.0338730093283964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD69,Early activation antigen CD69,21177,1847,1.04 [0.99-1.09],0.1159303449899012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD7,T-cell antigen CD7,17915,1559,1.29 [1.16-1.43],2.725556337701688e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD70,CD70 antigen,21282,1863,1.21 [1.10-1.33],7.981372768116404e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD72,B-cell differentiation antigen CD72,18077,1558,1.06 [0.95-1.19],0.3108666933963999
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,21484,1876,1.56 [1.38-1.75],1.0764279606386841e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,21543,1879,1.14 [1.04-1.24],0.0032391133280025
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD80,T-lymphocyte activation antigen CD80,18494,1603,1.57 [1.37-1.81],2.8421592913384103e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD82,CD82 antigen,18165,1571,1.12 [0.99-1.28],0.0745717021015086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD83,CD83 antigen,21282,1863,1.64 [1.48-1.81],5.649205006059136e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD84,SLAM family member 5,21282,1863,1.06 [0.93-1.20],0.390845139516213
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD86,T-lymphocyte activation antigen CD86,18435,1602,1.14 [0.98-1.34],0.0884069817617795
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD8A,T-cell surface glycoprotein CD8 alpha chain,21484,1876,1.04 [0.96-1.12],0.3897296351121238
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD93,Complement component C1q receptor,20522,1791,1.11 [0.97-1.27],0.1427191431561192
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99,CD99 antigen,21302,1865,1.50 [1.22-1.85],0.0001372751794335
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99L2,CD99 antigen-like protein 2,21302,1865,1.95 [1.65-2.31],4.664287752961446e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDA,Cytidine deaminase,18465,1603,0.90 [0.82-0.99],0.0375286597412881
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDAN1,Codanin-1,18446,1599,0.90 [0.71-1.13],0.3535756235099503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC123,Cell division cycle protein 123 homolog,17841,1543,0.98 [0.90-1.07],0.6308884652794349
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC25A,M-phase inducer phosphatase 1,17841,1543,0.95 [0.83-1.08],0.4102606523215791
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC26,Anaphase-promoting complex subunit CDC26,18396,1600,1.03 [0.97-1.10],0.3519470044709327
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC27,Cell division cycle protein 27 homolog,20784,1814,1.07 [1.01-1.15],0.0328209099789051
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC37,Hsp90 co-chaperone Cdc37,21352,1860,1.03 [0.99-1.09],0.1676270915388411
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC42BPB,Serine/threonine-protein kinase MRCK beta,18435,1602,1.05 [1.00-1.09],0.0552234929874294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDCP1,CUB domain-containing protein 1,21104,1848,1.40 [1.31-1.50],2.3998148989952578e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH1,Cadherin-1,20587,1798,1.22 [1.11-1.35],2.8856562582246084e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH15,Cadherin-15,21455,1874,0.99 [0.93-1.06],0.8271522813118659
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH17,Cadherin-17,21289,1860,1.02 [0.97-1.09],0.4276001386507001
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH2,Cadherin-2,21289,1860,1.43 [1.28-1.60],6.903673526652141e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH22,Cadherin-22,18165,1571,0.91 [0.76-1.09],0.3199838860113752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH23,Cadherin-23,18446,1599,0.89 [0.74-1.09],0.2630831772263153
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH3,Cadherin-3,21484,1876,0.98 [0.88-1.10],0.7457661210396563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH4,Cadherin-4,17877,1545,1.02 [0.92-1.14],0.6569985365795559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH5,Cadherin-5,21556,1882,0.82 [0.71-0.94],0.0044732870831627
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH6,Cadherin-6,21289,1860,1.01 [0.90-1.13],0.8635893698817242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR1,Cadherin-related family member 1,20838,1837,0.94 [0.84-1.04],0.2173392361743329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR2,Cadherin-related family member 2,21186,1853,1.14 [1.07-1.21],6.400469450469807e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR5,Cadherin-related family member 5,21289,1860,0.87 [0.78-0.96],0.0074296231604393
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDK1,Cyclin-dependent kinase 1,17841,1543,1.01 [0.89-1.16],0.8454346185174024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,18454,1594,1.02 [0.94-1.11],0.6177061203571664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDKL5,Cyclin-dependent kinase-like 5,17877,1545,0.91 [0.82-1.01],0.0861221680567711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDKN1A,Cyclin-dependent kinase inhibitor 1,21186,1853,1.02 [0.98-1.06],0.266259228168464
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,21186,1853,1.00 [0.96-1.05],0.982756850551884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDNF,Cerebral dopamine neurotrophic factor,21186,1853,0.88 [0.77-1.00],0.0515073538592091
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,21292,1863,1.11 [0.95-1.29],0.1810783827529962
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDSN,Corneodesmosin,21482,1872,1.08 [0.99-1.19],0.0912395226926467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,21322,1858,2.54 [2.10-3.07],8.2483283419173745e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,18435,1602,0.72 [0.68-0.76],2.0811687772805564e-32
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,18165,1571,0.97 [0.91-1.04],0.3729953153176796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,18435,1602,1.13 [1.00-1.28],0.0451093838070626
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,18165,1571,1.09 [0.99-1.21],0.073822154079425
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,21282,1863,1.03 [0.98-1.08],0.2498821309047011
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,20784,1814,1.09 [1.00-1.19],0.042846323516029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,20519,1790,1.44 [1.36-1.52],4.334233778645655e-36
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,18498,1605,1.51 [1.34-1.70],4.604696158813423e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,20906,1832,1.30 [1.20-1.40],1.5869315465689658e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEBPA,CCAAT/enhancer-binding protein alpha,17944,1562,1.13 [0.99-1.30],0.0713055388055906
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEBPB,CCAAT/enhancer-binding protein beta,20906,1832,1.01 [0.91-1.13],0.8141831264460355
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELA2A,Chymotrypsin-like elastase family member 2A,18498,1605,1.20 [1.12-1.29],3.223334359121478e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELA3A,Chymotrypsin-like elastase family member 3A,21521,1877,1.09 [1.01-1.16],0.0212832944230533
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,18077,1558,0.92 [0.77-1.10],0.3361950402025395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEMIP2,Cell surface hyaluronidase,17944,1562,1.22 [1.04-1.43],0.0154503046863495
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEND1,Cell cycle exit and neuronal differentiation protein 1,17877,1545,1.10 [1.02-1.19],0.0126306897000279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CENPF,Centromere protein F,18165,1571,1.02 [0.93-1.11],0.7333901107124197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CENPJ,Centromere protein J,18165,1571,1.02 [0.95-1.09],0.5858253969850594
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP112,Centrosomal protein of 112 kDa,17856,1551,1.02 [0.92-1.13],0.6449649332221103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP152,Centrosomal protein of 152 kDa,17841,1543,1.15 [1.03-1.27],0.0100543623399851
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP164,Centrosomal protein of 164 kDa,20914,1833,1.03 [0.97-1.10],0.3612037792210769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP170,Centrosomal protein of 170 kDa,17992,1559,1.04 [0.98-1.11],0.2086980533323845
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP20,Centrosomal protein 20,20784,1814,1.05 [0.99-1.11],0.0815336642462652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP290,Centrosomal protein of 290 kDa,18165,1571,0.91 [0.82-1.01],0.0754473030150371
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP350,Centrosome-associated protein 350,17841,1543,0.98 [0.85-1.13],0.7981260887655802
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP43,Centrosomal protein 43,20741,1817,1.03 [0.97-1.09],0.4108358766183771
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP85,Centrosomal protein of 85 kDa,20784,1814,1.03 [0.97-1.10],0.3661390651042937
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CERT,Ceramide transfer protein,20838,1837,1.07 [1.00-1.14],0.0577126800158491
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES1,Liver carboxylesterase 1,21353,1863,1.15 [1.09-1.20],1.0249138270281496e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES2,Cocaine esterase,21186,1853,1.13 [1.06-1.21],0.0004720012087383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES3,Carboxylesterase 3,21186,1853,1.00 [0.94-1.06],0.9768425632296234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CETN2,Centrin-2,20838,1837,1.06 [1.00-1.12],0.0613689135684996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CETN3,Centrin-3,18435,1602,1.05 [0.99-1.11],0.1337043833716779
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFB,Complement factor B,18203,1588,1.79 [1.54-2.08],6.317554094460818e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFC1,Cryptic protein,20784,1814,1.00 [0.91-1.11],0.9977025751027708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFD,Complement factor D,18511,1612,1.62 [1.31-2.02],1.0293817837436744e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFH,Complement factor H,17473,1531,1.70 [1.37-2.11],1.795539526503076e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR2,Complement factor H-related protein 2,18385,1597,1.07 [0.98-1.17],0.1165026210530801
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR4,Complement factor H-related protein 4,18476,1609,1.02 [0.95-1.09],0.6145496738373797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR5,Complement factor H-related protein 5,18281,1588,1.25 [1.11-1.41],0.0002093175175044
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFI,Complement factor I,18511,1612,2.27 [1.77-2.92],1.1684618234970919e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFP,Properdin,18511,1612,0.79 [0.63-1.00],0.0472767384652294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGA,Glycoprotein hormones alpha chain,21302,1865,1.25 [1.17-1.33],2.4804245886881303e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,18509,1603,1.05 [0.91-1.20],0.5078823435325506
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGN,Cingulin,18001,1566,1.17 [1.04-1.31],0.0075903322156345
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,21289,1860,1.20 [1.09-1.32],0.0002310262836604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,20784,1814,1.05 [0.98-1.13],0.1854228593219041
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHAD,Chondroadherin,18077,1558,0.84 [0.76-0.94],0.0015098389475402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",18446,1599,1.58 [1.41-1.76],1.522802112825349e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD6,MICOS complex subunit MIC25,18419,1587,1.73 [1.50-2.01],1.45404361485121e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHEK2,Serine/threonine-protein kinase Chk2,20906,1832,0.98 [0.86-1.11],0.7389475230444614
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGA,Chromogranin-A,18498,1605,1.17 [1.11-1.24],1.418214618170539e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGB,Secretogranin-1,21425,1868,1.08 [0.97-1.19],0.1551688430663868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHI3L1,Chitinase-3-like protein 1,20839,1815,1.33 [1.28-1.39],4.871367700778677e-43
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHIT1,Chitotriosidase-1,21379,1865,1.02 [1.00-1.05],0.104805171442088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHL1,Neural cell adhesion molecule L1-like protein,21360,1857,1.11 [0.97-1.26],0.132127542846917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHM,Rab proteins geranylgeranyltransferase component A 1,18001,1566,0.96 [0.89-1.04],0.3374209866030971
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHMP1A,Charged multivesicular body protein 1a,21104,1848,0.99 [0.94-1.05],0.7999292581846558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHMP6,Charged multivesicular body protein 6,18494,1603,1.06 [0.97-1.14],0.1844406575847121
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHP1,Calcineurin B homologous protein 1,17877,1545,0.98 [0.91-1.05],0.552468606420059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL1,Chordin-like protein 1,21336,1865,1.45 [1.28-1.65],1.1325166801971036e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL2,Chordin-like protein 2,21289,1860,0.96 [0.87-1.05],0.3245874551880299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRM1,Muscarinic acetylcholine receptor M1,18001,1566,1.01 [0.88-1.16],0.8635583474160256
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CIAPIN1,Anamorsin,21352,1860,1.05 [0.98-1.12],0.1805628081144106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CILP,Cartilage intermediate layer protein 1,18498,1605,1.30 [1.19-1.42],9.171838137420558e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CINP,Cyclin-dependent kinase 2-interacting protein,18165,1571,0.99 [0.88-1.11],0.8586534749439091
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CIRBP,Cold-inducible RNA-binding protein,18435,1602,1.03 [0.98-1.08],0.2582755224621053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CIT,Citron Rho-interacting kinase,18001,1566,1.08 [0.98-1.20],0.1229117227655941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,21433,1870,1.62 [1.44-1.82],2.116534269411745e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKB,Creatine kinase B-type,18498,1605,1.36 [1.25-1.47],1.9752035136050842e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",21192,1852,1.07 [1.00-1.13],0.0443600096205699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLASP1,CLIP-associating protein 1,17841,1543,0.93 [0.86-1.01],0.073086998426766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLC,Galectin-10,21257,1856,1.05 [0.99-1.11],0.09767191977348
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,21104,1848,1.36 [1.22-1.53],9.962144675433328e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC11A,C-type lectin domain family 11 member A,21273,1863,1.11 [1.02-1.20],0.0191855803338322
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC12A,C-type lectin domain family 12 member A,17944,1562,1.14 [0.88-1.49],0.3212947243078271
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,21302,1865,1.46 [1.28-1.65],5.721742278522519e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC1A,C-type lectin domain family 1 member A,20906,1832,1.27 [1.12-1.44],0.0001699283750157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC1B,C-type lectin domain family 1 member B,21484,1876,1.05 [1.00-1.09],0.0342759964852554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC2L,C-type lectin domain family 2 member L,18001,1566,0.90 [0.80-1.01],0.0698581366557163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC3B,Tetranectin,18107,1578,0.60 [0.48-0.76],1.4614541354730328e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4A,C-type lectin domain family 4 member A,21282,1863,0.88 [0.78-0.99],0.0315020232153563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4C,C-type lectin domain family 4 member C,21282,1863,1.09 [1.01-1.19],0.0341958569327154
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,21282,1863,1.31 [1.24-1.38],3.1781733694355624e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4G,C-type lectin domain family 4 member G,21282,1863,0.98 [0.87-1.11],0.728632601468969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4M,C-type lectin domain family 4 member M,18470,1602,1.08 [0.98-1.18],0.1070602547693047
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,21214,1853,1.81 [1.61-2.03],1.4457474945221573e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,20784,1814,1.30 [1.20-1.41],9.349661119767828e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC7A,C-type lectin domain family 7 member A,21543,1879,1.12 [1.04-1.21],0.001967257955205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLGN,Calmegin,18001,1566,1.28 [1.17-1.40],1.8877391969486085e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLIC5,Chloride intracellular channel protein 5,18001,1566,1.13 [0.99-1.29],0.0737896167386947
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLINT1,Clathrin interactor 1,17841,1543,1.00 [0.90-1.11],0.9359934030634944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLIP2,CAP-Gly domain-containing linker protein 2,21282,1863,1.00 [0.96-1.04],0.969586414415032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLMP,CXADR-like membrane protein,21472,1876,1.69 [1.40-2.03],3.2755072414210256e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLNS1A,Methylosome subunit pICln,18001,1566,0.96 [0.83-1.11],0.6017821418970316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",21075,1846,1.01 [0.97-1.06],0.6091258837333193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLPS,Colipase,21265,1862,0.95 [0.90-1.01],0.0942599698164575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSPN,Claspin,20809,1835,1.06 [0.95-1.18],0.2821077035830518
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN1,Calsyntenin-1,20838,1837,0.97 [0.89-1.06],0.5030950779223315
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN2,Calsyntenin-2,21543,1879,1.39 [1.26-1.54],6.840326417751277e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN3,Calsyntenin-3,18446,1599,1.15 [0.99-1.33],0.0675924646076299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLTA,Clathrin light chain A,20906,1832,1.04 [0.95-1.14],0.3436182311198467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLU,Clusterin,18511,1612,0.99 [0.83-1.18],0.893457569573535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLUL1,Clusterin-like protein 1,21248,1859,0.93 [0.85-1.02],0.1491903384200483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CMC1,COX assembly mitochondrial protein homolog,18494,1603,1.03 [0.98-1.08],0.244343749160832
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CMIP,C-Maf-inducing protein,18419,1587,1.01 [0.96-1.07],0.7063716895354696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNDP1,Beta-Ala-His dipeptidase,21393,1864,0.90 [0.83-0.98],0.0212386686464229
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNGB3,Cyclic nucleotide-gated cation channel beta-3,17877,1545,0.96 [0.88-1.06],0.4338245879103513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",17961,1557,1.04 [0.98-1.10],0.2430576268588301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNPY2,Protein canopy homolog 2,20906,1832,1.04 [0.97-1.11],0.2571190795692201
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNPY4,Protein canopy homolog 4,21186,1853,1.03 [0.97-1.08],0.3198370742518615
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNST,Consortin,21289,1860,1.02 [0.98-1.06],0.348837948593077
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTF,Ciliary neurotrophic factor,17877,1545,0.99 [0.85-1.15],0.8811686568552849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN1,Contactin-1,21556,1882,0.64 [0.55-0.74],2.1178197187481403e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN2,Contactin-2,21472,1876,1.07 [0.98-1.17],0.1464135393182856
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN3,Contactin-3,21302,1865,0.84 [0.73-0.97],0.0168652932722217
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN4,Contactin-4,21302,1865,0.95 [0.80-1.14],0.581316402607416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN5,Contactin-5,21344,1865,0.74 [0.66-0.83],2.081944125459691e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTNAP2,Contactin-associated protein-like 2,21282,1863,1.10 [1.00-1.21],0.04163981852806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTNAP4,Contactin-associated protein-like 4,18001,1566,0.98 [0.93-1.04],0.5361775632296802
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COCH,Cochlin,18494,1603,1.13 [1.03-1.25],0.0129628470196841
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL15A1,Collagen alpha-1(XV) chain,18498,1605,1.14 [0.96-1.36],0.144113006152611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,21379,1865,2.26 [1.89-2.70],3.07084959473373e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL1A1,Collagen alpha-1(I) chain,21556,1882,0.95 [0.80-1.13],0.5531140494235975
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL24A1,Collagen alpha-1(XXIV) chain,18435,1602,1.13 [1.04-1.23],0.004886061783592
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL28A1,Collagen alpha-1(XXVIII) chain,18001,1566,0.94 [0.89-1.00],0.0562491529654187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL2A1,Collagen alpha-1(II) chain,17992,1559,0.97 [0.91-1.03],0.2613890667689432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL3A1,Collagen alpha-1(III) chain,18498,1605,1.08 [0.88-1.34],0.4546731248996636
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,21289,1860,1.40 [1.26-1.55],2.4599659002019116e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A4,Collagen alpha-4(IV) chain,18136,1569,1.02 [0.92-1.12],0.7537610718446823
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL5A1,Collagen alpha-1(V) chain,18077,1558,1.32 [1.17-1.48],8.493035540814105e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,21556,1882,1.54 [1.38-1.73],1.081128934547662e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL9A1,Collagen alpha-1(IX) chain,21282,1863,1.15 [1.05-1.27],0.0036295448395723
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL9A2,Collagen alpha-2(IX) chain,18165,1571,1.00 [0.90-1.12],0.93937437813501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COLEC12,Collectin-12,21262,1860,1.70 [1.46-1.98],3.601432770093104e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMMD1,COMM domain-containing protein 1,17992,1559,1.03 [0.95-1.11],0.4382811469165931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMMD9,COMM domain-containing protein 9,18419,1587,0.94 [0.84-1.05],0.293185241172304
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMP,Cartilage oligomeric matrix protein,21075,1842,0.96 [0.85-1.09],0.5393082811006424
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMT,Catechol O-methyltransferase,20673,1815,1.05 [1.00-1.11],0.0395477862853459
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COPB2,Coatomer subunit beta',17856,1551,1.03 [0.92-1.15],0.6430394253733696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COPE,Coatomer subunit epsilon,20838,1837,0.95 [0.88-1.04],0.2839099942728004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",17992,1559,1.26 [1.13-1.42],5.3062966535398207e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CORO1A,Coronin-1A,20881,1814,1.06 [1.02-1.11],0.0086256583801246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CORO6,Coronin-6,17877,1545,1.00 [0.87-1.14],0.9442686136713468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",21186,1853,1.09 [1.03-1.15],0.0035641154009983
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COX6B1,Cytochrome c oxidase subunit 6B1,18494,1603,1.02 [0.88-1.17],0.7971540293856723
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA1,Carboxypeptidase A1,21556,1882,1.17 [1.11-1.24],1.5867327175233264e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA2,Carboxypeptidase A2,21424,1869,1.01 [0.95-1.08],0.6654195316280692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA4,Carboxypeptidase A4,17726,1533,0.86 [0.77-0.96],0.0082223828643871
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPB1,Carboxypeptidase B,21556,1882,1.14 [1.07-1.22],4.3405447134271024e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPB2,Carboxypeptidase B2,18483,1611,1.25 [1.01-1.55],0.0397341473809588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPE,Carboxypeptidase E,21296,1859,0.98 [0.88-1.09],0.7410416981554078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPLX2,Complexin-2,17841,1543,1.03 [0.89-1.19],0.6965043521548606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPM,Carboxypeptidase M,21373,1862,1.39 [1.23-1.56],4.980254865607672e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",17944,1562,1.23 [1.02-1.48],0.0330716075672217
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPPED1,Serine/threonine-protein phosphatase CPPED1,21484,1876,1.06 [0.99-1.13],0.0725401263823618
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPQ,Carboxypeptidase Q,18468,1602,1.27 [1.12-1.45],0.0002831166011104
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPTP,Ceramide-1-phosphate transfer protein,17856,1551,0.97 [0.86-1.09],0.5879714392622085
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPVL,Probable serine carboxypeptidase CPVL,21428,1871,1.23 [1.11-1.36],7.457810483324264e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPXM1,Probable carboxypeptidase X1,21352,1860,1.08 [1.02-1.15],0.0059511515090504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPXM2,Inactive carboxypeptidase-like protein X2,18494,1603,1.37 [1.15-1.64],0.0005012494620654
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CR1,Complement receptor type 1,18445,1600,0.98 [0.86-1.13],0.7973674741622152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CR2,Complement receptor type 2,21393,1864,0.85 [0.78-0.93],0.0002900254841737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,20784,1814,1.04 [0.99-1.10],0.0865841830183116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRADD,Death domain-containing protein CRADD,21075,1846,1.01 [0.96-1.07],0.7130131949034374
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREB3,Cyclic AMP-responsive element-binding protein 3,17841,1543,1.01 [0.92-1.10],0.9089387939199088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREBZF,CREB/ATF bZIP transcription factor,17841,1543,0.93 [0.77-1.14],0.497599296522371
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREG1,Protein CREG1,21021,1832,1.42 [1.30-1.55],5.301848940107103e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,18077,1558,1.29 [1.13-1.46],0.0001414926115239
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD2,Protein disulfide isomerase CRELD2,21336,1865,1.14 [1.05-1.24],0.0012806545553355
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRH,Corticoliberin,20747,1812,0.93 [0.89-0.98],0.0060637648241419
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,21262,1860,1.49 [1.28-1.73],1.971093500102148e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRHR1,Corticotropin-releasing factor receptor 1,20906,1832,1.02 [0.95-1.09],0.5389231250589299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,21367,1868,1.64 [1.33-2.02],3.2746022752650365e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIP2,Cysteine-rich protein 2,21104,1848,1.26 [1.13-1.40],4.53916637657646e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP2,Cysteine-rich secretory protein 2,21472,1876,0.92 [0.85-0.98],0.0161915368831968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP3,Cysteine-rich secretory protein 3,18340,1587,0.74 [0.62-0.88],0.0007620698070846
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRKL,Crk-like protein,21296,1861,1.02 [0.98-1.06],0.378672069966402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRLF1,Cytokine receptor-like factor 1,21367,1868,1.18 [1.01-1.39],0.0387376063091974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRNN,Cornulin,20694,1807,0.99 [0.93-1.06],0.8038034268939374
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAC1,Cartilage acidic protein 1,21556,1882,0.91 [0.80-1.04],0.1687860527592597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAM,Cytotoxic and regulatory T-cell molecule,21104,1848,1.03 [0.96-1.12],0.4010412662585361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAP,Cartilage-associated protein,18001,1566,0.93 [0.83-1.05],0.2452515291657552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRX,Cone-rod homeobox protein,20906,1832,0.99 [0.95-1.03],0.5217482912019327
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYBB1,Beta-crystallin B1,18494,1603,1.02 [0.95-1.09],0.6376298741543074
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYBB2,Beta-crystallin B2,18446,1599,1.07 [1.00-1.15],0.0468229076165445
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYGD,Gamma-crystallin D,18446,1599,1.04 [0.99-1.10],0.0949581894589184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYM,Ketimine reductase mu-crystallin,17877,1545,1.06 [0.99-1.13],0.0783357721696489
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYZL1,Quinone oxidoreductase-like protein 1,17992,1559,1.01 [0.96-1.07],0.7073864115550834
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSDE1,Cold shock domain-containing protein E1,17856,1551,0.97 [0.92-1.02],0.2250489084012451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,21367,1868,1.55 [1.34-1.79],2.232348856039536e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1R,Macrophage colony-stimulating factor 1 receptor,18509,1603,1.07 [0.95-1.20],0.2582514135000788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2,Granulocyte-macrophage colony-stimulating factor,17856,1551,1.08 [0.96-1.22],0.1979489996902495
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,21104,1848,1.13 [1.05-1.21],0.000753088604225
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2RB,Cytokine receptor common subunit beta,17944,1562,1.00 [0.89-1.12],0.9566811404227514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF3,Granulocyte colony-stimulating factor,20914,1833,1.07 [0.98-1.16],0.1153071330020519
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF3R,Granulocyte colony-stimulating factor receptor,17944,1562,1.38 [1.18-1.62],6.881685533876112e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSH1,Chorionic somatomammotropin hormone 1,18509,1603,1.07 [0.90-1.26],0.4616908014731447
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSNK1D,Casein kinase I isoform delta,17944,1562,0.97 [0.90-1.05],0.4646098406892178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSNK2A1,Casein kinase II subunit alpha,18454,1594,0.99 [0.89-1.10],0.8358425613266871
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSPG4,Chondroitin sulfate proteoglycan 4,18498,1605,0.78 [0.69-0.89],0.0002486017595358
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSPG5,Chondroitin sulfate proteoglycan 5,17877,1545,0.99 [0.89-1.10],0.795255967160399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSRP3,Cysteine and glycine-rich protein 3,17856,1551,1.03 [0.98-1.08],0.2339761717799165
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST1,Cystatin-SN,16094,1383,0.90 [0.86-0.95],0.0001235330060886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST3,Cystatin-C,21354,1860,1.69 [1.46-1.96],1.3377699849772708e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST5,Cystatin-D,20831,1822,0.99 [0.91-1.07],0.725118961914121
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST6,Cystatin-M,20725,1814,0.94 [0.86-1.03],0.1745922619169853
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST7,Cystatin-F,21293,1862,1.11 [1.07-1.16],4.290863218298733e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSTB,Cystatin-B,21003,1829,1.33 [1.21-1.46],1.9879303655653486e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTAG1A_CTAG1B,Cancer/testis antigen 1,18133,1566,0.99 [0.89-1.09],0.7734649928455961
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTBS,Di-N-acetylchitobiase,18249,1584,1.21 [1.00-1.45],0.0491843824251311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTF1,Cardiotrophin-1,20906,1832,1.00 [0.96-1.05],0.9047460497736536
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,18498,1605,1.48 [1.25-1.76],5.583346735556716e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTLA4,Cytotoxic T-lymphocyte protein 4,18498,1605,1.02 [0.87-1.20],0.802399839878259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTNNA1,Catenin alpha-1,17877,1545,1.11 [0.98-1.26],0.0988522547830521
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRB1,Chymotrypsinogen B,21302,1865,1.09 [1.02-1.16],0.011362354509535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRC,Chymotrypsin-C,21258,1860,0.95 [0.89-1.01],0.0842303887959847
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRL,Chymotrypsin-like protease CTRL-1,18446,1599,0.92 [0.87-0.98],0.0118330880794679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSB,Cathepsin B,21308,1858,1.17 [1.08-1.26],6.67338110244078e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSC,Dipeptidyl peptidase 1,21215,1858,1.23 [1.13-1.35],5.126796964459806e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSD,Cathepsin D,19923,1746,1.60 [1.49-1.72],3.811023792171941e-37
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSE,Cathepsin E,18077,1558,1.06 [0.97-1.16],0.1957472581712004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSF,Cathepsin F,21352,1860,1.31 [1.19-1.44],3.4155759249838056e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSH,Pro-cathepsin H,20830,1823,1.09 [1.03-1.15],0.0030467076236174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSL,Cathepsin L1,21289,1860,1.51 [1.28-1.79],1.5448624215213983e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSO,Cathepsin O,21543,1879,1.31 [1.16-1.47],8.461703504550805e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSS,Cathepsin S,16769,1472,1.36 [1.10-1.69],0.0051073132956658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSV,Cathepsin L2,21393,1867,1.07 [0.97-1.18],0.2020874309083005
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSZ,Cathepsin Z,21328,1859,1.42 [1.25-1.61],7.253866889562234e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CUZD1,CUB and zona pellucida-like domain-containing protein 1,18001,1566,1.05 [0.92-1.20],0.4873333519562745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CWC15,Spliceosome-associated protein CWC15 homolog,18336,1590,1.02 [0.94-1.11],0.64432668309656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CX3CL1,Fractalkine,21104,1848,1.04 [0.92-1.18],0.5233990049077386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,21282,1863,1.52 [1.41-1.64],6.392150751524309e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL1,Growth-regulated alpha protein,21227,1859,0.99 [0.95-1.04],0.6953051641719425
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL10,C-X-C motif chemokine 10,21367,1868,1.12 [1.06-1.19],0.0001492696602838
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL11,C-X-C motif chemokine 11,21484,1876,1.11 [1.06-1.16],3.166460934136106e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL12,Stromal cell-derived factor 1,20914,1833,1.25 [1.13-1.39],2.3301617112224253e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL13,C-X-C motif chemokine 13,21484,1876,1.13 [1.06-1.21],0.0001273346209466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL14,C-X-C motif chemokine 14,20914,1833,1.12 [1.05-1.19],0.000411134461993
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL16,C-X-C motif chemokine 16,21521,1879,1.94 [1.63-2.31],5.6136324297638343e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL17,C-X-C motif chemokine 17,21543,1879,1.88 [1.77-2.00],3.275049089443917e-89
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL3,C-X-C motif chemokine 3,21262,1859,1.03 [0.99-1.08],0.1350305774334557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL5,C-X-C motif chemokine 5,21212,1854,1.03 [1.00-1.07],0.0797471429121222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL6,C-X-C motif chemokine 6,21543,1879,0.97 [0.91-1.02],0.1995525898989373
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL8,Interleukin-8,21138,1850,1.15 [1.09-1.21],2.20305786372384e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL9,C-X-C motif chemokine 9,21367,1868,1.20 [1.13-1.27],1.7996934554018071e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYB5A,Cytochrome b5,17841,1543,1.09 [1.02-1.16],0.0104211703163824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYB5R2,NADH-cytochrome b5 reductase 2,18241,1582,1.14 [1.06-1.23],0.0008623803348814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",17856,1551,1.02 [0.96-1.08],0.595617202087356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYTH3,Cytohesin-3,17841,1543,0.98 [0.92-1.05],0.6382786002899152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYTL1,Cytokine-like protein 1,18498,1605,1.23 [1.02-1.49],0.0298669248400349
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAAM1,Disheveled-associated activator of morphogenesis 1,18077,1558,1.04 [0.98-1.10],0.2423369854478173
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAB2,Disabled homolog 2,21472,1876,1.01 [0.98-1.05],0.4943441321252664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAG1,Dystroglycan,21367,1868,1.13 [1.04-1.23],0.0056511881105697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAND5,DAN domain family member 5,17944,1562,1.01 [0.92-1.10],0.8862806960766334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAPK2,Death-associated protein kinase 2,17944,1562,1.04 [0.96-1.13],0.2988165244224668
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,21282,1863,0.99 [0.96-1.03],0.6544722861033331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DARS1,"Aspartate--tRNA ligase, cytoplasmic",21075,1846,0.96 [0.91-1.02],0.1759536817293928
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBH,Dopamine beta-hydroxylase,18480,1603,1.01 [0.96-1.05],0.8121632638456056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBI,Acyl-CoA-binding protein,21204,1853,1.09 [1.03-1.14],0.0018838935858288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBN1,Drebrin,17944,1562,1.03 [0.93-1.13],0.6233856117143615
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBNL,Drebrin-like protein,21367,1868,1.03 [0.98-1.07],0.2287061717200029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",21352,1860,1.32 [1.17-1.48],4.618363738361272e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCC,Netrin receptor DCC,18001,1566,0.89 [0.72-1.10],0.2847999939839114
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCDC2C,Doublecortin domain-containing protein 2C,17841,1543,0.96 [0.88-1.05],0.3605244905213611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCLRE1C,Protein artemis,17841,1543,1.01 [0.86-1.18],0.9185320528822084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCN,Decorin,20906,1832,0.95 [0.79-1.14],0.5605836411376452
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTD,Deoxycytidylate deaminase,18077,1558,1.00 [0.96-1.06],0.8756233105458038
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTN1,Dynactin subunit 1,21472,1876,0.97 [0.91-1.03],0.3608001641257848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTN2,Dynactin subunit 2,21186,1853,0.98 [0.94-1.02],0.3522022711810044
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTN6,Dynactin subunit 6,20838,1837,1.01 [0.95-1.07],0.7800591555305272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTPP1,dCTP pyrophosphatase 1,21289,1860,1.08 [0.95-1.23],0.2587809373093803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCUN1D1,DCN1-like protein 1,17877,1545,0.91 [0.84-0.98],0.0178000858473894
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCUN1D2,DCN1-like protein 2,17841,1543,0.98 [0.92-1.05],0.5476020139188993
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCXR,L-xylulose reductase,21352,1860,1.08 [1.01-1.16],0.0289770227303639
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDA1,DET1- and DDB1-associated protein 1,17856,1551,1.01 [0.89-1.14],0.8745397709419016
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",21186,1853,1.35 [1.24-1.47],5.539014499564652e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDC,Aromatic-L-amino-acid decarboxylase,21260,1858,1.08 [0.99-1.18],0.0795116116725389
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDHD2,Phospholipase DDHD2,18454,1594,1.04 [0.97-1.11],0.2910429036256041
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDI2,Protein DDI1 homolog 2,18077,1558,1.00 [0.94-1.07],0.9283539045339524
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,21484,1876,1.93 [1.65-2.26],3.8775744660822236e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDT,D-dopachrome decarboxylase,18498,1605,1.16 [1.04-1.29],0.0085474647071937
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX1,ATP-dependent RNA helicase DDX1,18435,1602,1.02 [0.93-1.13],0.6231552350574058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX25,ATP-dependent RNA helicase DDX25,18001,1566,1.00 [0.88-1.14],0.9697327584410128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX39A,ATP-dependent RNA helicase DDX39A,17944,1562,0.99 [0.81-1.21],0.9349252371045156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX4,Probable ATP-dependent RNA helicase DDX4,17944,1562,0.90 [0.82-1.00],0.0416341038322038
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX53,Probable ATP-dependent RNA helicase DDX53,18001,1566,0.99 [0.86-1.14],0.9008932957112744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX58,Antiviral innate immune response receptor RIG-I,20784,1814,1.05 [0.98-1.12],0.153527853740473
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",21282,1863,1.07 [1.02-1.11],0.0028365276163549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFA1_DEFA1B,Neutrophil defensin 1,20875,1819,1.13 [1.06-1.22],0.0004432227631558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB103A_DEFB103B,Beta-defensin 103,17818,1556,1.05 [0.95-1.17],0.3259486751029952
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB104A_DEFB104B,Beta-defensin 104,17877,1545,0.89 [0.81-0.98],0.0171943807449841
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB116,Beta-defensin 116,17877,1545,1.02 [0.95-1.09],0.5467592224441172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB118,Beta-defensin 118,17877,1545,1.06 [0.98-1.15],0.1189230855370818
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB4A_DEFB4B,Beta-defensin 4A,20974,1838,1.04 [1.01-1.07],0.0031148977119989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DENND2B,DENN domain-containing protein 2B,17856,1551,1.07 [0.96-1.19],0.2145088149383601
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DENR,Density-regulated protein,17944,1562,1.01 [0.93-1.10],0.7357945792364361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DFFA,DNA fragmentation factor subunit alpha,21543,1879,1.06 [1.00-1.12],0.0660385536627529
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DGCR6,Protein DGCR6,17877,1545,1.14 [1.01-1.29],0.0345473159713476
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DGKA,Diacylglycerol kinase alpha,17944,1562,1.09 [1.00-1.19],0.0448069115036535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DGKZ,Diacylglycerol kinase zeta,20914,1833,0.94 [0.84-1.05],0.2505255678108976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DHODH,Dihydroorotate dehydrogenase,17856,1551,1.00 [0.89-1.11],0.9468976549932604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DHPS,Deoxyhypusine synthase,18419,1587,1.06 [0.94-1.19],0.3360432449407637
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,18446,1599,1.02 [0.92-1.14],0.7041944308567565
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DIABLO,"Diablo homolog, mitochondrial",21214,1853,1.02 [0.98-1.06],0.3320783652371517
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DIPK1C,Divergent protein kinase domain 1C,18001,1566,0.99 [0.88-1.11],0.8326825698629908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DIPK2B,Divergent protein kinase domain 2B,18077,1558,0.90 [0.76-1.07],0.2323466844273057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK1,Dickkopf-related protein 1,21484,1876,1.05 [0.98-1.12],0.1454901175518518
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK3,Dickkopf-related protein 3,21556,1882,0.84 [0.73-0.97],0.0161380339817468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK4,Dickkopf-related protein 4,21064,1841,1.01 [0.92-1.10],0.9017434829399564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKKL1,Dickkopf-like protein 1,21186,1853,0.97 [0.93-1.02],0.2687002606195343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLG4,Disks large homolog 4,18446,1599,0.98 [0.92-1.05],0.5694472845808536
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLGAP5,Disks large-associated protein 5,18454,1594,1.06 [0.95-1.17],0.319032410413647
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLK1,Protein delta homolog 1,21556,1882,0.83 [0.78-0.89],3.511883536562847e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL1,Delta-like protein 1,21352,1860,1.36 [1.19-1.55],6.6259219011472746e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL4,Delta-like protein 4,17992,1559,1.02 [0.97-1.07],0.4738127820419427
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DMD,Dystrophin,17992,1559,1.11 [1.01-1.23],0.0347682879926269
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DMP1,Dentin matrix acidic phosphoprotein 1,17992,1559,0.83 [0.76-0.90],4.927662397022356e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJA1,DnaJ homolog subfamily A member 1,17841,1543,0.97 [0.86-1.08],0.5686220519841175
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJA2,DnaJ homolog subfamily A member 2,21469,1873,1.01 [0.96-1.06],0.6364604136952785
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJA4,DnaJ homolog subfamily A member 4,18446,1599,1.04 [0.97-1.11],0.2280850007695986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB1,DnaJ homolog subfamily B member 1,21186,1853,1.03 [0.98-1.08],0.263022901963882
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB14,DnaJ homolog subfamily B member 14,18435,1602,1.09 [1.02-1.17],0.0133842965378359
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB2,DnaJ homolog subfamily B member 2,18077,1558,1.00 [0.92-1.10],0.9517500042045108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB6,DnaJ homolog subfamily B member 6,17914,1547,1.02 [0.97-1.08],0.4588086368859722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB8,DnaJ homolog subfamily B member 8,20906,1832,1.00 [0.93-1.08],0.988313757098306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJC21,DnaJ homolog subfamily C member 21,18446,1599,0.93 [0.82-1.05],0.2508367372809278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJC6,Putative tyrosine-protein phosphatase auxilin,17992,1559,1.03 [0.97-1.09],0.3208501550877111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJC9,DnaJ homolog subfamily C member 9,18435,1602,1.05 [0.99-1.12],0.1071694060148317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNER,Delta and Notch-like epidermal growth factor-related receptor,21222,1859,0.80 [0.68-0.93],0.0047307220840281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNLZ,DNL-type zinc finger protein,17877,1545,0.95 [0.88-1.01],0.1019434613657648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNM1,Dynamin-1,18435,1602,0.98 [0.94-1.02],0.2830127866026295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNM3,Dynamin-3,18454,1594,1.12 [1.03-1.22],0.0088402057829349
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNMBP,Dynamin-binding protein,21104,1848,1.09 [1.02-1.17],0.0102151513309478
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNPEP,Aspartyl aminopeptidase,18446,1599,1.02 [0.94-1.10],0.6839929283299269
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,21327,1864,1.07 [0.99-1.16],0.1000020419963109
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOC2B,Double C2-like domain-containing protein beta,18001,1566,1.07 [0.94-1.22],0.3142011413343588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOCK9,Dedicator of cytokinesis protein 9,17877,1545,0.98 [0.93-1.02],0.302716621828963
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOK1,Docking protein 1,18446,1599,1.00 [0.97-1.04],0.8026404090317791
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOK2,Docking protein 2,21289,1860,1.03 [0.99-1.06],0.0964277752051803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPEP1,Dipeptidase 1,21075,1846,0.86 [0.79-0.94],0.0005349073148708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPEP2,Dipeptidase 2,21186,1853,1.14 [0.99-1.31],0.0679654894103407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP10,Inactive dipeptidyl peptidase 10,21282,1863,1.53 [1.39-1.69],1.9517218339687493e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP4,Dipeptidyl peptidase 4,20905,1825,1.13 [0.97-1.32],0.1250068896075622
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,21186,1853,0.73 [0.64-0.82],3.931794603734336e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP7,Dipeptidyl peptidase 2,21129,1847,1.30 [1.21-1.38],1.9196704211169163e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPT,Dermatopontin,21556,1882,0.97 [0.83-1.14],0.7215464023632552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPY30,Protein dpy-30 homolog,21415,1872,1.17 [1.10-1.25],9.158952307125282e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DRAXIN,Draxin,21104,1848,1.07 [0.97-1.18],0.1563783481306824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DRG2,Developmentally-regulated GTP-binding protein 2,21186,1853,1.01 [0.94-1.08],0.8438007649501651
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSC2,Desmocollin-2,21041,1848,1.20 [1.07-1.35],0.0018895413331135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSCAM,Down syndrome cell adhesion molecule,18454,1594,0.98 [0.86-1.12],0.7552315657747819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG2,Desmoglein-2,21302,1865,0.83 [0.71-0.98],0.0234706932494647
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG3,Desmoglein-3,21404,1868,0.83 [0.73-0.93],0.0013140073185867
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG4,Desmoglein-4,21118,1848,0.99 [0.91-1.08],0.8346055111763282
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTD1,D-aminoacyl-tRNA deacylase 1,18077,1558,0.99 [0.94-1.05],0.7984019548868461
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTNB,Dystrobrevin beta,18380,1585,1.28 [1.15-1.42],4.389778480473695e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX2,Probable E3 ubiquitin-protein ligase DTX2,18001,1566,0.95 [0.87-1.04],0.271049802633798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,21186,1853,1.59 [1.37-1.84],6.959410528649593e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTYMK,Thymidylate kinase,18494,1603,1.03 [0.96-1.10],0.4361793081640964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUOX2,Dual oxidase 2,20906,1832,1.05 [0.99-1.11],0.075853129062307
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUSP13,Dual specificity protein phosphatase 13 isoform A,18419,1587,0.99 [0.89-1.11],0.9099723814712724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUSP29,Dual specificity phosphatase 29,18001,1566,0.98 [0.91-1.06],0.5683858152034371
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUSP3,Dual specificity protein phosphatase 3,20838,1837,0.99 [0.94-1.04],0.7334227460927887
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",18435,1602,1.04 [0.99-1.09],0.1084052201479863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DXO,Decapping and exoribonuclease protein,18446,1599,1.11 [1.00-1.23],0.0506896903784863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,18419,1587,0.91 [0.82-1.00],0.0613987473369973
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DYNLT1,Dynein light chain Tctex-type 1,18001,1566,1.02 [0.96-1.08],0.4602699100771383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DYNLT3,Dynein light chain Tctex-type 3,18419,1587,1.01 [0.91-1.12],0.8861667313347765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,21104,1848,1.02 [0.98-1.07],0.3444129065416083
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EBI3_IL27,Interleukin-27,21448,1875,1.06 [0.93-1.21],0.3855765656772024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECE1,Endothelin-converting enzyme 1,20838,1837,1.06 [0.95-1.19],0.3116722797145093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",18494,1603,1.26 [1.19-1.33],5.150013950349291e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHS1,"Enoyl-CoA hydratase, mitochondrial",17992,1559,1.14 [1.09-1.20],2.130906787763486e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECI2,Enoyl-CoA delta isomerase 2,17856,1551,1.12 [1.05-1.20],0.0011261232352889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECM1,Extracellular matrix protein 1,18037,1568,1.01 [0.89-1.15],0.8431242159715264
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECSCR,Endothelial cell-specific chemotaxis regulator,17877,1545,0.90 [0.80-1.01],0.0613674807433323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,21472,1876,1.39 [1.25-1.55],1.664949468008948e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDAR,Tumor necrosis factor receptor superfamily member EDAR,21282,1863,0.93 [0.89-0.97],0.0017746060397833
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDDM3B,Epididymal secretory protein E3-beta,18419,1587,1.02 [0.94-1.10],0.7085518963041315
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,17856,1551,1.07 [0.93-1.23],0.3450720949339808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDF1,Endothelial differentiation-related factor 1,18454,1594,1.02 [0.95-1.09],0.657334151307079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,20906,1832,1.44 [1.31-1.58],3.0400917572590486e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDN1,Endothelin-1,17992,1559,2.09 [1.79-2.45],6.817887864573586e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDNRB,Endothelin receptor type B,17944,1562,1.00 [0.88-1.13],0.961443380635904
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EEF1D,Elongation factor 1-delta,18494,1603,1.09 [1.03-1.14],0.0011230131249245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFCAB14,EF-hand calcium-binding domain-containing protein 14,18435,1602,1.38 [1.16-1.64],0.0003221433300601
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFCAB2,Dynein regulatory complex protein 8,18165,1571,0.95 [0.83-1.09],0.4467444298203422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,21359,1861,1.45 [1.28-1.65],1.1604234946054592e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFHD1,EF-hand domain-containing protein D1,18454,1594,1.12 [0.98-1.28],0.0981543162827845
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA1,Ephrin-A1,21263,1858,1.73 [1.50-1.99],1.6698148874377204e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA4,Ephrin-A4,21064,1844,1.64 [1.45-1.85],2.5360025392767626e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNB2,Ephrin-B2,18001,1566,0.98 [0.91-1.07],0.7122924808329192
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGF,Pro-epidermal growth factor,21230,1857,1.02 [0.98-1.06],0.3342316477018164
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,20784,1814,1.34 [1.20-1.48],7.226170269304914e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFLAM,Pikachurin,18435,1602,1.31 [1.12-1.52],0.000588413803413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFR,Epidermal growth factor receptor,21556,1882,0.44 [0.34-0.56],1.4448673519075063e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGLN1,Egl nine homolog 1,21282,1863,1.17 [1.11-1.24],7.3609377546572706e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EHBP1,EH domain-binding protein 1,18494,1603,1.05 [0.99-1.12],0.1025567519636549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EHD3,EH domain-containing protein 3,17992,1559,1.01 [0.97-1.05],0.6409953001827482
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",18446,1599,0.94 [0.86-1.03],0.1866093688641749
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",18362,1594,1.06 [1.01-1.10],0.0093259291375821
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,17856,1551,1.06 [0.98-1.14],0.1359146055982013
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,17992,1559,0.95 [0.83-1.08],0.3933367581944945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4B,Eukaryotic translation initiation factor 4B,21104,1848,0.99 [0.92-1.07],0.8349598825719402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4E,Eukaryotic translation initiation factor 4E,17944,1562,1.05 [0.99-1.10],0.0948562627017103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,21289,1860,1.15 [1.09-1.23],4.190329734937211e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,21543,1879,1.06 [1.01-1.10],0.0105851246257454
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,18454,1594,1.07 [0.99-1.14],0.0805507012234952
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF5,Eukaryotic translation initiation factor 5,17856,1551,1.04 [0.92-1.17],0.5408322022476306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF5A,Eukaryotic translation initiation factor 5A-1,20914,1833,0.92 [0.80-1.05],0.2104961801457181
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELAC1,Zinc phosphodiesterase ELAC protein 1,18454,1594,1.00 [0.94-1.05],0.876252119234818
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELAVL4,ELAV-like protein 4,17877,1545,1.07 [1.01-1.14],0.0165749329519597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELN,Elastin,18494,1603,1.39 [1.21-1.60],3.114330645074164e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELOA,Elongin-A,21186,1853,1.12 [1.05-1.20],0.0003238414844521
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELOB,Elongin-B,17856,1551,1.04 [0.91-1.18],0.5689282090624568
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENAH,Protein enabled homolog,20914,1833,1.15 [1.06-1.26],0.0012999950475586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENDOU,Poly(U)-specific endoribonuclease,17070,1465,0.85 [0.78-0.94],0.0008241957271737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENG,Endoglin,21556,1882,1.37 [1.09-1.74],0.0081771166107583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO1,Alpha-enolase,21278,1856,1.03 [0.98-1.09],0.2418721466030877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO2,Gamma-enolase,21484,1876,1.01 [0.95-1.08],0.6673709401662271
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO3,Beta-enolase,17992,1559,0.90 [0.83-0.98],0.0121118452915718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENOPH1,Enolase-phosphatase E1,18419,1587,0.88 [0.79-0.99],0.0311246881128643
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,17856,1551,1.05 [0.89-1.24],0.5648337159257815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPEP,Glutamyl aminopeptidase,17856,1551,1.18 [1.07-1.30],0.0010506803995156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,21556,1882,1.29 [1.09-1.52],0.0027038098744809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,21367,1868,0.79 [0.73-0.85],1.695822192445541e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,17992,1559,0.89 [0.78-1.02],0.1057826779721118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,20647,1804,1.22 [1.16-1.28],4.566957854157812e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENSA,Alpha-endosulfine,18419,1587,1.03 [0.94-1.13],0.4974809431245733
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,20784,1814,1.21 [1.10-1.33],4.734962329870297e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,20906,1832,1.05 [0.87-1.28],0.590827828018309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,20906,1832,1.27 [1.08-1.49],0.0032836884807681
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTR1,Endosome-associated-trafficking regulator 1,17992,1559,1.09 [1.01-1.17],0.0251196532596251
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EP300,Histone acetyltransferase p300,17944,1562,1.02 [0.89-1.17],0.7572442985410035
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPB41L5,Band 4.1-like protein 5,18001,1566,1.04 [0.97-1.11],0.2671423205813496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPCAM,Epithelial cell adhesion molecule,21256,1859,1.05 [1.00-1.09],0.0567841347882557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPGN,Epigen,18419,1587,1.06 [0.95-1.19],0.2878860778846865
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA1,Ephrin type-A receptor 1,21327,1864,1.12 [0.98-1.27],0.0875100628499009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA10,Ephrin type-A receptor 10,20838,1837,1.04 [0.98-1.10],0.2232332702894417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA2,Ephrin type-A receptor 2,20504,1782,1.47 [1.29-1.68],5.125641405220269e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA4,Ephrin type-A receptor 4,18077,1558,0.73 [0.62-0.87],0.0002735850470827
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB4,Ephrin type-B receptor 4,21556,1882,1.41 [1.20-1.66],2.37741017279423e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB6,Ephrin type-B receptor 6,21075,1846,1.08 [0.95-1.23],0.257938801067234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHX2,Bifunctional epoxide hydrolase 2,20906,1832,1.05 [0.98-1.12],0.1693081355736235
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPN1,Epsin-1,18165,1571,1.04 [0.92-1.17],0.5702291148600617
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPO,Erythropoietin,21282,1863,1.10 [1.05-1.16],0.0001872667095266
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPPK1,Epiplakin,17992,1559,1.08 [1.01-1.14],0.01424925886073
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,21439,1873,1.50 [1.32-1.70],5.895328436939694e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB2,Receptor tyrosine-protein kinase erbB-2,21352,1860,1.75 [1.49-2.07],2.809173002572884e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB3,Receptor tyrosine-protein kinase erbB-3,21178,1853,1.50 [1.22-1.84],0.0001334244176977
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB4,Receptor tyrosine-protein kinase erbB-4,21352,1860,1.01 [0.86-1.18],0.9457826706750287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBIN,Erbin,21186,1853,1.01 [0.97-1.05],0.6190002346799169
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERC2,ERC protein 2,18001,1566,1.02 [0.96-1.09],0.4882789404596789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERCC1,DNA excision repair protein ERCC-1,17841,1543,0.88 [0.76-1.03],0.1166100336870143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EREG,Proepiregulin,21075,1846,1.01 [0.96-1.06],0.6565050702319858
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERI1,3'-5' exoribonuclease 1,18165,1571,1.27 [1.12-1.44],0.0002417921588029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERMAP,Erythroid membrane-associated protein,17944,1562,1.04 [0.94-1.16],0.4617425078251891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,18419,1587,1.04 [0.92-1.19],0.5146965864358037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERP29,Endoplasmic reticulum resident protein 29,18077,1558,1.02 [0.98-1.06],0.2939298478290139
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERP44,Endoplasmic reticulum resident protein 44,21156,1849,1.09 [0.93-1.28],0.2750373878876715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,17856,1551,0.97 [0.87-1.09],0.6461137835423271
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESAM,Endothelial cell-selective adhesion molecule,21556,1882,1.17 [1.03-1.32],0.0151565498728138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESM1,Endothelial cell-specific molecule 1,21262,1860,1.00 [0.88-1.12],0.934770493908378
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESPL1,Separin,17841,1543,1.00 [0.90-1.11],0.9656399281027896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESR1,Estrogen receptor,17944,1562,0.93 [0.84-1.04],0.1907623601104671
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESYT2,Extended synaptotagmin-2,18446,1599,1.05 [0.99-1.11],0.131739446243067
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EVI2B,Protein EVI2B,17841,1543,1.00 [0.88-1.13],0.946279541784016
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EVI5,Ecotropic viral integration site 5 protein homolog,17944,1562,1.02 [0.96-1.07],0.5559024550757974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EVPL,Envoplakin,18165,1571,0.94 [0.80-1.10],0.4440891982594963
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EXOSC10,Exosome component 10,17856,1551,1.04 [0.96-1.13],0.309173239261409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EXTL1,Exostosin-like 1,17856,1551,0.82 [0.72-0.92],0.0010926054919345
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EZR,Ezrin,21484,1876,1.48 [1.27-1.72],4.98361945863919e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F10,Coagulation factor X,18509,1603,1.19 [0.98-1.44],0.0734292325919862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F11,Coagulation factor XI,18260,1594,0.93 [0.79-1.09],0.3601788460218751
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F11R,Junctional adhesion molecule A,21302,1865,1.13 [1.05-1.22],0.0007324082631597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F12,Coagulation factor XII,18511,1612,1.17 [1.04-1.31],0.0079384260738105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F13B,Coagulation factor XIII B chain,18425,1606,1.26 [1.05-1.51],0.0131562224287181
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F2,Prothrombin,18511,1612,1.13 [0.82-1.56],0.4447285852112731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F2R,Proteinase-activated receptor 1,21336,1865,1.09 [1.01-1.16],0.0198058805208688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F3,Tissue factor,21334,1863,1.17 [1.00-1.37],0.046186313676336
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F7,Coagulation factor VII,21352,1860,1.09 [0.95-1.25],0.2349865213227124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F9,Coagulation factor IX,21360,1861,1.99 [1.57-2.52],9.531242116824029e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP1,"Fatty acid-binding protein, liver",21262,1860,1.18 [1.14-1.23],4.769192859970308e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",21289,1860,1.08 [1.03-1.14],0.0031851941001519
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP3,"Fatty acid-binding protein, heart",18494,1603,1.21 [1.11-1.32],1.101139333144466e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",21556,1882,1.42 [1.31-1.54],1.1436300237805492e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP5,Fatty acid-binding protein 5,21410,1872,1.15 [1.09-1.22],1.7802970003250555e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP6,Gastrotropin,20875,1829,1.04 [0.97-1.12],0.2751280910334684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP9,Fatty acid-binding protein 9,21282,1863,1.01 [0.93-1.09],0.8461233685769943
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FADD,FAS-associated death domain protein,21289,1860,1.01 [0.96-1.07],0.7085814965840924
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM13A,Protein FAM13A,18435,1602,1.05 [0.98-1.12],0.1801987718869703
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM171A2,Protein FAM171A2,18454,1594,1.05 [1.02-1.08],0.001213103866753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM171B,Protein FAM171B,18419,1587,1.10 [0.93-1.30],0.2798641471722322
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM172A,Cotranscriptional regulator FAM172A,17992,1559,0.97 [0.90-1.05],0.5261273759203664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM20A,Pseudokinase FAM20A,18494,1603,2.03 [1.76-2.34],6.42052920738819e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3B,Protein FAM3B,21186,1853,1.35 [1.20-1.52],6.690515029125384e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3C,Protein FAM3C,21260,1858,1.44 [1.25-1.65],2.927539378246036e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3D,Protein FAM3D,18435,1602,1.09 [1.03-1.15],0.003614097147278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAP,Prolyl endopeptidase FAP,21556,1882,0.76 [0.65-0.88],0.0002752140209449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FARSA,Phenylalanine--tRNA ligase alpha subunit,18001,1566,0.98 [0.91-1.06],0.6832705938512688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAS,Tumor necrosis factor receptor superfamily member 6,21480,1875,1.10 [0.98-1.24],0.1183664081134009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FASLG,Tumor necrosis factor ligand superfamily member 6,21543,1879,0.75 [0.68-0.83],2.1466382211993644e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBLN2,Fibulin-2,18498,1605,1.02 [0.88-1.18],0.7889611600128663
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBN2,Fibrillin-2,18001,1566,1.05 [0.97-1.14],0.2055948520217174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBP1,"Fructose-1,6-bisphosphatase 1",21289,1860,1.10 [1.04-1.17],0.0004338760347192
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,18494,1603,0.98 [0.91-1.04],0.4774136304025349
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAR,Immunoglobulin alpha Fc receptor,21282,1863,1.19 [1.10-1.30],5.4794457584795634e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,18454,1594,1.22 [0.99-1.50],0.0686851803405573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCER2,Low affinity immunoglobulin epsilon Fc receptor,21302,1865,0.98 [0.90-1.06],0.5458658421007152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,21214,1850,1.02 [0.95-1.09],0.5953380130759159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,20784,1814,1.04 [0.97-1.11],0.2873456873712299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,21321,1857,1.10 [1.01-1.20],0.021607427701792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN1,Ficolin-1,18480,1603,1.41 [1.28-1.54],1.3448471618544e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN2,Ficolin-2,21213,1856,1.15 [1.03-1.27],0.0104642935739485
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL1,Fc receptor-like protein 1,21289,1860,0.89 [0.81-0.98],0.0136531345754727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL2,Fc receptor-like protein 2,21443,1870,1.08 [0.99-1.17],0.0828002292418666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL3,Fc receptor-like protein 3,20914,1833,0.96 [0.89-1.04],0.3108313159933081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL5,Fc receptor-like protein 5,21302,1865,1.09 [1.02-1.17],0.0122168443496891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL6,Fc receptor-like protein 6,21282,1863,0.99 [0.93-1.05],0.6556440394393744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRLB,Fc receptor-like B,20784,1814,1.18 [1.10-1.25],4.361862098445488e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FDX1,"Adrenodoxin, mitochondrial",17856,1551,1.05 [0.97-1.13],0.2075823637661396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FDX2,"Ferredoxin-2, mitochondrial",17856,1551,1.05 [0.97-1.15],0.2365060242384992
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FEN1,Flap endonuclease 1,20784,1814,1.05 [0.99-1.11],0.0759012170268163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FES,Tyrosine-protein kinase Fes/Fps,20784,1814,0.96 [0.88-1.05],0.3455361858180922
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FETUB,Fetuin-B,21360,1861,0.91 [0.80-1.04],0.182925370798881
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGA,Fibrinogen alpha chain,18100,1579,1.65 [1.41-1.93],2.9499321277154863e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",18454,1594,1.03 [0.97-1.09],0.3813072057717835
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF12,Fibroblast growth factor 12,17944,1562,1.07 [0.96-1.18],0.2156342768853767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF16,Fibroblast growth factor 16,17944,1562,0.91 [0.81-1.03],0.126364047765273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF19,Fibroblast growth factor 19,21367,1868,1.10 [1.05-1.16],0.0003537520190957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF2,Fibroblast growth factor 2,21282,1863,1.11 [1.04-1.17],0.0005282215979395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF20,Fibroblast growth factor 20,17944,1562,1.01 [0.90-1.13],0.8292937618898311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF21,Fibroblast growth factor 21,21448,1875,1.24 [1.21-1.28],2.222465660101435e-50
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF23,Fibroblast growth factor 23,21433,1872,1.30 [1.22-1.39],3.9339001466816695e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF3,Fibroblast growth factor 3,17944,1562,0.90 [0.76-1.07],0.2198216655765698
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF5,Fibroblast growth factor 5,20914,1833,1.28 [1.13-1.45],6.105854408007679e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF6,Fibroblast growth factor 6,17944,1562,1.01 [0.89-1.14],0.9138598332671122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF7,Fibroblast growth factor 7,17841,1543,1.06 [1.00-1.12],0.0485385735423993
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF9,Fibroblast growth factor 9,17810,1538,1.04 [0.91-1.17],0.575576360525738
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP1,Fibroblast growth factor-binding protein 1,21352,1860,0.79 [0.71-0.89],6.077750580450361e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP2,Fibroblast growth factor-binding protein 2,18498,1605,0.93 [0.85-1.01],0.0907996934269192
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP3,Fibroblast growth factor-binding protein 3,18446,1599,0.94 [0.82-1.06],0.3117147932182355
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,21352,1860,1.93 [1.61-2.31],1.6642824732183982e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR4,Fibroblast growth factor receptor 4,18077,1558,0.93 [0.85-1.02],0.142170797968851
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGL1,Fibrinogen-like protein 1,18509,1603,1.36 [1.27-1.46],3.4234819349577705e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGR,Tyrosine-protein kinase Fgr,20838,1837,1.09 [1.03-1.16],0.0035747153083043
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FH,"Fumarate hydratase, mitochondrial",17877,1545,1.00 [0.94-1.06],0.9985342524093728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FHIP2A,FHF complex subunit HOOK interacting protein 2A,17856,1551,1.01 [0.92-1.11],0.8399027205492106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FHIT,Bis(5'-adenosyl)-triphosphatase,20838,1837,1.03 [0.97-1.09],0.3605937690918493
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FIS1,Mitochondrial fission 1 protein,21253,1858,1.12 [1.06-1.18],1.764531988104242e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,18454,1594,1.05 [1.00-1.10],0.0359172743711344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,21368,1857,0.98 [0.95-1.02],0.2832668184117195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,21104,1848,1.17 [1.06-1.30],0.0017087804485596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,21104,1848,1.06 [1.01-1.11],0.0121795400175806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,20809,1835,1.06 [0.98-1.15],0.1693069039530098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBPL,FK506-binding protein-like,18435,1602,1.06 [0.98-1.15],0.1623626349571464
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLI1,Friend leukemia integration 1 transcription factor,20784,1814,1.02 [0.98-1.05],0.4150398015182892
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,21104,1848,1.11 [0.96-1.29],0.1514139641529263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT1,Vascular endothelial growth factor receptor 1,21146,1850,1.32 [1.09-1.59],0.0040126874937323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT3,Receptor-type tyrosine-protein kinase FLT3,20784,1814,0.85 [0.73-0.97],0.0192078746714297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT3LG,Fms-related tyrosine kinase 3 ligand,21543,1879,1.09 [0.97-1.22],0.1639376240492114
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT4,Vascular endothelial growth factor receptor 3,21352,1860,1.04 [0.93-1.17],0.5137177474099689
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FMNL1,Formin-like protein 1,20838,1837,1.07 [1.01-1.13],0.0218661867182805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FMR1,Synaptic functional regulator FMR1,20784,1814,1.01 [0.90-1.14],0.8224818684234755
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FN1,Fibronectin,18511,1612,1.21 [1.01-1.44],0.0419486431555755
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FNDC1,Fibronectin type III domain-containing protein 1,18446,1599,1.12 [1.01-1.25],0.0248534883737455
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,18419,1587,1.12 [0.98-1.28],0.0945572029765627
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLH1,Glutamate carboxypeptidase 2,17944,1562,1.00 [0.94-1.07],0.9201266626803096
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR1,Folate receptor alpha,21272,1850,1.18 [1.03-1.35],0.0202830329064299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR2,Folate receptor beta,21484,1876,1.30 [1.13-1.49],0.000179357911023
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR3,Folate receptor gamma,21290,1857,1.00 [0.98-1.02],0.9893627525100456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOS,Proto-oncogene c-Fos,17810,1538,1.13 [0.98-1.30],0.0844337265290691
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOSB,Protein fosB,20838,1837,1.00 [0.91-1.11],0.9542690726223956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXJ3,Forkhead box protein J3,17944,1562,1.00 [0.90-1.11],0.9791386316228629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXO1,Forkhead box protein O1,21282,1863,1.03 [0.98-1.08],0.287769305915322
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXO3,Forkhead box protein O3,20784,1814,1.04 [0.99-1.08],0.1150423957366612
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FRMD4B,FERM domain-containing protein 4B,17856,1551,1.03 [0.96-1.11],0.3576439861424169
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FRMD7,FERM domain-containing protein 7,18001,1566,0.99 [0.85-1.15],0.8787791551979846
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FRZB,Secreted frizzled-related protein 3,21035,1840,1.01 [0.86-1.18],0.8964712560678288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSHB,Follitropin subunit beta,17992,1559,1.01 [0.89-1.14],0.8779136321485902
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FST,Follistatin,21336,1865,1.29 [1.19-1.40],8.126154594804264e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL1,Follistatin-related protein 1,17992,1559,1.93 [1.56-2.38],1.0109034943845634e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL3,Follistatin-related protein 3,21234,1859,2.00 [1.78-2.26],5.7320351072475696e-30
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FTCD,Formimidoyltransferase-cyclodeaminase,18407,1597,1.10 [1.05-1.16],0.0002209688694763
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUCA1,Tissue alpha-L-fucosidase,21415,1871,1.03 [0.98-1.08],0.2547130285128268
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUOM,Fucose mutarotase,18077,1558,1.18 [1.10-1.28],1.765143546141388e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FURIN,Furin,21352,1860,1.49 [1.32-1.68],4.6671324327282766e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUS,RNA-binding protein FUS,20745,1810,1.19 [1.08-1.31],0.000596873538389
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",18135,1569,1.00 [0.93-1.08],0.9458398980777836
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,21484,1876,1.46 [1.34-1.59],5.73592040288285e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT8,"Alpha-(1,6)-fucosyltransferase",21104,1848,1.02 [0.95-1.09],0.6442707447807762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FXN,"Frataxin, mitochondrial",21472,1876,1.04 [0.98-1.10],0.1756725966565561
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FXYD5,FXYD domain-containing ion transport regulator 5,20914,1833,1.01 [0.95-1.08],0.7092208583926776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FYB1,FYN-binding protein 1,21265,1862,1.02 [0.97-1.07],0.4042648949854083
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FZD10,Frizzled-10,18001,1566,1.05 [0.96-1.14],0.3053142628138146
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FZD8,Frizzled-8,17877,1545,1.07 [0.95-1.20],0.2826953969231964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GABARAP,Gamma-aminobutyric acid receptor-associated protein,18419,1587,1.03 [0.93-1.14],0.6002731994694503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,18165,1571,0.95 [0.87-1.03],0.225195441192734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,17877,1545,1.04 [0.97-1.13],0.2781489476775858
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAD1,Glutamate decarboxylase 1,17841,1543,1.04 [0.86-1.26],0.7091965012519531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAD2,Glutamate decarboxylase 2,17944,1562,1.00 [0.91-1.10],0.984334085812266
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,18165,1571,1.02 [0.92-1.12],0.7308176653528469
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,17992,1559,1.12 [1.02-1.22],0.015028064912165
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAGE2A,G antigen 2A,17841,1543,0.99 [0.91-1.08],0.890070629321359
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAL,Galanin peptides,21367,1868,0.86 [0.81-0.92],2.157813314567233e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,21186,1853,1.65 [1.43-1.91],6.7875420023001755e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,21472,1876,0.69 [0.60-0.81],2.817501845661146e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,20914,1833,0.91 [0.83-1.00],0.0622794928595791
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,18494,1603,1.24 [1.05-1.48],0.0130329455951033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT7,N-acetylgalactosaminyltransferase 7,21186,1853,0.87 [0.71-1.06],0.1600939784218081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAMT,Guanidinoacetate N-methyltransferase,17856,1551,1.01 [0.88-1.16],0.8906447438439397
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,17677,1530,1.31 [1.09-1.57],0.0036283027318575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GART,Trifunctional purine biosynthetic protein adenosine-3,18454,1594,0.96 [0.78-1.17],0.6790855381984986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAS2,Growth arrest-specific protein 2,18165,1571,1.05 [0.96-1.14],0.2893277594162715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAS6,Growth arrest-specific protein 6,21422,1870,1.60 [1.36-1.89],1.05820535588202e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GASK1A,Golgi-associated kinase 1A,17856,1551,0.89 [0.79-1.00],0.0509899233797772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAST,Gastrin,18446,1599,1.14 [1.10-1.18],3.4151348196417936e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,17841,1543,1.03 [0.86-1.24],0.7290122881752636
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",17992,1559,1.04 [0.97-1.11],0.261292254907008
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBA,Lysosomal acid glucosylceramidase,18001,1566,1.07 [0.98-1.17],0.1479107695915085
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP1,Guanylate-binding protein 1,18412,1597,1.16 [1.07-1.25],0.000178848737483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP2,Guanylate-binding protein 2,20914,1833,1.01 [0.94-1.09],0.7544995564170881
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP4,Guanylate-binding protein 4,20838,1837,1.01 [0.92-1.10],0.8721277146208303
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP6,Guanylate-binding protein 6,17856,1551,1.02 [0.92-1.14],0.6808331179899958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GC,Vitamin D-binding protein,18511,1612,1.10 [0.91-1.32],0.3131966859264511
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCC1,GRIP and coiled-coil domain-containing protein 1,18446,1599,1.03 [0.99-1.08],0.1522772051325722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCG,Pro-glucagon,20784,1814,1.02 [0.99-1.06],0.1365127620668343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,17628,1527,1.35 [1.25-1.46],1.549766576946533e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCLM,Glutamate--cysteine ligase regulatory subunit,17856,1551,1.02 [0.92-1.14],0.659641657684126
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",21186,1853,1.20 [1.06-1.35],0.0032922336401611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF15,Growth/differentiation factor 15,21556,1882,1.87 [1.74-2.01],3.3794484203003573e-65
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF2,Growth/differentiation factor 2,21289,1860,1.20 [1.07-1.34],0.0022156574831903
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDNF,Glial cell line-derived neurotrophic factor,20838,1837,1.14 [1.02-1.28],0.0186575859278052
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GET3,ATPase GET3,18494,1603,1.02 [0.94-1.11],0.6071725268155201
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFAP,Glial fibrillary acidic protein,20750,1810,1.07 [0.97-1.17],0.1721827102076602
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFER,FAD-linked sulfhydryl oxidase ALR,20784,1814,1.20 [1.12-1.27],1.5771202576534942e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,20784,1814,1.03 [0.99-1.06],0.1141483846347108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA1,GDNF family receptor alpha-1,21448,1875,1.76 [1.52-2.03],1.0407044916291436e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA2,GDNF family receptor alpha-2,21186,1853,1.06 [0.87-1.29],0.5707454698968895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA3,GDNF family receptor alpha-3,21040,1845,0.82 [0.71-0.96],0.0133532114568302
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRAL,GDNF family receptor alpha-like,17928,1551,0.79 [0.73-0.86],3.778159743738788e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGA1,ADP-ribosylation factor-binding protein GGA1,20838,1837,1.01 [0.95-1.08],0.693126045774866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGACT,Gamma-glutamylaminecyclotransferase,18494,1603,1.00 [0.94-1.07],0.9918769355965952
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGCT,Gamma-glutamylcyclotransferase,18464,1600,1.00 [0.91-1.10],0.9991489568325616
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGH,Gamma-glutamyl hydrolase,20937,1828,1.19 [1.06-1.35],0.0037685807699841
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,21263,1858,1.52 [1.41-1.63],4.233668379514344e-30
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,21104,1848,1.82 [1.55-2.14],6.078900160340499e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GH1,Somatotropin,21260,1858,1.01 [0.98-1.03],0.5655617376089106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GH2,Growth hormone variant,20784,1814,1.00 [0.98-1.03],0.8248113412994768
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHR,Growth hormone receptor,18077,1558,0.77 [0.65-0.90],0.001497889050222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHRHR,Growth hormone-releasing hormone receptor,20838,1837,0.99 [0.91-1.08],0.8068241977233976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHRL,Appetite-regulating hormone,21289,1860,1.06 [1.01-1.12],0.0198119372165588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GID8,Glucose-induced degradation protein 8 homolog,18454,1594,1.04 [0.90-1.20],0.6254873031351017
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIGYF2,GRB10-interacting GYF protein 2,18454,1594,1.08 [1.02-1.15],0.0142539002572882
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIMAP7,GTPase IMAP family member 7,18077,1558,1.08 [0.96-1.23],0.2136413793837722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIMAP8,GTPase IMAP family member 8,17841,1543,1.14 [1.05-1.25],0.0028179774627736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIP,Gastric inhibitory polypeptide,17992,1559,1.08 [0.99-1.19],0.0892342606721207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,18446,1599,1.54 [1.34-1.77],2.007598310378864e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPC3,PDZ domain-containing protein GIPC3,18435,1602,1.02 [0.98-1.07],0.3468681677340015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPR,Gastric inhibitory polypeptide receptor,17944,1562,1.07 [0.96-1.19],0.2304284108616734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIT1,ARF GTPase-activating protein GIT1,17944,1562,1.02 [0.97-1.07],0.4662623860981969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GJA8,Gap junction alpha-8 protein,17841,1543,1.01 [0.92-1.10],0.8886712423545573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GKN1,Gastrokine-1,20455,1792,1.33 [1.13-1.55],0.0004506611916148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLA,Alpha-galactosidase A,18046,1554,1.32 [1.17-1.50],8.852766531778585e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLB1,Beta-galactosidase,21104,1848,1.21 [1.11-1.33],4.760923898999434e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLI2,Zinc finger protein GLI2,17944,1562,1.01 [0.85-1.21],0.8854757293580275
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLO1,Lactoylglutathione lyase,20906,1832,1.22 [1.14-1.32],3.0870429410318184e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLOD4,Glyoxalase domain-containing protein 4,21222,1855,1.08 [0.95-1.21],0.2306248655733251
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLP1R,Glucagon-like peptide 1 receptor,17877,1545,1.04 [0.91-1.19],0.5827726297167107
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLRX,Glutaredoxin-1,21155,1849,1.07 [1.00-1.15],0.0631339887946448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",18077,1558,1.06 [1.01-1.12],0.0199732173469335
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,20838,1837,0.97 [0.88-1.07],0.488797193627728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLYR1,Putative oxidoreductase GLYR1,18419,1587,1.02 [0.94-1.11],0.6442179029238246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GM2A,Ganglioside GM2 activator,18049,1563,1.32 [1.16-1.51],3.1370733896826285e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GMFG,Glia maturation factor gamma,18494,1603,1.02 [0.95-1.08],0.6456557810446453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GMPR,GMP reductase 1,21543,1879,0.98 [0.90-1.07],0.6867052646660083
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GMPR2,GMP reductase 2,18077,1558,1.01 [0.94-1.08],0.8532711838902509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNAS,Neuroendocrine secretory protein 55,18454,1594,1.05 [1.00-1.11],0.056482906447551
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,20784,1814,1.07 [1.01-1.14],0.0323932222623503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,18001,1566,0.93 [0.83-1.04],0.186888094159054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNLY,Granulysin,21302,1865,1.06 [0.98-1.14],0.1263799870809161
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNPDA1,Glucosamine-6-phosphate isomerase 1,17992,1559,1.04 [0.92-1.19],0.5050820823825961
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNPDA2,Glucosamine-6-phosphate isomerase 2,18077,1558,0.89 [0.78-1.01],0.0783653771724147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOLGA3,Golgin subfamily A member 3,18454,1594,1.04 [0.98-1.11],0.1610821067262904
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOLM2,Protein GOLM2,21484,1876,1.75 [1.45-2.10],3.1757904231089063e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,21282,1863,1.01 [0.97-1.05],0.7903501382704237
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GORASP2,Golgi reassembly-stacking protein 2,18435,1602,0.98 [0.88-1.08],0.6644921457477715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOT1,"Aspartate aminotransferase, cytoplasmic",18498,1605,1.08 [0.97-1.20],0.173538207057479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP1BA,Platelet glycoprotein Ib alpha chain,21220,1852,1.03 [0.91-1.17],0.6432046990411298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP1BB,Platelet glycoprotein Ib beta chain,17856,1551,1.05 [0.98-1.13],0.1470934211026184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,20631,1814,1.02 [0.97-1.07],0.4895816922798889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP5,Platelet glycoprotein V,18077,1558,1.00 [0.88-1.14],0.9415379067162978
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP6,Platelet glycoprotein VI,21265,1862,1.02 [0.98-1.07],0.3775233042495063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPA33,Cell surface A33 antigen,21186,1853,1.01 [0.98-1.04],0.4619849816117399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPC1,Glypican-1,21472,1876,0.84 [0.72-0.96],0.0127847310630195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPC5,Glypican-5,21104,1848,0.86 [0.80-0.92],4.243432110470191e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPD1,Glycerol-3-phosphate dehydrogenase,18419,1587,1.29 [1.19-1.41],2.117589489337127e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPHA2,Glycoprotein hormone alpha-2,18435,1602,0.97 [0.86-1.09],0.5935462661311351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPI,Glucose-6-phosphate isomerase,18509,1603,1.11 [1.01-1.22],0.023116850777088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,18435,1602,0.97 [0.91-1.03],0.3530264172806923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPKOW,G-patch domain and KOW motifs-containing protein,20838,1837,1.34 [1.20-1.49],1.6309334394948284e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPNMB,Transmembrane glycoprotein NMB,20713,1814,1.16 [1.00-1.34],0.0514061655213516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR101,Probable G-protein coupled receptor 101,17877,1545,1.00 [0.92-1.09],0.9606593820840548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR158,Probable G-protein coupled receptor 158,18454,1594,1.04 [0.90-1.20],0.6275007739809291
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR15L,Protein GPR15L,18435,1602,1.14 [1.06-1.23],0.0004243374481
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR37,Prosaposin receptor GPR37,20906,1832,1.28 [1.20-1.37],1.1121950813652836e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,18419,1587,1.34 [1.25-1.45],2.87216090188439e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRAP2,GRB2-related adapter protein 2,21289,1860,1.00 [0.97-1.03],0.90666512121141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,18494,1603,1.07 [0.99-1.15],0.0973665642567131
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRIK2,"Glutamate receptor ionotropic, kainate 2",18454,1594,0.90 [0.80-1.02],0.1018771841481161
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",17877,1545,0.99 [0.91-1.09],0.8876827430605441
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRK5,G protein-coupled receptor kinase 5,20906,1832,1.08 [1.00-1.17],0.0459659467190035
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRN,Progranulin,21191,1854,1.71 [1.47-2.00],1.0394122934355395e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRP,Gastrin-releasing peptide,17992,1559,1.15 [1.05-1.25],0.0023297146126782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",21186,1853,1.36 [1.28-1.44],3.4102852617392656e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRSF1,G-rich sequence factor 1,17745,1531,1.00 [0.94-1.07],0.9933116847183848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSAP,Gamma-secretase-activating protein,20784,1814,1.04 [0.99-1.08],0.1195361108748385
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSN,Gelsolin,18433,1597,0.47 [0.36-0.61],1.1036694050966376e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSR,"Glutathione reductase, mitochondrial",18414,1596,1.25 [1.01-1.54],0.0389357478776579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTA1,Glutathione S-transferase A1,21257,1856,1.06 [1.01-1.11],0.0256679367497678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTA3,Glutathione S-transferase A3,20784,1814,1.02 [0.97-1.08],0.3942515005649993
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTM4,Glutathione S-transferase Mu 4,17856,1551,1.06 [1.00-1.13],0.0552402145078365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTP1,Glutathione S-transferase P,20703,1825,0.99 [0.92-1.05],0.6727359623000637
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTT2B,Glutathione S-transferase theta-2B,18446,1599,1.02 [1.00-1.04],0.0786834433219309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,18165,1571,1.09 [1.02-1.16],0.0101490075160007
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GTPBP2,GTP-binding protein 2,18001,1566,1.00 [0.94-1.06],0.9359169421880952
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUCA2A,Guanylin,21191,1857,1.24 [1.10-1.40],0.0003674805408862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUCY2C,Heat-stable enterotoxin receptor,18165,1571,1.04 [0.98-1.11],0.2002081102545457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUK1,Guanylate kinase,17856,1551,1.01 [0.90-1.13],0.9128970108286492
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUSB,Beta-glucuronidase,21379,1864,1.19 [1.11-1.27],5.618940256335535e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GYS1,"Glycogen [starch] synthase, muscle",20906,1832,1.03 [0.98-1.07],0.2387394811282517
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GZMA,Granzyme A,21543,1879,0.93 [0.82-1.04],0.2119408106963309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GZMB,Granzyme B,21282,1863,0.96 [0.90-1.02],0.1532159358735101
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GZMH,Granzyme H,20906,1832,1.01 [0.96-1.07],0.6286458226593545
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",H2AP,Huntingtin-interacting protein M,17841,1543,0.95 [0.85-1.07],0.397565389104637
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",17856,1551,0.96 [0.89-1.04],0.2890175920592962
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",21418,1871,1.02 [0.97-1.09],0.4125769128777673
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAO1,Hydroxyacid oxidase 1,21472,1876,1.10 [1.06-1.13],2.3655327809943092e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HARS1,"Histidine--tRNA ligase, cytoplasmic",21302,1865,1.03 [0.98-1.09],0.2075415852014252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,21442,1872,1.38 [1.30-1.46],6.207107131494159e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,21302,1865,1.60 [1.43-1.79],5.455832177574557e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HBEGF,Proheparin-binding EGF-like growth factor,21418,1871,0.94 [0.89-1.00],0.0404365859730975
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HBQ1,Hemoglobin subunit theta-1,21472,1876,0.96 [0.89-1.03],0.2321164609611849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HBZ,Hemoglobin subunit zeta,18494,1603,1.00 [0.96-1.05],0.917685590584677
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HCG22,Protein PBMUCL2,17856,1551,1.01 [0.91-1.11],0.8928208462609198
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HCLS1,Hematopoietic lineage cell-specific protein,21543,1879,1.07 [1.00-1.16],0.0579865174640278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDAC8,Histone deacetylase 8,17944,1562,1.01 [0.91-1.11],0.892803562392425
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDAC9,Histone deacetylase 9,17877,1545,1.03 [0.96-1.12],0.4106946223321197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDDC2,5'-deoxynucleotidase HDDC2,18435,1602,0.94 [0.85-1.05],0.2909978552508551
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDGF,Hepatoma-derived growth factor,21439,1874,1.03 [0.99-1.08],0.150669702931878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDGFL2,Hepatoma-derived growth factor-related protein 2,18446,1599,1.07 [0.99-1.15],0.0810292321776242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEBP1,Heme-binding protein 1,20906,1832,1.03 [0.95-1.11],0.523447827469721
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEG1,Protein HEG homolog 1,18077,1558,1.79 [1.52-2.12],7.247215872842079e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEPACAM2,HEPACAM family member 2,18446,1599,0.91 [0.81-1.01],0.0754717607074392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEPH,Hephaestin,18494,1603,1.37 [1.14-1.65],0.0006717331975234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEXIM1,Protein HEXIM1,21282,1863,1.05 [0.99-1.10],0.0864772631789086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGF,Hepatocyte growth factor,21543,1879,1.74 [1.57-1.94],7.148981022630269e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGFAC,Hepatocyte growth factor activator,18354,1592,1.09 [0.91-1.30],0.3654775375445894
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,20784,1814,1.07 [1.01-1.12],0.0149095571185765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HHEX,Hematopoietically-expressed homeobox protein HHEX,18446,1599,1.08 [1.01-1.15],0.0201932124757088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIF1A,Hypoxia-inducible factor 1-alpha,17944,1562,1.02 [0.94-1.09],0.6787154130153674
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1,Huntingtin-interacting protein 1,17856,1551,0.90 [0.78-1.04],0.15112151030064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,18409,1595,1.25 [1.16-1.35],1.242425338952074e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HJV,Hemojuvelin,18454,1594,1.25 [1.12-1.40],6.143881517062138e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HK2,Hexokinase-2,20906,1832,1.03 [0.88-1.20],0.7426499348498696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",18454,1594,1.16 [1.00-1.34],0.0441142593061124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",21215,1854,1.15 [1.03-1.29],0.0138241204455367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",21282,1863,1.37 [1.19-1.58],1.3212876374271651e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMBS,Porphobilinogen deaminase,21472,1876,1.07 [0.96-1.18],0.2240776396983423
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMCN2,Hemicentin-2,18048,1556,0.92 [0.85-1.00],0.0597798565472358
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",17992,1559,1.14 [1.03-1.26],0.0090529016847597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",17856,1551,1.03 [0.92-1.15],0.6526073389432154
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMMR,Hyaluronan mediated motility receptor,17802,1541,0.98 [0.87-1.10],0.7198015957252402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX1,Heme oxygenase 1,21048,1837,1.16 [1.07-1.25],0.000325119071667
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX2,Heme oxygenase 2,20838,1837,1.27 [1.17-1.37],7.484836120686084e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNF1A,Hepatocyte nuclear factor 1-alpha,18001,1566,1.00 [0.94-1.07],0.9105724916298656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNMT,Histamine N-methyltransferase,21009,1839,1.23 [1.13-1.34],1.1188334502838994e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,20832,1829,1.02 [0.97-1.07],0.4559325114138173
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,18454,1594,1.14 [1.04-1.25],0.0065154438982466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPCAL1,Hippocalcin-like protein 1,21543,1879,1.01 [0.96-1.07],0.6426914173146208
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,20784,1814,0.72 [0.64-0.80],3.898432402535657e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPSE,Heparanase,18273,1588,1.11 [1.06-1.17],6.157194081416053e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HRAS,GTPase Hras,18132,1568,0.97 [0.92-1.02],0.2233407567157692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,17992,1559,0.86 [0.75-1.00],0.0497361150306975
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HRG,Histidine-rich glycoprotein,18425,1606,0.93 [0.81-1.07],0.3002647679441643
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS1BP3,HCLS1-binding protein 3,17992,1559,1.02 [0.97-1.07],0.5263749989272227
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,21186,1853,1.31 [1.17-1.46],2.23645668637774e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,21472,1876,1.07 [0.96-1.19],0.2487729933344977
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,17944,1562,0.87 [0.76-1.00],0.0461481483396339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSBP1,Heat shock factor-binding protein 1,17992,1559,0.99 [0.94-1.04],0.7395053949836885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,21282,1863,1.34 [1.22-1.48],2.1624800569974643e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,18446,1599,1.19 [1.10-1.28],2.160408462958214e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD17B3,Testosterone 17-beta-dehydrogenase 3,17856,1551,1.00 [0.91-1.11],0.9618251609813356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,17992,1559,1.06 [0.96-1.17],0.2622316577931384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSP90B1,Endoplasmin,20740,1825,0.99 [0.92-1.06],0.6886879127557126
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPA1A,Heat shock 70 kDa protein 1A,21327,1864,1.06 [1.00-1.12],0.0525418053137513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPA2,Heat shock-related 70 kDa protein 2,18419,1587,1.11 [0.95-1.29],0.1844057372616908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPB1,Heat shock protein beta-1,20955,1830,0.98 [0.93-1.04],0.5271140775183456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPB6,Heat shock protein beta-6,21472,1876,1.16 [1.04-1.28],0.0053983622532241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,21148,1845,1.49 [1.27-1.75],7.362002352043332e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTR1A,5-hydroxytryptamine receptor 1A,17877,1545,0.99 [0.93-1.06],0.7495644845392555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTR1B,5-hydroxytryptamine receptor 1B,17877,1545,0.81 [0.71-0.93],0.0022266775046965
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTRA2,"Serine protease HTRA2, mitochondrial",21352,1860,1.13 [1.06-1.21],0.0002491771899496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYAL1,Hyaluronidase-1,21201,1850,1.69 [1.42-2.01],2.2323530372402198e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYOU1,Hypoxia up-regulated protein 1,21556,1882,1.32 [1.11-1.58],0.0019332261579162
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICA1,Islet cell autoantigen 1,20914,1833,1.04 [0.99-1.09],0.1440321480949858
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM1,Intercellular adhesion molecule 1,21210,1850,2.00 [1.76-2.27],2.546835259984649e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM2,Intercellular adhesion molecule 2,21556,1882,1.08 [0.95-1.22],0.2391428203272277
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM3,Intercellular adhesion molecule 3,21556,1882,1.42 [1.23-1.64],2.957292923993683e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM4,Intercellular adhesion molecule 4,21282,1863,1.02 [0.94-1.10],0.6125757121070352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM5,Intercellular adhesion molecule 5,21289,1860,1.57 [1.44-1.72],1.7765131969065549e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICOSLG,ICOS ligand,21186,1853,0.82 [0.66-1.01],0.0657037853594854
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ID4,DNA-binding protein inhibitor ID-4,18165,1571,1.07 [0.96-1.18],0.2077667764599508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDI2,Isopentenyl-diphosphate delta-isomerase 2,20838,1837,0.97 [0.88-1.06],0.4540194342622187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDO1,"Indoleamine 2,3-dioxygenase 1",17992,1559,0.93 [0.86-1.00],0.0663576990693197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDS,Iduronate 2-sulfatase,21543,1879,1.21 [0.77-1.90],0.414931318590709
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDUA,Alpha-L-iduronidase,21472,1876,1.30 [1.19-1.42],5.927045190403722e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,17992,1562,1.81 [1.61-2.03],2.461732210879028e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,18165,1571,1.05 [0.95-1.16],0.3384178918615078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,18165,1571,1.04 [0.92-1.17],0.5289324718850019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNAR1,Interferon alpha/beta receptor 1,18435,1602,1.05 [0.87-1.27],0.5925827839978279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNG,Interferon gamma,20914,1833,1.05 [1.02-1.09],0.0043265058483933
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR1,Interferon gamma receptor 1,21367,1868,1.23 [1.01-1.49],0.0412922924514633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR2,Interferon gamma receptor 2,21104,1848,1.25 [1.16-1.34],6.0507830628851035e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNL1,Interferon lambda-1,20838,1837,1.07 [0.98-1.16],0.1406249227467779
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNL2,Interferon lambda-2,17877,1545,1.04 [0.97-1.13],0.2829865352647722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNLR1,Interferon lambda receptor 1,21282,1863,1.28 [1.15-1.42],4.28834788638901e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNW1,Interferon omega-1,17856,1551,1.02 [0.90-1.16],0.7321221732949587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFT20,Intraflagellar transport protein 20 homolog,18001,1566,0.98 [0.87-1.11],0.7748825574350283
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGBP1,Immunoglobulin-binding protein 1,18454,1594,1.03 [0.95-1.12],0.4215831034262344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,17877,1545,1.02 [0.92-1.13],0.6510311848078263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,18498,1605,0.63 [0.55-0.72],2.0986448915579057e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF1R,Insulin-like growth factor 1 receptor,21186,1853,1.18 [0.97-1.43],0.0998061026229016
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,17856,1551,0.97 [0.85-1.10],0.61054045794108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF2R,Cation-independent mannose-6-phosphate receptor,21302,1865,1.80 [1.51-2.14],2.059683551656261e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,21523,1879,1.13 [1.10-1.17],3.798885734221944e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,21527,1880,1.31 [1.22-1.41],1.2146821373363395e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP3,Insulin-like growth factor-binding protein 3,21393,1864,0.84 [0.74-0.95],0.0059274812525696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,21040,1846,1.70 [1.56-1.84],5.468718482429783e-35
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP6,Insulin-like growth factor-binding protein 6,21215,1850,0.95 [0.83-1.09],0.4859896375690662
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,21556,1882,1.77 [1.58-1.99],3.692313672895786e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,21289,1860,1.83 [1.63-2.06],6.112365876115972e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFL4,Insulin growth factor-like family member 4,17944,1562,1.03 [0.97-1.09],0.2811204443549842
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGHMBP2,DNA-binding protein SMUBP-2,17856,1551,1.02 [0.93-1.12],0.7346667061062747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,18488,1607,1.61 [1.43-1.81],3.1499551243414204e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLON5,IgLON family member 5,17841,1543,1.06 [1.00-1.11],0.0340537257333295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF21,Immunoglobulin superfamily member 21,17992,1559,0.83 [0.73-0.94],0.003441239939937
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,21186,1853,1.37 [1.24-1.51],6.851267846537499e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,21289,1860,1.63 [1.45-1.84],6.735605727270674e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF9,Protein turtle homolog A,18494,1603,1.18 [1.12-1.24],2.907847834240272e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IKBKG,NF-kappa-B essential modulator,21282,1863,1.01 [0.96-1.05],0.8129601402758736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IKZF2,Zinc finger protein Helios,20784,1814,1.01 [0.95-1.07],0.7417434442178261
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10,Interleukin-10,20914,1833,1.08 [1.03-1.13],0.0025677133516996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RA,Interleukin-10 receptor subunit alpha,20914,1833,1.07 [1.00-1.15],0.0464340401076241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,21367,1868,1.64 [1.43-1.88],1.2065580837400444e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL11,Interleukin-11,20914,1833,1.08 [1.01-1.16],0.01827228590116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12A_IL12B,Interleukin-12,21186,1853,0.96 [0.91-1.01],0.1308145276365374
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12B,Interleukin-12 subunit beta,21543,1879,0.93 [0.87-1.00],0.0405423914289057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12RB1,Interleukin-12 receptor subunit beta-1,20914,1833,1.02 [0.91-1.15],0.7029219143059411
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12RB2,Interleukin-12 receptor subunit beta-2,17944,1562,0.88 [0.78-0.99],0.0383678922696774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13,Interleukin-13,20914,1833,1.01 [0.94-1.09],0.7076863909677856
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13RA1,Interleukin-13 receptor subunit alpha-1,21037,1830,1.22 [1.04-1.44],0.0170620686618614
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13RA2,Interleukin-13 receptor subunit alpha-2,17877,1545,0.96 [0.81-1.14],0.6285735000559427
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15,Interleukin-15,21282,1863,1.75 [1.55-1.99],2.6458748021056482e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15RA,Interleukin-15 receptor subunit alpha,20914,1833,1.27 [1.13-1.43],6.944535193456601e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL16,Pro-interleukin-16,21543,1879,1.13 [1.03-1.23],0.0073434844218366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17A,Interleukin-17A,20868,1829,1.02 [0.93-1.11],0.7119312741256018
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17C,Interleukin-17C,20914,1833,1.08 [1.02-1.15],0.0066017181211595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17D,Interleukin-17D,20914,1833,1.02 [0.92-1.13],0.7422664875022764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17F,Interleukin-17F,20914,1833,1.06 [1.00-1.11],0.0338484048113178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17RA,Interleukin-17 receptor A,21302,1865,0.96 [0.88-1.06],0.4177456081100883
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17RB,Interleukin-17 receptor B,21016,1841,0.94 [0.87-1.01],0.1096216755087546
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18,Interleukin-18,21191,1854,1.25 [1.14-1.37],1.262158437893223e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18BP,Interleukin-18-binding protein,21393,1864,1.47 [1.28-1.68],1.7418996181076335e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18R1,Interleukin-18 receptor 1,21543,1879,1.32 [1.17-1.49],7.372288167433801e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18RAP,Interleukin-18 receptor accessory protein,20966,1836,1.00 [0.97-1.02],0.9161272021680776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL19,Interleukin-19,20757,1817,1.17 [1.11-1.23],1.0733468870069972e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1A,Interleukin-1 alpha,20914,1833,1.04 [0.97-1.10],0.2832904602417445
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1B,Interleukin-1 beta,20814,1828,1.11 [1.04-1.19],0.0010229544459891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1R1,Interleukin-1 receptor type 1,21263,1858,1.53 [1.28-1.83],2.91412904413348e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1R2,Interleukin-1 receptor type 2,21221,1856,1.61 [1.30-1.98],9.373614434243078e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RAP,Interleukin-1 receptor accessory protein,21302,1865,0.90 [0.82-0.99],0.0232309362360768
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,21480,1875,1.36 [1.25-1.49],4.5376241535448476e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL2,Interleukin-1 receptor-like 2,20914,1833,0.72 [0.64-0.80],1.0020543267178531e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,21217,1857,1.32 [1.24-1.41],2.293909117574644e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2,Interleukin-2,20914,1833,1.16 [1.01-1.33],0.0352731388168245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL20,Interleukin-20,20914,1833,1.01 [0.92-1.10],0.9081718845969554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL20RA,Interleukin-20 receptor subunit alpha,20914,1833,0.96 [0.87-1.06],0.4122433364011881
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL20RB,Interleukin-20 receptor subunit beta,17944,1562,0.94 [0.83-1.05],0.2657080180665035
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL21R,Interleukin-21 receptor,17944,1562,1.03 [0.94-1.12],0.5637936715727174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22,Interleukin-22,18419,1587,1.27 [1.20-1.35],2.6562140192312376e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22RA1,Interleukin-22 receptor subunit alpha-1,20914,1833,1.09 [1.01-1.19],0.0342031980096379
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL24,Interleukin-24,20914,1833,1.10 [1.00-1.21],0.0583767259673269
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL25,Interleukin-25,17777,1534,1.21 [1.05-1.40],0.0097774300477878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,21147,1853,1.52 [1.39-1.67],2.660471313574346e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RB,Interleukin-2 receptor subunit beta,20914,1833,0.93 [0.82-1.05],0.2372707072464902
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RG,Cytokine receptor common subunit gamma,18419,1587,1.02 [0.89-1.18],0.7494786400896551
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL3,Interleukin-3,17841,1543,1.04 [0.95-1.13],0.3960591024581795
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL31,Interleukin-31,17944,1562,1.09 [1.00-1.20],0.054565630132991
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL31RA,Interleukin-31 receptor subunit alpha,17881,1557,0.98 [0.86-1.11],0.7238460836301426
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL32,Interleukin-32,21282,1863,1.31 [1.20-1.43],1.0773871749494176e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL33,Interleukin-33,20914,1833,1.02 [0.91-1.14],0.7637704997685235
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL34,Interleukin-34,20803,1831,1.03 [0.92-1.16],0.588328118013761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL36A,Interleukin-36 alpha,17944,1562,1.06 [0.98-1.14],0.1589021953444292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL36G,Interleukin-36 gamma,17887,1558,1.02 [0.96-1.09],0.5476041489897894
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL3RA,Interleukin-3 receptor subunit alpha,20914,1833,1.06 [0.93-1.21],0.3661698253549106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4,Interleukin-4,20914,1833,1.00 [0.96-1.04],0.9038271571126758
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,21282,1863,1.64 [1.48-1.81],2.8422862765919256e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL5,Interleukin-5,20914,1833,1.01 [0.98-1.04],0.6248100942164054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL5RA,Interleukin-5 receptor subunit alpha,21282,1863,1.03 [0.96-1.11],0.3687050652628305
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6,Interleukin-6,21186,1853,1.29 [1.24-1.33],4.067421800254431e-43
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6R,Interleukin-6 receptor subunit alpha,21182,1846,0.99 [0.88-1.12],0.9331022871221492
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6ST,Interleukin-6 receptor subunit beta,21289,1860,1.79 [1.42-2.28],1.377725850660147e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL7,Interleukin-7,21282,1863,1.02 [0.96-1.09],0.5397486072160604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL7R,Interleukin-7 receptor subunit alpha,21302,1865,0.83 [0.78-0.90],1.115794793778192e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL9,Interleukin-9,18165,1571,1.05 [0.96-1.15],0.2718261832664873
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,20803,1836,1.08 [1.01-1.16],0.0314467557652237
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMMT,MICOS complex subunit MIC60,18419,1587,1.43 [1.30-1.57],4.1619457618142054e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMPA1,Inositol monophosphatase 1,21104,1848,1.01 [0.94-1.08],0.7771080386878021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMPACT,Protein IMPACT,18446,1599,1.05 [0.96-1.15],0.246834995185541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMPG1,Interphotoreceptor matrix proteoglycan 1,17877,1545,0.82 [0.69-0.98],0.0254087514034779
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ING1,Inhibitor of growth protein 1,20809,1835,1.05 [0.96-1.14],0.3073655067992801
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBB,Inhibin beta B chain,18077,1558,1.50 [1.37-1.64],1.0062355565631624e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBC,Inhibin beta C chain,21302,1865,1.08 [0.96-1.20],0.188821993828363
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP1,Inositol polyphosphate 1-phosphatase,21186,1853,1.03 [0.95-1.11],0.4677429023496473
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",17992,1559,1.12 [1.03-1.21],0.0066339497848153
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",18454,1594,0.98 [0.88-1.10],0.7741660865739164
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",21186,1853,1.03 [0.98-1.07],0.2397519506034793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL3,Insulin-like 3,18446,1599,0.88 [0.83-0.92],8.459151891045316e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL4,Early placenta insulin-like peptide,18419,1587,1.08 [0.98-1.20],0.140211104492488
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL5,Insulin-like peptide INSL5,18435,1602,1.16 [1.10-1.21],1.225880163804642e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSR,Insulin receptor,17944,1562,2.11 [1.57-2.85],9.803299082514905e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IPCEF1,Interactor protein for cytohesin exchange factors 1,21064,1844,1.05 [1.00-1.10],0.0302432198360363
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IQGAP2,Ras GTPase-activating-like protein IQGAP2,21186,1853,1.10 [1.02-1.18],0.0146677769851293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",20906,1832,1.05 [1.01-1.10],0.0283993097573454
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAK1,Interleukin-1 receptor-associated kinase 1,20914,1833,1.06 [1.00-1.13],0.0404718712847968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAK4,Interleukin-1 receptor-associated kinase 4,21282,1863,1.01 [0.97-1.05],0.6280889496764779
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,20535,1800,1.07 [0.96-1.19],0.2415052796390782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISM1,Isthmin-1,21282,1863,1.23 [1.10-1.36],0.0001237264183746
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISM2,Isthmin-2,18498,1605,0.96 [0.87-1.07],0.4768619000660455
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IST1,IST1 homolog,18294,1588,1.02 [0.97-1.08],0.3462069885115256
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA11,Integrin alpha-11,21282,1863,0.74 [0.65-0.83],7.773694790048251e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA2,Integrin alpha-2,18077,1558,0.81 [0.71-0.94],0.0042448662051574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA5,Integrin alpha-5,21302,1865,1.71 [1.45-2.01],1.0014473146177576e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA6,Integrin alpha-6,21282,1863,0.95 [0.88-1.03],0.2185552453632536
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAL,Integrin alpha-L,17944,1562,1.05 [0.94-1.18],0.3833802850664214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAM,Integrin alpha-M,21302,1865,0.86 [0.76-0.98],0.0256206420862748
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAV,Integrin alpha-V,21472,1876,0.63 [0.50-0.80],0.0001476382680835
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAX,Integrin alpha-X,18165,1571,1.13 [1.04-1.23],0.0039632576468823
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB1,Integrin beta-1,21283,1855,1.01 [0.82-1.23],0.9564725700054976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB1BP1,Integrin beta-1-binding protein 1,20784,1814,1.00 [0.90-1.11],0.9995993489614692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB1BP2,Integrin beta-1-binding protein 2,20906,1832,1.02 [0.98-1.06],0.2535223378138877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB2,Integrin beta-2,21172,1845,0.91 [0.79-1.06],0.2393330456853433
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB5,Integrin beta-5,21352,1860,1.07 [0.97-1.19],0.1610496641489092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB6,Integrin beta-6,20914,1833,0.96 [0.83-1.10],0.5189909120206889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB7,Integrin beta-7,21472,1876,1.06 [0.97-1.15],0.2220163047578921
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGBL1,Integrin beta-like protein 1,18498,1605,1.48 [1.31-1.66],1.2965115185344754e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,18511,1612,0.97 [0.75-1.26],0.84491092320202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,21393,1864,1.40 [1.26-1.56],1.5317029777707015e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,18511,1612,1.46 [1.20-1.77],0.0001486716669213
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,18419,1587,1.03 [0.93-1.15],0.5793947683028322
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITM2A,Integral membrane protein 2A,21282,1863,0.97 [0.91-1.04],0.3466661824923911
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPA,Inosine triphosphate pyrophosphatase,17856,1551,1.11 [1.03-1.19],0.0048740161169724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",17992,1559,1.04 [0.96-1.11],0.3259745192239793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",17877,1545,0.98 [0.87-1.10],0.7474566886101133
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",20838,1837,0.99 [0.91-1.07],0.7683470395194997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IZUMO1,Izumo sperm-egg fusion protein 1,17841,1543,1.09 [0.99-1.19],0.0922007666050223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JAM2,Junctional adhesion molecule B,21484,1876,1.07 [0.92-1.25],0.3746942205644762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JAM3,Junctional adhesion molecule C,18077,1558,1.14 [1.04-1.24],0.0057914266099394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JCHAIN,Immunoglobulin J chain,20914,1833,1.19 [1.11-1.27],5.121408418441717e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,17841,1543,0.94 [0.85-1.03],0.1736187873790713
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JPT2,Jupiter microtubule associated homolog 2,18435,1602,1.02 [0.97-1.08],0.429611286231163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JUN,Transcription factor AP-1,20914,1833,1.10 [1.01-1.20],0.0320888360714907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,21186,1853,0.79 [0.72-0.86],7.71312717850037e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KAZN,Kazrin,18435,1602,1.05 [1.00-1.10],0.0368993388629395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCNC4,Potassium voltage-gated channel subfamily C member 4,17877,1545,1.07 [0.98-1.17],0.130417513738881
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCNH2,Potassium voltage-gated channel subfamily H member 2,18001,1566,1.05 [0.99-1.12],0.110228772522312
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCNIP4,Kv channel-interacting protein 4,20838,1837,1.06 [0.97-1.15],0.2153737190805254
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCTD5,BTB/POZ domain-containing protein KCTD5,18099,1569,1.14 [1.04-1.25],0.0046796884194521
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KDM3A,Lysine-specific demethylase 3A,17944,1562,0.95 [0.89-1.03],0.1981353254752627
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KDR,Vascular endothelial growth factor receptor 2,21352,1860,1.19 [1.01-1.39],0.0357280380483216
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KEL,Kell blood group glycoprotein,20838,1837,0.92 [0.82-1.03],0.1276866055516623
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KHDC3L,KH domain-containing protein 3,17841,1543,0.95 [0.89-1.02],0.1722186306766666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KHK,Ketohexokinase,17992,1559,1.10 [1.02-1.19],0.015570302239479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA0319,Dyslexia-associated protein KIAA0319,18446,1599,1.06 [0.91-1.24],0.431588819982745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA1549,UPF0606 protein KIAA1549,18165,1571,1.00 [0.93-1.08],0.9361138006705106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA1549L,UPF0606 protein KIAA1549L,18165,1571,0.96 [0.81-1.12],0.5856986165154274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA2013,Uncharacterized protein KIAA2013,18419,1587,0.98 [0.89-1.08],0.6827522902557934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF1C,Kinesin-like protein KIF1C,17856,1551,1.19 [1.04-1.35],0.0098247954840648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF20B,Kinesin-like protein KIF20B,17877,1545,1.01 [0.95-1.08],0.7099374748285777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF22,Kinesin-like protein KIF22,17856,1551,1.00 [0.96-1.04],0.9940176631829608
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIFBP,KIF-binding protein,21186,1853,1.01 [0.97-1.06],0.586743304354042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,18419,1587,1.04 [0.98-1.09],0.1916222846486559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,20784,1814,1.07 [1.02-1.13],0.0116290617878409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,18435,1602,1.01 [0.98-1.04],0.4090023460603413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,20784,1814,0.98 [0.95-1.01],0.2738555864571225
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,17841,1543,1.00 [0.94-1.07],0.9504872444121965
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIRREL1,Kin of IRRE-like protein 1,17877,1545,0.97 [0.89-1.06],0.5019475077843512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIRREL2,Kin of IRRE-like protein 2,20838,1837,1.08 [0.97-1.20],0.1503818320671698
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIT,Mast/stem cell growth factor receptor Kit,21360,1861,0.91 [0.79-1.05],0.1886753382010123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KITLG,Kit ligand,21289,1860,0.61 [0.55-0.68],3.7724485926779377e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLB,Beta-klotho,20838,1837,0.95 [0.90-1.00],0.0548750722504165
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLF4,Krueppel-like factor 4,17877,1545,1.16 [1.05-1.29],0.0048655930175574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLHL41,Kelch-like protein 41,18454,1594,0.89 [0.80-0.98],0.0230752671087419
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK1,Kallikrein-1,21104,1832,1.03 [1.00-1.06],0.0562680442065388
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK10,Kallikrein-10,21296,1851,1.31 [1.19-1.44],6.145011623439087e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK11,Kallikrein-11,21147,1841,1.36 [1.20-1.54],1.5757152774437568e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK12,Kallikrein-12,20784,1814,1.01 [0.98-1.04],0.6065330943327327
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK13,Kallikrein-13,20796,1826,1.17 [1.06-1.28],0.0012122770910786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK14,Kallikrein-14,21472,1876,1.17 [1.08-1.28],0.0002634028980128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK15,Kallikrein-15,18381,1585,1.01 [0.92-1.11],0.8383083586494599
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK3,Prostate-specific antigen,18498,1605,1.01 [0.97-1.06],0.6477018547951454
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK4,Kallikrein-4,21472,1876,1.28 [1.20-1.36],5.993829437570933e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK6,Kallikrein-6,21310,1858,0.87 [0.77-0.98],0.0227741769786529
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK7,Kallikrein-7,17629,1521,1.08 [0.95-1.22],0.2522993765603785
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK8,Kallikrein-8,20576,1790,1.26 [1.12-1.41],0.0001230535262215
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLKB1,Plasma kallikrein,18140,1580,1.02 [0.83-1.24],0.8618750415201111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRB1,Killer cell lectin-like receptor subfamily B member 1,21543,1879,0.98 [0.88-1.09],0.6929151475939461
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,17877,1545,1.02 [0.94-1.10],0.6863979826533816
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRD1,Natural killer cells antigen CD94,21543,1879,0.95 [0.88-1.04],0.2629524164206415
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRF1,Killer cell lectin-like receptor subfamily F member 1,17944,1562,1.05 [0.93-1.18],0.4113630496491206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRK1,NKG2-D type II integral membrane protein,18446,1599,1.09 [0.98-1.21],0.1095015781669603
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT14,"Keratin, type I cytoskeletal 14",20203,1781,0.96 [0.83-1.11],0.5781589020373761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT17,"Keratin, type I cytoskeletal 17",17856,1551,0.97 [0.86-1.09],0.5910038523176402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",21186,1853,1.18 [1.12-1.23],3.6368160993693443e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",21245,1861,1.17 [1.11-1.24],9.37035150797924e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT5,"Keratin, type II cytoskeletal 5",20838,1837,0.96 [0.88-1.03],0.2630468849417542
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT6C,"Keratin, type II cytoskeletal 6C",17856,1551,0.98 [0.85-1.14],0.8183074887534447
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT8,"Keratin, type II cytoskeletal 8",17877,1545,1.12 [1.06-1.18],2.834862464460061e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KYAT1,Kynurenine--oxoglutarate transaminase 1,21254,1857,1.06 [0.99-1.14],0.1015010671488734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KYNU,Kynureninase,21543,1879,1.25 [1.14-1.36],7.015518330270018e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",L1CAM,Neural cell adhesion molecule L1,21352,1860,1.09 [0.95-1.24],0.2116349453007184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,18494,1603,1.07 [1.01-1.12],0.0159852230956098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LACRT,Extracellular glycoprotein lacritin,18382,1584,0.95 [0.85-1.07],0.42821817262658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LACTB2,Endoribonuclease LACTB2,21289,1860,1.05 [0.98-1.11],0.1571620819728393
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAG3,Lymphocyte activation gene 3 protein,21186,1853,0.91 [0.82-1.00],0.0620665159560341
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,21262,1860,1.40 [1.28-1.54],4.1828412619027753e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,21104,1848,1.08 [1.04-1.13],0.0001252907072334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMA1,Laminin subunit alpha-1,17856,1551,0.98 [0.89-1.08],0.7062026774613666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMA4,Laminin subunit alpha-4,21367,1868,1.34 [1.20-1.50],2.619078644142179e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMB1,Laminin subunit beta-1,17992,1559,1.08 [0.93-1.27],0.3177079309073267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP1,Lysosome-associated membrane glycoprotein 1,17987,1563,1.36 [1.12-1.64],0.0018697447031386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP2,Lysosome-associated membrane glycoprotein 2,20630,1802,1.57 [1.27-1.93],2.15232552056522e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,21507,1876,1.53 [1.43-1.63],2.883335196409524e-35
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMTOR5,Ragulator complex protein LAMTOR5,18419,1587,1.04 [0.92-1.17],0.5629839131692895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAP3,Cytosol aminopeptidase,20914,1833,1.11 [1.02-1.21],0.0174020843934402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LARP1,La-related protein 1,18419,1587,1.09 [1.01-1.17],0.0208755491771188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAT,Linker for activation of T-cells family member 1,21543,1879,1.03 [0.98-1.09],0.2318377261452701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAT2,Linker for activation of T-cells family member 2,21186,1853,1.03 [1.00-1.07],0.0440194021437701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LATS1,Serine/threonine-protein kinase LATS1,17944,1562,1.03 [0.98-1.09],0.2729920661222288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAYN,Layilin,21075,1846,1.45 [1.29-1.63],4.790475484873021e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBP,Lipopolysaccharide-binding protein,21393,1864,1.13 [1.05-1.21],0.0008594583682804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBR,Delta(14)-sterol reductase LBR,21484,1876,1.12 [1.06-1.18],3.4067011835288654e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCAT,Phosphatidylcholine-sterol acyltransferase,18509,1603,0.87 [0.70-1.09],0.2311003285202515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN15,Lipocalin-15,18454,1594,1.11 [1.03-1.20],0.0055309227130695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,20655,1806,1.28 [1.16-1.42],1.773316512894721e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCP1,Plastin-2,18498,1605,1.12 [1.02-1.23],0.0137277097819321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LDLR,Low-density lipoprotein receptor,21344,1858,0.98 [0.90-1.06],0.6180838292319359
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LDLRAP1,Low density lipoprotein receptor adapter protein 1,18454,1594,1.02 [0.98-1.07],0.3056853276807457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LECT2,Leukocyte cell-derived chemotaxin-2,18494,1603,1.21 [1.12-1.30],3.1664255020794626e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEFTY2,Left-right determination factor 2,21448,1875,0.93 [0.86-1.01],0.0718503332062737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEG1,Protein LEG1 homolog,17489,1509,1.21 [1.13-1.29],3.4855013310226344e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LELP1,Late cornified envelope-like proline-rich protein 1,17877,1545,0.94 [0.87-1.01],0.0862442041970093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEO1,RNA polymerase-associated protein LEO1,18454,1594,1.21 [1.03-1.42],0.019923156150308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEP,Leptin,21289,1860,1.03 [0.97-1.09],0.3069618852804001
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEPR,Leptin receptor,21289,1860,1.24 [1.10-1.41],0.000548175037221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LETM1,Mitochondrial proton/calcium exchanger protein,18454,1594,1.22 [1.12-1.33],6.80439539882329e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS1,Galectin-1,21289,1860,1.37 [1.22-1.53],6.185537625875846e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3,Galectin-3,21351,1863,1.37 [1.20-1.58],5.066050021936826e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3BP,Galectin-3-binding protein,18511,1612,1.65 [1.44-1.89],1.804187997367753e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS4,Galectin-4,21262,1860,1.41 [1.31-1.51],6.167118166688228e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS7_LGALS7B,Galectin-7,21232,1857,1.14 [1.04-1.24],0.0051948877081362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS8,Galectin-8,21484,1876,1.06 [0.99-1.13],0.0758096504086054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS9,Galectin-9,21262,1859,1.66 [1.47-1.87],8.382829351399623e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGMN,Legumain,21367,1868,1.58 [1.42-1.76],2.0021045287318265e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LHB,Lutropin subunit beta,20784,1814,1.06 [1.01-1.11],0.0156935550464586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,21291,1863,1.11 [1.04-1.19],0.001863816441435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIF,Leukemia inhibitory factor,20838,1837,1.17 [1.08-1.26],0.0001093580472434
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIFR,Leukemia inhibitory factor receptor,21282,1863,1.34 [1.14-1.58],0.0003737327086559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,21302,1865,1.18 [1.05-1.33],0.0051575946438132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,18498,1605,1.03 [1.00-1.07],0.0805798874727454
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,17856,1551,1.02 [0.93-1.12],0.6566681200434874
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,21260,1858,1.57 [1.39-1.78],7.465412109411168e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,18494,1603,1.09 [1.02-1.16],0.0121214370084935
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,21556,1882,1.43 [1.23-1.66],2.178052877490233e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,21451,1873,1.35 [1.20-1.53],1.033263384945856e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,20914,1833,1.31 [1.19-1.43],1.5554995315761026e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,21556,1882,1.00 [0.95-1.06],0.8822342410137307
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIPF,Gastric triacylglycerol lipase,17992,1559,1.07 [0.98-1.15],0.1144152976265194
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMNB1,Lamin-B1,18403,1597,1.03 [0.96-1.11],0.4114015836492694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMNB2,Lamin-B2,18446,1599,1.52 [1.28-1.80],1.7574709423251446e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMOD1,Leiomodin-1,18454,1594,1.33 [1.18-1.51],6.000873146332103e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMOD2,Leiomodin-2,17877,1545,0.92 [0.84-1.01],0.0839912251992115
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LONP1,"Lon protease homolog, mitochondrial",17992,1559,1.09 [1.03-1.15],0.0023201058328897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPA,Apolipoprotein(a),18100,1579,1.01 [0.98-1.03],0.5742314655650929
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPCAT2,Lysophosphatidylcholine acyltransferase 2,21186,1853,1.10 [1.02-1.19],0.0133603491364945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPL,Lipoprotein lipase,21289,1860,0.95 [0.87-1.03],0.2427788885965591
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPO,Lactoperoxidase,20532,1798,1.11 [1.04-1.19],0.0023312151362918
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPP,Lipoma-preferred partner,17856,1551,1.00 [0.93-1.07],0.9730798720358652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,17856,1551,1.11 [1.04-1.19],0.0021870922033939
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,18001,1566,0.89 [0.80-1.00],0.0455876190486548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,18511,1612,1.83 [1.54-2.17],4.574727137629129e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,21418,1871,1.15 [1.02-1.29],0.0212754208966686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,17888,1555,1.10 [0.91-1.33],0.3106147326402139
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP1,Prolow-density lipoprotein receptor-related protein 1,21186,1853,1.29 [1.12-1.50],0.0005172653276238
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,21289,1860,1.22 [1.09-1.37],0.0006138808951385
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP2,Low-density lipoprotein receptor-related protein 2,18001,1566,0.89 [0.78-1.03],0.1163127625270566
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP2BP,LRP2-binding protein,18001,1566,0.99 [0.93-1.06],0.8458993846622067
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,21484,1876,1.12 [1.05-1.20],0.0003981348123682
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,21186,1853,1.33 [1.20-1.47],3.7758982707198086e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC37A2,Leucine-rich repeat-containing protein 37A2,18435,1602,1.13 [1.02-1.26],0.024419951785394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC38,Leucine-rich repeat-containing protein 38,18001,1566,1.02 [0.92-1.12],0.7299009869075296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC59,Leucine-rich repeat-containing protein 59,18494,1603,1.04 [0.95-1.14],0.3896363446864723
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,18419,1587,1.10 [1.00-1.21],0.0467899578783009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,20914,1833,0.62 [0.56-0.69],3.5960085167693725e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,18001,1566,1.10 [0.99-1.23],0.082055685943584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,18454,1594,0.73 [0.60-0.89],0.0014756518722906
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSM1,U6 snRNA-associated Sm-like protein LSm1,20784,1814,1.05 [0.98-1.12],0.1971192168938605
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSM8,U6 snRNA-associated Sm-like protein LSm8,18165,1571,0.98 [0.91-1.05],0.566330540617207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSP1,Lymphocyte-specific protein 1,21282,1863,1.11 [1.01-1.23],0.0336022371394483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTA,Lymphotoxin-alpha,21282,1863,0.90 [0.81-1.01],0.0632966830973986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTA4H,Leukotriene A-4 hydrolase,21472,1876,1.16 [1.10-1.23],3.466161294525202e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTB,Lymphotoxin-beta,18419,1587,0.94 [0.80-1.11],0.4866767707149595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,21556,1882,1.56 [1.37-1.77],9.991999131466046e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP3,Latent-transforming growth factor beta-binding protein 3,20784,1814,1.29 [1.20-1.38],1.1119892717575404e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,21148,1850,1.44 [1.25-1.66],3.9003328525104406e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTO1,Protein LTO1 homolog,20914,1833,1.00 [0.91-1.11],0.935915149933056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LUZP2,Leucine zipper protein 2,18419,1587,0.89 [0.79-1.00],0.0492704914825425
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LXN,Latexin,21002,1837,0.96 [0.90-1.02],0.1426853741155136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY6D,Lymphocyte antigen 6D,21149,1851,1.17 [1.06-1.31],0.0031403185173514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY75,Lymphocyte antigen 75,21282,1863,0.97 [0.87-1.08],0.6252336340891427
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY9,T-lymphocyte surface antigen Ly-9,21040,1833,1.24 [1.08-1.42],0.002477957385142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY96,Lymphocyte antigen 96,21104,1848,1.42 [1.29-1.58],6.343624185041724e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYAR,Cell growth-regulating nucleolar protein,20784,1814,1.03 [0.95-1.11],0.5029748029681873
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYN,Tyrosine-protein kinase Lyn,21186,1853,1.02 [0.97-1.07],0.5412240030290947
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD1,Ly6/PLAUR domain-containing protein 1,20838,1837,0.99 [0.93-1.05],0.7496585311177516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD3,Ly6/PLAUR domain-containing protein 3,21190,1845,1.11 [0.98-1.24],0.0942553191410563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD8,Ly6/PLAUR domain-containing protein 8,20784,1814,1.04 [0.96-1.13],0.3374030784760538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPLA2,Acyl-protein thioesterase 2,17877,1545,1.05 [1.00-1.09],0.0376341074610019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,18001,1566,0.99 [0.95-1.04],0.8098269218105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,18511,1612,0.99 [0.77-1.27],0.9140135680297948
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYZL2,Lysozyme-like protein 2,17841,1543,1.02 [0.89-1.16],0.8003740415223862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LZTFL1,Leucine zipper transcription factor-like protein 1,18077,1558,0.99 [0.93-1.06],0.8045825166060349
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",M6PR,Cation-dependent mannose-6-phosphate receptor,17992,1559,1.09 [0.96-1.23],0.1939382510599298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,21037,1843,1.18 [1.10-1.26],2.2758831193575914e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAEA,E3 ubiquitin-protein transferase MAEA,20784,1814,1.00 [0.90-1.11],0.9660050505443364
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAG,Myelin-associated glycoprotein,18001,1566,0.99 [0.90-1.09],0.82787703438603
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAGEA3,Melanoma-associated antigen 3,18165,1571,0.98 [0.93-1.04],0.5566690916824104
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAGED1,Melanoma-associated antigen D1,20784,1814,1.05 [0.97-1.14],0.2550514645970268
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAMDC2,MAM domain-containing protein 2,18494,1603,0.97 [0.84-1.11],0.6127462181842023
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAMDC4,Apical endosomal glycoprotein,18419,1587,1.25 [1.16-1.35],6.06075828855354e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",17992,1559,1.46 [1.21-1.76],8.483846565857145e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAN2B2,Epididymis-specific alpha-mannosidase,18494,1603,1.11 [1.03-1.21],0.0078714873009595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",17841,1543,1.04 [0.95-1.14],0.406972331590908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANF,Mesencephalic astrocyte-derived neurotrophic factor,21367,1868,1.03 [1.00-1.07],0.048308269316694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANSC1,MANSC domain-containing protein 1,21352,1860,1.31 [1.14-1.51],0.0002317973812844
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANSC4,MANSC domain-containing protein 4,17856,1551,1.09 [1.02-1.17],0.010887979611367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,17877,1545,0.95 [0.80-1.12],0.5407159576670059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,17856,1551,1.07 [0.99-1.16],0.0758632602641287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP2,Microtubule-associated protein 2,18446,1599,1.13 [1.03-1.25],0.0113916279941834
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,18435,1602,1.03 [0.96-1.11],0.4267166772198494
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,21282,1863,1.01 [0.97-1.05],0.7667803722795556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,20784,1814,1.03 [0.98-1.07],0.2236805019132365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,21075,1846,1.01 [0.97-1.05],0.6463560630435514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPK13,Mitogen-activated protein kinase 13,17841,1543,1.11 [1.00-1.23],0.0531026753284109
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPK9,Mitogen-activated protein kinase 9,21282,1863,1.11 [1.01-1.22],0.0261291576065031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPKAPK2,MAP kinase-activated protein kinase 2,18165,1571,1.03 [0.96-1.10],0.4562168107804165
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPRE3,Microtubule-associated protein RP/EB family member 3,17841,1543,0.92 [0.88-0.97],0.0011797737289944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPT,Microtubule-associated protein tau,20838,1837,0.98 [0.90-1.07],0.663247586012331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MARCO,Macrophage receptor MARCO,21289,1860,1.46 [1.24-1.72],3.797702168093383e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MARS1,"Methionine--tRNA ligase, cytoplasmic",18046,1554,1.03 [0.97-1.09],0.3358117335840768
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MASP1,Mannan-binding lectin serine protease 1,21075,1846,1.00 [0.84-1.20],0.9692175799299056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN2,Matrilin-2,21292,1863,1.64 [1.43-1.88],1.2695377872486474e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN3,Matrilin-3,21064,1844,1.21 [1.07-1.37],0.0031912671323311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAVS,Mitochondrial antiviral-signaling protein,20784,1814,1.07 [1.03-1.12],0.0020987952753604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAX,Protein max,20838,1837,1.00 [0.96-1.04],0.9776233755613142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MB,Myoglobin,21556,1882,0.94 [0.87-1.01],0.0839619866648501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MBL2,Mannose-binding protein C,18265,1595,1.07 [1.02-1.12],0.0033422150878331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCAM,Cell surface glycoprotein MUC18,21393,1864,0.86 [0.76-0.98],0.0230253550243696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",18454,1594,0.94 [0.83-1.06],0.285913077116505
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCEMP1,Mast cell-expressed membrane protein 1,17944,1562,1.08 [1.02-1.13],0.0077339168458418
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCFD2,Multiple coagulation factor deficiency protein 2,21178,1848,1.14 [1.05-1.25],0.0030651590428381
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCTS1,Malignant T-cell-amplified sequence 1,18435,1602,0.97 [0.81-1.16],0.7576868573094404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,21104,1848,0.95 [0.89-1.01],0.0830758662911852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDH1,"Malate dehydrogenase, cytoplasmic",18414,1598,1.02 [0.91-1.15],0.6976409553135867
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDK,Midkine,21287,1853,1.36 [1.26-1.47],2.3891713348588206e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDM1,Nuclear protein MDM1,18001,1566,1.03 [0.89-1.20],0.6854768949547039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",17992,1559,1.08 [1.02-1.13],0.0053314322367003
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MED18,Mediator of RNA polymerase II transcription subunit 18,20784,1814,1.04 [0.98-1.09],0.1866834602122445
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MED21,Mediator of RNA polymerase II transcription subunit 21,17856,1551,0.98 [0.88-1.08],0.666818021494084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF10,Multiple epidermal growth factor-like domains protein 10,21262,1860,1.01 [0.91-1.13],0.84942740424583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF11,Multiple epidermal growth factor-like domains protein 11,17856,1551,1.03 [0.88-1.20],0.7091959204934553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF9,Multiple epidermal growth factor-like domains protein 9,21480,1875,1.79 [1.45-2.22],9.420876321889284e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MELTF,Melanotransferrin,18494,1603,1.11 [0.95-1.30],0.1838107277833509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MENT,Protein MENT,18077,1558,0.77 [0.62-0.95],0.0144402716714856
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1A,Meprin A subunit alpha,18435,1602,1.02 [0.96-1.09],0.5221342203575685
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1B,Meprin A subunit beta,21289,1860,0.90 [0.87-0.94],8.645546968217975e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEPE,Matrix extracellular phosphoglycoprotein,21262,1860,0.66 [0.56-0.78],1.0842310435795285e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MERTK,Tyrosine-protein kinase Mer,21543,1879,1.20 [1.01-1.42],0.0365200616578498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MESD,LRP chaperone MESD,21302,1865,1.02 [0.99-1.06],0.1674806382002913
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MET,Hepatocyte growth factor receptor,21345,1859,0.63 [0.51-0.78],2.024039863655821e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP1,Methionine aminopeptidase 1,20838,1837,0.95 [0.83-1.10],0.5044990162753353
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",21282,1863,1.06 [1.01-1.11],0.0157146377484556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP2,Methionine aminopeptidase 2,21448,1875,1.07 [1.00-1.16],0.050981670205058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP3,Microfibril-associated glycoprotein 3,20906,1832,1.02 [0.93-1.11],0.6553691736543384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP3L,Microfibrillar-associated protein 3-like,18001,1566,0.98 [0.91-1.05],0.581776267400079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP4,Microfibril-associated glycoprotein 4,18077,1558,0.94 [0.80-1.09],0.3972748154640918
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP5,Microfibrillar-associated protein 5,21556,1882,0.98 [0.89-1.09],0.7570304774041409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFGE8,Lactadherin,21302,1865,1.26 [1.15-1.37],1.705323593686887e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MGLL,Monoglyceride lipase,21336,1865,1.02 [0.97-1.07],0.393066250386465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MGMT,Methylated-DNA--protein-cysteine methyltransferase,21282,1863,1.00 [0.96-1.03],0.8794995325278234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MIA,Melanoma-derived growth regulatory protein,21352,1860,0.90 [0.81-1.01],0.0617596057335574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MICALL2,MICAL-like protein 2,18001,1566,1.07 [1.00-1.14],0.0538181000797005
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,21282,1863,1.00 [0.98-1.03],0.7846205639068586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MIF,Macrophage migration inhibitory factor,21260,1863,1.05 [0.99-1.11],0.1228564193482503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MILR1,Allergin-1,20914,1833,1.13 [1.04-1.22],0.0023847876354728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,18419,1587,1.04 [0.99-1.08],0.1117148782756923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MINK1,Misshapen-like kinase 1,18446,1599,1.03 [0.98-1.08],0.2544898348939972
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MITD1,MIT domain-containing protein 1,21104,1848,1.01 [0.97-1.05],0.7180228632636545
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MKI67,Proliferation marker protein Ki-67,17944,1562,1.09 [0.98-1.22],0.1113410193761925
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MLLT1,Protein ENL,17841,1543,1.01 [0.94-1.09],0.7455087250618144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MLN,Promotilin,21282,1863,1.09 [1.04-1.14],0.0004859118471518
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MME,Neprilysin,21186,1853,1.23 [1.17-1.29],3.0662300124499224e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP1,Interstitial collagenase,20586,1806,1.08 [1.03-1.14],0.0011478714574986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP10,Stromelysin-2,21222,1859,1.24 [1.16-1.33],1.5538684706565549e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP12,Macrophage metalloelastase,21324,1859,1.53 [1.43-1.64],6.418627110728406e-36
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP13,Collagenase 3,20838,1837,1.16 [1.01-1.32],0.0329464333163056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP15,Matrix metalloproteinase-15,18494,1603,1.09 [1.00-1.19],0.0497153729395972
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP3,Stromelysin-1,21302,1865,1.12 [1.03-1.21],0.00682820927013
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP7,Matrilysin,20877,1830,1.40 [1.29-1.53],3.5581309509312067e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP8,Neutrophil collagenase,21450,1874,1.21 [1.16-1.28],1.2597108915179766e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP9,Matrix metalloproteinase-9,21274,1865,1.29 [1.21-1.38],5.338702752651027e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",17856,1551,1.06 [0.96-1.18],0.2567394609555127
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MN1,Transcriptional activator MN1,18001,1566,0.97 [0.89-1.05],0.4479451530308564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MNAT1,CDK-activating kinase assembly factor MAT1,18165,1571,1.03 [0.93-1.15],0.5123105263149315
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MNDA,Myeloid cell nuclear differentiation antigen,21257,1856,1.06 [1.02-1.10],0.0031322313343865
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MOCS2,Molybdopterin synthase catalytic subunit,18077,1558,1.06 [0.99-1.14],0.0872891887720702
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MOG,Myelin-oligodendrocyte glycoprotein,21472,1876,0.92 [0.82-1.04],0.174111852488415
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORC3,MORC family CW-type zinc finger protein 3,18446,1599,0.96 [0.79-1.15],0.6292249580227424
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORF4L1,Mortality factor 4-like protein 1,18165,1571,0.98 [0.87-1.11],0.7910885070792465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORF4L2,Mortality factor 4-like protein 2,17841,1543,0.87 [0.74-1.01],0.0672949334148081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORN4,MORN repeat-containing protein 4,17841,1543,0.99 [0.93-1.04],0.6167293431752593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPHOSPH8,M-phase phosphoprotein 8,20906,1832,1.03 [0.98-1.09],0.2143773694054856
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPI,Mannose-6-phosphate isomerase,21186,1853,1.03 [0.99-1.08],0.1653783647635549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,21336,1865,1.05 [0.99-1.11],0.0863939960227251
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPO,Myeloperoxidase,21302,1865,1.19 [1.09-1.29],4.917673089043451e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPRIP,Myosin phosphatase Rho-interacting protein,18389,1585,1.09 [0.99-1.21],0.0907245926841001
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRC1,Macrophage mannose receptor 1,18509,1603,2.04 [1.74-2.40],2.7455444867576497e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRI1,Methylthioribose-1-phosphate isomerase,18001,1566,0.97 [0.90-1.04],0.3955546193254425
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL24,"39S ribosomal protein L24, mitochondrial",17856,1551,1.12 [1.00-1.27],0.0595153757283154
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL28,"39S ribosomal protein L28, mitochondrial",18454,1594,0.89 [0.77-1.03],0.1150848646681856
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL46,"39S ribosomal protein L46, mitochondrial",20838,1837,1.14 [0.99-1.32],0.0757105150138474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL52,"39S ribosomal protein L52, mitochondrial",17802,1541,0.97 [0.81-1.17],0.7407790127982596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",18454,1594,1.01 [0.94-1.08],0.7358239046979012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPS16,"28S ribosomal protein S16, mitochondrial",17944,1562,1.03 [0.85-1.25],0.7785009459923664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLN,Mesothelin,21151,1853,1.30 [1.23-1.36],8.514610435556264e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLNL,Mesothelin-like protein,18001,1566,0.97 [0.85-1.10],0.6178277325985493
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSMB,Beta-microseminoprotein,21267,1856,1.16 [1.09-1.23],8.1095768889848e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,21484,1876,1.37 [1.26-1.49],1.3481508425907717e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSRA,Mitochondrial peptide methionine sulfoxide reductase,21352,1860,1.05 [0.99-1.11],0.1124807785214194
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MST1,Hepatocyte growth factor-like protein,18245,1585,1.19 [1.09-1.30],8.773249959981384e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSTN,Growth/differentiation factor 8,20906,1832,0.81 [0.75-0.87],6.73180557167171e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTDH,Protein LYRIC,17944,1562,1.03 [0.98-1.08],0.2884469731928287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",18446,1599,1.13 [0.94-1.37],0.1961012317972341
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,18165,1571,1.07 [1.03-1.12],0.0009624618575337
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTIF3,"Translation initiation factor IF-3, mitochondrial",18435,1602,1.02 [0.97-1.08],0.4443985941045538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTPN,Myotrophin,20906,1832,0.95 [0.83-1.08],0.4290939656676662
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTR,Methionine synthase,17856,1551,0.93 [0.86-1.01],0.0920496079564866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTSS1,Protein MTSS 1,18435,1602,1.04 [0.99-1.08],0.1116135955214834
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTSS2,Protein MTSS 2,18419,1587,1.06 [1.01-1.11],0.0191777345021954
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTUS1,Microtubule-associated tumor suppressor 1,18165,1571,1.19 [1.10-1.28],1.292270110466607e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC13,Mucin-13,20838,1837,1.17 [1.08-1.27],5.595226936357331e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC16,Mucin-16,21186,1853,1.00 [0.98-1.03],0.6984010791772963
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC2,Mucin-2,18498,1605,0.96 [0.91-1.01],0.1221175129731644
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUCL3,Mucin-like protein 3,17841,1543,1.09 [0.99-1.20],0.0904857140588272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MVK,Mevalonate kinase,20914,1833,1.22 [1.17-1.28],1.6185437238512374e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MXRA8,Matrix remodeling-associated protein 8,18077,1558,0.77 [0.66-0.91],0.0021471953283661
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYBPC1,"Myosin-binding protein C, slow-type",18494,1603,0.99 [0.93-1.05],0.6662062911596376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYBPC2,"Myosin-binding protein C, fast-type",17992,1559,1.00 [0.94-1.06],0.9363458544649248
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,18454,1594,1.08 [1.01-1.16],0.0230078545230018
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYDGF,Myeloid-derived growth factor,18494,1603,1.05 [1.01-1.11],0.0252241944536353
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYH4,Myosin-4,17856,1551,1.00 [0.89-1.13],0.969406359104216
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYH7B,Myosin-7B,17841,1543,1.01 [0.91-1.13],0.7950183924870409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYH9,Myosin-9,18498,1605,1.02 [0.98-1.07],0.2746781279204002
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",17856,1551,0.80 [0.70-0.92],0.0016110172713056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL3,Myosin light chain 3,17992,1559,0.96 [0.90-1.02],0.1827118681516452
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL4,Myosin light chain 4,17992,1559,1.01 [0.93-1.11],0.7554989807840081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL6B,Myosin light chain 6B,18001,1566,0.90 [0.84-0.96],0.0007404351886361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",18001,1566,0.94 [0.85-1.03],0.1973170913575206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYO6,Unconventional myosin-VI,18454,1594,1.08 [0.97-1.21],0.1602255995674076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYO9B,Unconventional myosin-IXb,20914,1833,1.07 [1.01-1.14],0.0292834747260887
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOC,Myocilin,21302,1865,0.99 [0.91-1.09],0.8776023925116117
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOM1,Myomesin-1,17877,1545,1.03 [0.93-1.14],0.5157668666375868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOM2,Myomesin-2,17856,1551,0.91 [0.83-1.00],0.0577550858778515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOM3,Myomesin-3,18077,1558,0.93 [0.88-0.97],0.0029083738170043
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,21323,1866,1.45 [1.35-1.55],3.4639219762875165e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZT1,Mitotic-spindle organizing protein 1,20784,1814,1.07 [0.99-1.16],0.0956048044623832
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAA10,N-alpha-acetyltransferase 10,17856,1551,0.99 [0.89-1.09],0.774022918578163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAA80,N-alpha-acetyltransferase 80,18001,1566,1.00 [0.96-1.04],0.9735684599577196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAAA,N-acylethanolamine-hydrolyzing acid amidase,21007,1836,1.01 [0.94-1.08],0.8148598592421699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NACC1,Nucleus accumbens-associated protein 1,18419,1587,1.09 [1.01-1.19],0.030571978196183
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NADK,NAD kinase,21289,1860,1.06 [0.98-1.13],0.1254140079512113
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGA,Alpha-N-acetylgalactosaminidase,17915,1559,1.03 [0.93-1.14],0.5598929453137693
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGK,N-acetyl-D-glucosamine kinase,17961,1557,0.97 [0.89-1.05],0.4657048778863736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,18077,1558,1.13 [0.92-1.39],0.2510012525005853
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAMPT,Nicotinamide phosphoribosyltransferase,20784,1814,1.06 [0.99-1.13],0.1186096111278067
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAP1L4,Nucleosome assembly protein 1-like 4,18396,1600,1.01 [0.89-1.14],0.8779621524163014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAPRT,Nicotinate phosphoribosyltransferase,18446,1599,0.83 [0.71-0.97],0.016962875475553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NARS1,"Asparagine--tRNA ligase, cytoplasmic",18454,1594,0.97 [0.88-1.08],0.5997236272340141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,21352,1860,1.32 [1.13-1.53],0.0003394692431242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBN,Nibrin,20914,1833,1.08 [1.01-1.15],0.0235821141732611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAM1,Neural cell adhesion molecule 1,21393,1864,0.82 [0.73-0.93],0.0020200306410524
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAM2,Neural cell adhesion molecule 2,21302,1865,0.96 [0.82-1.12],0.5778293741643629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAN,Neurocan core protein,21484,1876,0.75 [0.67-0.83],4.3106229687015406e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCF2,Neutrophil cytosol factor 2,21238,1861,1.07 [1.03-1.12],0.0016911706835993
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCK2,Cytoplasmic protein NCK2,21367,1868,1.01 [0.98-1.05],0.483956110079034
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCLN,Nicalin,20914,1833,0.94 [0.85-1.05],0.2699679815254919
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCR1,Natural cytotoxicity triggering receptor 1,21252,1862,0.92 [0.83-1.03],0.1638660549832588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,18435,1602,1.12 [0.97-1.29],0.1371037448707641
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCS1,Neuronal calcium sensor 1,21472,1876,1.11 [0.96-1.29],0.1668330098396448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDRG1,Protein NDRG1,20838,1837,1.00 [0.94-1.07],0.9455327163462988
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,18419,1587,1.01 [0.93-1.10],0.7846343584070669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,17915,1557,1.02 [0.88-1.18],0.8151653320433279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,18435,1602,1.00 [0.95-1.06],0.9799147240318178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",20784,1814,1.06 [1.01-1.11],0.0195240360596665
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEB,Nebulin,17856,1551,0.97 [0.85-1.11],0.6774579914343672
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECAP2,Adaptin ear-binding coat-associated protein 2,17856,1551,1.02 [0.95-1.09],0.6092606429400744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN1,Nectin-1,17944,1562,1.11 [0.95-1.29],0.1763600475572129
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN2,Nectin-2,21260,1858,1.59 [1.40-1.82],4.132424804404975e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN4,Nectin-4,21352,1860,1.28 [1.13-1.45],0.0001122428192343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,17944,1562,0.98 [0.88-1.09],0.70183242164583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEDD9,Enhancer of filamentation 1,17944,1562,1.02 [0.90-1.16],0.7239474207504386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEFL,Neurofilament light polypeptide,20779,1831,1.34 [1.23-1.46],2.0108664213945448e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEK7,Serine/threonine-protein kinase Nek7,18165,1571,1.04 [0.97-1.12],0.2572526438148427
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,21352,1860,0.85 [0.77-0.93],0.0006036193475577
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NELL2,Protein kinase C-binding protein NELL2,21367,1868,0.97 [0.84-1.12],0.6494739316995093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NENF,Neudesin,18419,1587,0.95 [0.90-1.00],0.0746389120728205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEO1,Neogenin,18454,1594,0.98 [0.78-1.23],0.8391423525327978
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEXN,Nexilin,18509,1603,1.02 [0.95-1.09],0.6622620771600758
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFASC,Neurofascin,21543,1879,1.47 [1.28-1.68],2.668367367389659e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFAT5,Nuclear factor of activated T-cells 5,17944,1562,1.07 [1.01-1.13],0.0269266510591001
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",21282,1863,1.00 [0.96-1.04],0.83771278845734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",20914,1833,1.17 [1.10-1.24],2.0170898029411622e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFE2,Transcription factor NF-E2 45 kDa subunit,17992,1559,1.03 [0.97-1.10],0.3620115292436457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFIC,Nuclear factor 1 C-type,18454,1594,0.97 [0.87-1.08],0.5971338732163392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKB1,Nuclear factor NF-kappa-B p105 subunit,17856,1551,1.04 [0.98-1.12],0.1934540854744862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKB2,Nuclear factor NF-kappa-B p100 subunit,18165,1571,1.01 [0.91-1.11],0.9032733554923272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKBIE,NF-kappa-B inhibitor epsilon,20784,1814,1.07 [0.98-1.16],0.1293173650042799
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",18435,1602,1.04 [0.99-1.08],0.1238912520895522
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFX1,Transcriptional repressor NF-X1,17856,1551,1.03 [0.95-1.10],0.4735703025457268
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFYA,Nuclear transcription factor Y subunit alpha,17856,1551,1.06 [0.94-1.20],0.3327992575055808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NGF,Beta-nerve growth factor,21104,1848,1.15 [0.80-1.65],0.4453770217500757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NGFR,Tumor necrosis factor receptor superfamily member 16,18494,1603,0.93 [0.78-1.10],0.3755804110686335
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NGRN,Neugrin,18446,1599,1.20 [0.96-1.50],0.1024962302869772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NHLRC3,NHL repeat-containing protein 3,17655,1527,1.89 [1.61-2.21],2.041080747792106e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NID1,Nidogen-1,21325,1860,1.16 [1.04-1.29],0.0091992339108581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NID2,Nidogen-2,21302,1865,1.05 [0.99-1.10],0.1062054735910777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NINJ1,Ninjurin-1,20784,1814,1.05 [0.97-1.13],0.2283328408306545
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NIT1,Deaminated glutathione amidase,17992,1559,0.94 [0.83-1.05],0.2479547510763858
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NIT2,Omega-amidase NIT2,18425,1598,1.06 [1.00-1.13],0.0559670412482754
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NLGN1,Neuroligin-1,18001,1566,1.00 [0.93-1.08],0.9777256612641708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NLGN2,Neuroligin-2,17877,1545,0.93 [0.82-1.05],0.2432798958891381
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NME1,Nucleoside diphosphate kinase A,17944,1562,1.04 [0.82-1.31],0.7659592925431248
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NME3,Nucleoside diphosphate kinase 3,21292,1863,1.53 [1.29-1.80],6.828243022807718e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMI,N-myc-interactor,18343,1580,1.09 [1.02-1.16],0.0113925395853277
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,21104,1848,1.03 [0.98-1.09],0.2402064792749743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMRK2,Nicotinamide riboside kinase 2,17841,1543,0.94 [0.83-1.07],0.3629367670560216
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,18454,1594,0.95 [0.88-1.03],0.2143230560700543
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOMO1,Nodal modulator 1,21302,1865,1.59 [1.33-1.90],3.3093487315253465e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOP56,Nucleolar protein 56,17856,1551,1.02 [0.97-1.07],0.3684504914848143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS1,"Nitric oxide synthase, brain",20838,1837,1.02 [0.94-1.10],0.6975940774976125
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS2,"Nitric oxide synthase, inducible",17856,1551,1.02 [0.91-1.15],0.756225925786903
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS3,"Nitric oxide synthase, endothelial",20838,1837,1.13 [1.05-1.22],0.0014994495005321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH1,Neurogenic locus notch homolog protein 1,21556,1882,0.72 [0.56-0.94],0.013351732537347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH2,Neurogenic locus notch homolog protein 2,18498,1605,0.86 [0.72-1.03],0.1061023890223118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH3,Neurogenic locus notch homolog protein 3,21556,1882,1.02 [0.90-1.15],0.7381297707643657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,18187,1579,1.76 [1.54-2.02],4.935623626295001e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,21289,1860,1.45 [1.28-1.64],2.443655913602968e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPHS1,Nephrin,17944,1562,1.09 [0.95-1.25],0.2352564099325157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPHS2,Podocin,17944,1562,1.02 [0.98-1.07],0.2741386415442759
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPL,N-acetylneuraminate lyase,18494,1603,1.27 [1.15-1.40],1.712569578677123e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPB,Natriuretic peptides B,20906,1832,1.10 [1.07-1.14],4.647539006315003e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPC,C-type natriuretic peptide,21282,1863,0.99 [0.92-1.07],0.7856155970206529
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPR1,Atrial natriuretic peptide receptor 1,17856,1551,0.82 [0.71-0.96],0.0158945623071031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTN,Neuroplastin,20784,1814,1.02 [0.97-1.08],0.4449835098284228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX1,Neuronal pentraxin-1,21302,1865,1.45 [1.34-1.58],3.992086381424198e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX2,Neuronal pentraxin-2,18498,1605,1.31 [1.14-1.50],0.0001636927334948
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTXR,Neuronal pentraxin receptor,21289,1860,0.87 [0.77-0.98],0.0274517984037538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPY,Pro-neuropeptide Y,21472,1876,1.00 [0.94-1.06],0.9951453427035672
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRCAM,Neuronal cell adhesion molecule,21289,1860,0.94 [0.81-1.09],0.4007904837251248
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRGN,Neurogranin,18509,1603,1.03 [0.98-1.08],0.3249817765294253
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRN1,Neuritin,18454,1594,1.06 [0.94-1.20],0.3250942398275732
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRP1,Neuropilin-1,21427,1865,1.24 [1.06-1.44],0.0063584042855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRP2,Neuropilin-2,21302,1865,1.14 [0.99-1.31],0.0604006712455521
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRTN,Neurturin,20914,1833,1.06 [0.98-1.14],0.1518704928848196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRXN3,Neurexin-3,18001,1566,0.91 [0.78-1.06],0.2407467664727218
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NSFL1C,NSFL1 cofactor p47,21484,1876,1.04 [0.98-1.11],0.216968224820131
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",18494,1603,0.99 [0.92-1.05],0.6450584742941301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,18446,1599,1.66 [1.44-1.92],4.10764421252775e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C3A,Cytosolic 5'-nucleotidase 3A,21246,1860,0.95 [0.91-1.00],0.0473139278190099
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5E,5'-nucleotidase,21352,1860,1.28 [1.18-1.38],1.722656224306173e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTF3,Neurotrophin-3,21282,1863,1.13 [1.00-1.26],0.0436858661092633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTF4,Neurotrophin-4,20784,1814,0.99 [0.87-1.11],0.8160496352148663
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK2,BDNF/NT-3 growth factors receptor,21289,1860,0.85 [0.72-1.00],0.049052810741376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK3,NT-3 growth factor receptor,21484,1876,0.68 [0.57-0.83],8.605443737441688e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,21289,1860,1.19 [1.14-1.23],3.1075013724525653e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUB1,NEDD8 ultimate buster 1,21282,1863,1.01 [0.96-1.06],0.7207979620624552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,18419,1587,0.95 [0.90-1.01],0.104767504434265
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUCB2,Nucleobindin-2,21439,1873,1.21 [1.09-1.35],0.0002909184812839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDC,Nuclear migration protein nudC,21543,1879,1.06 [0.99-1.13],0.087388755939998
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,17992,1559,1.08 [0.87-1.33],0.4992626209793965
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,17856,1551,1.05 [0.95-1.16],0.304062038054684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT16,U8 snoRNA-decapping enzyme,18403,1599,1.08 [1.02-1.14],0.0047092354372267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],21186,1853,0.90 [0.84-0.97],0.0067397727815998
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT5,ADP-sugar pyrophosphatase,21302,1865,1.15 [1.06-1.25],0.0007185714841099
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUMB,Protein numb homolog,17944,1562,1.03 [0.97-1.09],0.2936683982811721
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUP50,Nuclear pore complex protein Nup50,17856,1551,1.11 [0.97-1.28],0.14096677916899
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NXPE4,NXPE family member 4,17856,1551,1.04 [0.91-1.20],0.5542811742504553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NXPH1,Neurexophilin-1,20838,1837,0.96 [0.86-1.08],0.4936268240322595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NXPH3,Neurexophilin-3,17944,1562,1.02 [0.86-1.20],0.8381641970425955
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OBP2B,Odorant-binding protein 2b,21032,1841,0.92 [0.85-0.99],0.0189204615243442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OCLN,Occludin,18454,1594,1.96 [1.77-2.16],1.886753268996058e-38
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ODAM,Odontogenic ameloblast-associated protein,20803,1831,0.94 [0.87-1.02],0.118126691512444
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OFD1,Oral-facial-digital syndrome 1 protein,18165,1571,1.06 [0.98-1.14],0.138210027083094
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGA,Protein O-GlcNAcase,18435,1602,1.03 [0.97-1.10],0.3055409749796642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGFR,Opioid growth factor receptor,21186,1853,1.02 [0.90-1.16],0.766962381659311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGN,Mimecan,21302,1865,1.18 [1.07-1.30],0.001213745506499
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,18165,1571,0.97 [0.89-1.06],0.5273042169148796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLFM4,Olfactomedin-4,17412,1496,1.08 [1.04-1.12],0.000251811822634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLR1,Oxidized low-density lipoprotein receptor 1,21076,1843,1.17 [1.11-1.24],2.027614484291561e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMD,Osteomodulin,21367,1868,0.74 [0.68-0.82],3.257395428872174e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMG,Oligodendrocyte-myelin glycoprotein,21186,1853,0.84 [0.79-0.89],7.977572354691066e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMP,Olfactory marker protein,17877,1545,0.97 [0.87-1.07],0.5179023796863172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OPHN1,Oligophrenin-1,18446,1599,1.02 [0.97-1.06],0.4318762108404568
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OPLAH,5-oxoprolinase,17992,1559,1.06 [0.99-1.14],0.0852949653064218
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OPTC,Opticin,21186,1853,1.00 [0.91-1.10],0.9482458980305029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ORM1,Alpha-1-acid glycoprotein 1,18443,1605,2.29 [1.83-2.87],5.264925230083235e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSBPL2,Oxysterol-binding protein-related protein 2,18446,1599,1.05 [0.92-1.20],0.4442528810403064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,21292,1863,1.68 [1.49-1.89],6.066580703839952e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSM,Oncostatin-M,21175,1854,1.28 [1.21-1.35],1.9044282184730048e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,21427,1865,2.30 [1.86-2.84],1.3581697692886443e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSTN,Osteocrin,18001,1566,0.98 [0.88-1.09],0.7166836366407519
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OTOA,Otoancorin,17877,1545,0.95 [0.86-1.05],0.3412562907128932
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OTUD6B,Deubiquitinase OTUD6B,18435,1602,1.05 [0.97-1.13],0.2749829097811488
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OTUD7B,OTU domain-containing protein 7B,18454,1594,1.10 [1.02-1.18],0.0106545173545821
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",17992,1559,1.07 [1.00-1.14],0.0585840796028307
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXT,Oxytocin-neurophysin 1,21484,1876,1.06 [1.03-1.09],4.171706583941616e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",P4HB,Protein disulfide-isomerase,21193,1845,1.21 [1.09-1.34],0.0002251140026509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PACS2,Phosphofurin acidic cluster sorting protein 2,17856,1551,1.03 [0.95-1.11],0.4673855978117741
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PADI2,Protein-arginine deiminase type-2,20914,1833,0.99 [0.92-1.07],0.8115438188453321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PADI4,Protein-arginine deiminase type-4,20803,1831,1.02 [0.97-1.08],0.3955214039655715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAEP,Glycodelin,21104,1848,1.01 [0.96-1.05],0.7988583950429868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,18454,1594,0.94 [0.89-0.99],0.0301350514658743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",18165,1571,1.02 [0.93-1.13],0.6670519429211009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,20906,1832,1.09 [1.02-1.17],0.0140132678349881
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAGR1,PAXIP1-associated glutamate-rich protein 1,17992,1559,1.00 [0.89-1.11],0.951406977474959
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,17810,1538,0.99 [0.89-1.10],0.8297987482007687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAK4,Serine/threonine-protein kinase PAK 4,20838,1837,1.00 [0.94-1.07],0.9234901811144902
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALLD,Palladin,17944,1562,1.00 [0.88-1.13],0.961188197467556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM,Paralemmin-1,18330,1591,1.14 [0.98-1.34],0.0945990498904804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM2,Paralemmin-2,18446,1599,1.84 [1.64-2.07],1.336713104404372e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM3,Paralemmin-3,17856,1551,0.97 [0.89-1.06],0.5325481602098528
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAM,Peptidyl-glycine alpha-amidating monooxygenase,21469,1872,1.17 [1.01-1.36],0.042204065211508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAMR1,Inactive serine protease PAMR1,21302,1865,1.11 [0.96-1.29],0.172284691086566
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAPPA,Pappalysin-1,20914,1833,1.03 [0.94-1.12],0.5661076034839416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARD3,Partitioning defective 3 homolog,18165,1571,0.97 [0.90-1.04],0.3563455838040278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARK7,Parkinson disease protein 7,21302,1865,1.06 [0.98-1.15],0.1606794170678913
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARP1,Poly [ADP-ribose] polymerase 1,21282,1863,1.08 [1.02-1.15],0.0091590094487274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAXX,Protein PAXX,18077,1558,1.09 [0.99-1.21],0.0858585353659481
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PBK,Lymphokine-activated killer T-cell-originated protein kinase,17841,1543,1.01 [0.86-1.18],0.9455076404364102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PBLD,Phenazine biosynthesis-like domain-containing protein,20838,1837,0.99 [0.92-1.07],0.8243155652512406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,18435,1602,1.14 [0.98-1.33],0.0895639583964273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCARE,Photoreceptor cilium actin regulator,17877,1545,1.00 [0.95-1.06],0.9268567822702924
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,18042,1555,1.19 [1.09-1.31],0.0001985402261879
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCBP2,Poly(rC)-binding protein 2,18454,1594,1.03 [0.96-1.10],0.4077987500042012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH1,Protocadherin-1,21472,1872,0.96 [0.79-1.16],0.6825859784728283
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH12,Protocadherin-12,18454,1594,0.94 [0.78-1.15],0.5632202508934507
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH17,Protocadherin-17,21289,1860,0.87 [0.78-0.98],0.0232372268220934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH7,Protocadherin-7,18435,1602,0.90 [0.77-1.04],0.154038536660014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH9,Protocadherin-9,18435,1602,0.82 [0.72-0.93],0.0023322986309619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDHB15,Protocadherin beta-15,18419,1587,0.85 [0.75-0.97],0.0153224558314802
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCNA,Proliferating cell nuclear antigen,17841,1543,0.97 [0.90-1.05],0.4944239622114269
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCSK7,Proprotein convertase subtilisin/kexin type 7,18419,1587,0.99 [0.89-1.10],0.872515702666285
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCSK9,Proprotein convertase subtilisin/kexin type 9,21556,1882,1.33 [1.20-1.47],4.7183470755038774e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCYT2,Ethanolamine-phosphate cytidylyltransferase,18435,1602,1.04 [0.98-1.10],0.239648325532791
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDAP1,28 kDa heat- and acid-stable phosphoprotein,18494,1603,1.01 [0.96-1.05],0.7991402679444999
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD1,Programmed cell death protein 1,21436,1873,1.06 [0.96-1.18],0.2187589446895095
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD1LG2,Programmed cell death 1 ligand 2,21186,1853,1.07 [0.93-1.22],0.3402631323086531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD5,Programmed cell death protein 5,21484,1876,1.12 [1.04-1.20],0.0015919212599016
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD6,Programmed cell death protein 6,21289,1860,1.04 [0.98-1.10],0.1791522043534056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCL2,Phosducin-like protein 2,17841,1543,1.07 [0.96-1.18],0.2218475659374875
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",17841,1543,1.09 [1.00-1.19],0.0525351319818989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",17856,1551,0.98 [0.90-1.06],0.6168193796278143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",18077,1558,1.00 [0.96-1.05],0.8916050895922737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFA,Platelet-derived growth factor subunit A,21556,1882,1.07 [1.01-1.13],0.018302057432903
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFB,Platelet-derived growth factor subunit B,21367,1868,1.09 [1.04-1.14],0.0005803565609855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFC,Platelet-derived growth factor C,20784,1814,1.05 [0.90-1.23],0.5183115132019287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFRA,Platelet-derived growth factor receptor alpha,21289,1860,1.16 [1.00-1.35],0.0471024661996896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFRB,Platelet-derived growth factor receptor beta,21556,1882,1.06 [0.95-1.19],0.3074182606014667
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA2,Protein disulfide-isomerase A2,17841,1543,0.98 [0.87-1.11],0.7917623026833474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA3,Protein disulfide-isomerase A3,18077,1558,1.52 [1.24-1.85],4.885681984537104e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA4,Protein disulfide-isomerase A4,18498,1605,1.06 [0.98-1.14],0.1391177776068925
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA5,Protein disulfide-isomerase A5,17841,1543,1.09 [1.00-1.18],0.0482533581879868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDLIM5,PDZ and LIM domain protein 5,18454,1594,1.01 [0.98-1.05],0.4841731106278939
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDLIM7,PDZ and LIM domain protein 7,21367,1868,1.03 [1.00-1.06],0.0895246564128216
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",20784,1814,0.96 [0.88-1.05],0.3459106522330837
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDRG1,p53 and DNA damage-regulated protein 1,18001,1566,0.96 [0.87-1.06],0.4603088122221593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,17841,1543,1.05 [0.98-1.14],0.1664393559898578
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZD2,PDZ domain-containing protein 2,17856,1551,1.13 [1.05-1.23],0.0022584590772366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,17944,1562,1.42 [1.29-1.56],8.461910679322901e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PEAR1,Platelet endothelial aggregation receptor 1,21556,1882,0.93 [0.78-1.11],0.4470172223471274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PEBP1,Phosphatidylethanolamine-binding protein 1,21302,1865,1.08 [1.01-1.16],0.035507343273165
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PECAM1,Platelet endothelial cell adhesion molecule,21302,1865,1.16 [1.02-1.33],0.0253319585011086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PECR,Peroxisomal trans-2-enoyl-CoA reductase,17992,1559,1.07 [0.91-1.26],0.3907680739465742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PENK,Proenkephalin-A,18077,1558,1.20 [1.02-1.42],0.027781162876024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PEPD,Xaa-Pro dipeptidase,18509,1603,1.24 [1.04-1.48],0.0190998948400686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PER3,Period circadian protein homolog 3,17944,1562,1.04 [1.00-1.08],0.0645924892493416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PF4,Platelet factor 4,18365,1602,1.07 [1.02-1.13],0.0043406138348167
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFDN2,Prefoldin subunit 2,20838,1837,1.06 [0.98-1.15],0.1418696826438459
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFDN4,Prefoldin subunit 4,17841,1543,0.98 [0.89-1.08],0.6851788450017353
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFDN6,Prefoldin subunit 6,18001,1566,1.01 [0.94-1.09],0.7012455465141886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",21156,1849,1.01 [0.96-1.07],0.614234932658561
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGA4,Pepsin A-4,18509,1603,1.18 [1.10-1.27],1.7315069672683252e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",18494,1603,1.03 [0.94-1.12],0.5654992935677878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGF,Placenta growth factor,21543,1879,1.58 [1.41-1.78],9.558096568824068e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,21451,1873,1.27 [1.17-1.39],7.650341553619883e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,18289,1596,1.41 [1.19-1.67],5.676259220082102e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP4,Peptidoglycan recognition protein 4,17856,1551,1.02 [0.94-1.11],0.6659094495976978
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGM2,Phosphoglucomutase-2,18001,1566,1.01 [0.93-1.10],0.7348452531440124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGR,Progesterone receptor,17944,1562,0.98 [0.92-1.04],0.4700717153727722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHACTR2,Phosphatase and actin regulator 2,18454,1594,1.02 [0.98-1.06],0.3676477487454785
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHLDB1,Pleckstrin homology-like domain family B member 1,18435,1602,1.17 [1.06-1.28],0.0009099505115367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHLDB2,Pleckstrin homology-like domain family B member 2,17841,1543,0.99 [0.94-1.05],0.8486712068275284
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,21104,1848,1.28 [1.10-1.48],0.0011681014231352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,18077,1558,1.09 [0.98-1.21],0.1192661453171957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI16,Peptidase inhibitor 16,18509,1603,0.78 [0.64-0.96],0.0165475143246234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI3,Elafin,21012,1833,1.20 [1.12-1.29],3.295036056183724e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",18454,1594,1.03 [0.97-1.09],0.372388802869786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIGR,Polymeric immunoglobulin receptor,21029,1849,2.39 [2.16-2.63],1.942604196875392e-68
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,21282,1863,1.10 [1.03-1.17],0.0039104066418754
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,21302,1865,1.50 [1.30-1.73],1.9931679671873743e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,17944,1562,1.03 [0.95-1.12],0.4883164575332314
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,21302,1865,1.44 [1.30-1.59],6.473894473541847e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,21289,1860,1.24 [1.15-1.33],2.590868721402628e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,18077,1558,1.03 [0.96-1.10],0.4264123263053919
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PITHD1,PITH domain-containing protein 1,17810,1538,1.05 [0.98-1.11],0.1658331643549785
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKD1,Polycystin-1,18494,1603,1.24 [1.03-1.49],0.0220347486601721
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKD2,Polycystin-2,17856,1551,1.13 [1.04-1.23],0.0029006307478517
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKLR,Pyruvate kinase PKLR,21296,1861,1.06 [1.00-1.13],0.0703281280969542
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKN3,Serine/threonine-protein kinase N3,18165,1571,1.08 [1.01-1.14],0.0149247367297004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G10,Group 10 secretory phospholipase A2,21104,1848,0.97 [0.91-1.05],0.481920971115682
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G15,Phospholipase A2 group XV,21352,1860,2.26 [1.98-2.58],6.2969809317896495e-34
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G1B,Phospholipase A2,21526,1880,0.90 [0.82-0.99],0.0226449003959269
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G2A,"Phospholipase A2, membrane associated",21264,1857,1.21 [1.13-1.30],5.9183519028222553e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G4A,Cytosolic phospholipase A2,21367,1868,1.03 [0.99-1.08],0.1950076542287731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G7,Platelet-activating factor acetylhydrolase,21302,1865,1.02 [0.90-1.15],0.7862035735515973
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAT,Tissue-type plasminogen activator,21480,1875,1.36 [1.25-1.47],2.245694836987331e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAU,Urokinase-type plasminogen activator,21302,1865,1.34 [1.16-1.56],8.133354304403274e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,21121,1852,2.69 [2.34-3.09],1.0549538089711908e-44
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLB1,"Phospholipase B1, membrane-associated",18446,1599,0.94 [0.87-1.02],0.1464431741758304
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",17944,1562,0.90 [0.80-1.03],0.1242778318500242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",18446,1599,1.04 [0.99-1.09],0.1281142503338083
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLEKHO1,Pleckstrin homology domain-containing family O member 1,18446,1599,1.06 [0.99-1.13],0.0789923932411462
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLG,Plasminogen,18063,1579,1.96 [1.56-2.48],1.2079511797609132e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLIN1,Perilipin-1,20838,1837,1.15 [1.02-1.29],0.0179501715572757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLIN3,Perilipin-3,21289,1860,1.13 [1.03-1.25],0.0088224463360151
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLPBP,Pyridoxal phosphate homeostasis protein,21289,1860,1.04 [0.98-1.10],0.2386007776015447
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLSCR3,Phospholipid scramblase 3,18404,1594,1.09 [1.01-1.18],0.0351964014317851
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLTP,Phospholipid transfer protein,21498,1878,1.02 [0.92-1.13],0.7317429450565531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXDC1,Plexin domain-containing protein 1,20784,1814,0.76 [0.65-0.88],0.0004244722887479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXDC2,Plexin domain-containing protein 2,18446,1599,1.12 [0.94-1.35],0.2033676807077067
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNA4,Plexin-A4,21282,1863,1.02 [0.97-1.07],0.4421097926222916
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNB2,Plexin-B2,21444,1871,1.49 [1.27-1.76],1.8665351909555413e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNB3,Plexin-B3,21218,1852,1.03 [0.94-1.12],0.5461138029006183
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,21194,1851,0.99 [0.97-1.01],0.2446854437082808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMCH,Pro-MCH,17856,1551,1.00 [0.94-1.06],0.8840809514129055
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMM2,Phosphomannomutase 2,17856,1551,1.01 [0.93-1.09],0.867224639557219
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMS1,PMS1 protein homolog 1,18001,1566,1.11 [1.01-1.22],0.0292962256811629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMVK,Phosphomevalonate kinase,20805,1835,1.02 [0.98-1.06],0.3692053882451085
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIP,Pancreatic triacylglycerol lipase,18509,1603,1.03 [0.96-1.10],0.3816969682580531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIPRP1,Inactive pancreatic lipase-related protein 1,18446,1599,1.05 [1.00-1.11],0.0656366302311747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIPRP2,Pancreatic lipase-related protein 2,21262,1860,1.00 [0.99-1.01],0.9646857103260396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNMA1,Paraneoplastic antigen Ma1,17992,1559,1.00 [0.92-1.08],0.9178067025475186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNMA2,Paraneoplastic antigen Ma2,17877,1545,1.01 [0.90-1.14],0.8127184168509825
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",20914,1833,1.01 [0.97-1.05],0.6240165448103536
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PODXL,Podocalyxin,21186,1853,0.84 [0.64-1.11],0.2186321785069654
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PODXL2,Podocalyxin-like protein 2,21352,1860,0.98 [0.85-1.13],0.7874661582645903
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POF1B,Protein POF1B,17944,1562,1.16 [1.05-1.27],0.0031167466831633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POLR2A,DNA-directed RNA polymerase II subunit RPB1,17944,1562,0.88 [0.74-1.05],0.1457368080199313
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",21186,1853,1.28 [1.16-1.40],2.6535813693109626e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POMC,Pro-opiomelanocortin,17992,1559,0.98 [0.92-1.05],0.5275767765562208
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON1,Serum paraoxonase/arylesterase 1,18509,1603,0.75 [0.64-0.87],0.0002151745733462
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON2,Serum paraoxonase/arylesterase 2,20906,1832,1.31 [1.16-1.47],6.253233918747867e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON3,Serum paraoxonase/lactonase 3,21367,1868,0.91 [0.81-1.03],0.1230197988408724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POSTN,Periostin,18498,1605,0.85 [0.75-0.97],0.0118587658301984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPBP,Platelet basic protein,18367,1604,1.09 [1.03-1.15],0.0042202310472913
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPCDC,Phosphopantothenoylcysteine decarboxylase,21484,1876,1.12 [1.02-1.22],0.0124182547742527
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPIB,Peptidyl-prolyl cis-trans isomerase B,21311,1860,1.03 [0.99-1.08],0.1450049560639001
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPIE,Peptidyl-prolyl cis-trans isomerase E,18165,1571,1.03 [0.96-1.10],0.4352324788299349
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",18498,1605,1.03 [0.96-1.11],0.4172960967251691
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPL,Periplakin,17944,1562,1.41 [1.21-1.63],6.387507661826619e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPM1A,Protein phosphatase 1A,20784,1814,1.05 [0.92-1.21],0.4456953572006753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPM1B,Protein phosphatase 1B,17944,1562,0.97 [0.88-1.07],0.561891699868746
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPM1F,Protein phosphatase 1F,18494,1603,0.99 [0.91-1.08],0.8256610743100226
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPME1,Protein phosphatase methylesterase 1,21186,1853,1.04 [0.97-1.12],0.2687988143630273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,18419,1587,0.98 [0.93-1.04],0.5570826044837529
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,21352,1860,1.03 [0.99-1.07],0.184561190055524
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,18165,1571,1.04 [0.97-1.11],0.2370357765605119
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,18454,1594,1.02 [0.96-1.08],0.5053425648480984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,18454,1594,1.27 [1.14-1.41],1.4987243681663809e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R2,Protein phosphatase inhibitor 2,21289,1860,1.02 [0.97-1.08],0.3660928436608173
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R9B,Neurabin-2,21543,1879,1.00 [0.96-1.05],0.8795020829167906
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,18435,1602,1.01 [0.97-1.05],0.737340522522064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP3R1,Calcineurin subunit B type 1,21104,1848,1.03 [0.94-1.14],0.5006442924098128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPT1,Palmitoyl-protein thioesterase 1,18001,1566,1.04 [0.98-1.10],0.1701620517341049
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPY,Pancreatic prohormone,21230,1848,1.05 [1.01-1.09],0.0172330109202688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PQBP1,Polyglutamine-binding protein 1,20784,1814,1.11 [1.05-1.19],0.0008861010192317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAME,Melanoma antigen preferentially expressed in tumors,17841,1543,0.92 [0.75-1.12],0.4014112399815596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAP1,Proline-rich acidic protein 1,18498,1605,1.59 [1.39-1.81],2.418197914492609e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRC1,Protein regulator of cytokinesis 1,18419,1587,1.01 [0.90-1.14],0.8315370481718399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,21425,1869,1.57 [1.38-1.78],4.380080219981997e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX1,Peroxiredoxin-1,20661,1804,0.98 [0.93-1.02],0.2963688910966796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX2,Peroxiredoxin-2,18197,1576,0.97 [0.89-1.04],0.3899682712040232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",20914,1833,1.07 [1.01-1.14],0.0161616493648379
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX5,"Peroxiredoxin-5, mitochondrial",21543,1879,1.01 [0.95-1.07],0.7731436116970937
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX6,Peroxiredoxin-6,21472,1876,0.89 [0.83-0.95],0.000460152628084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PREB,Prolactin regulatory element-binding protein,20914,1833,1.32 [1.15-1.51],5.429516855128715e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRELP,Prolargin,21262,1860,1.00 [0.83-1.20],0.9968276880714712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRG2,Bone marrow proteoglycan,18498,1605,1.17 [1.07-1.28],0.0008982644953534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRG3,Proteoglycan 3,18498,1605,1.09 [0.99-1.20],0.0775571150071371
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,20914,1833,1.04 [0.97-1.12],0.2457342685319389
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,18001,1566,0.95 [0.81-1.13],0.5641278753172737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,21289,1860,1.01 [0.96-1.06],0.8093582294370403
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,18407,1596,1.05 [0.99-1.12],0.0906875103064512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKCQ,Protein kinase C theta type,20914,1833,1.00 [0.90-1.11],0.9866996980066132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKD2,Serine/threonine-protein kinase D2,17856,1551,0.98 [0.86-1.12],0.7717086249156806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKG1,cGMP-dependent protein kinase 1,18077,1558,1.02 [0.98-1.06],0.3537472527011159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,20784,1814,1.07 [1.01-1.14],0.0302791172552564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRL,Prolactin,21484,1876,0.99 [0.94-1.05],0.7840147603106311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRND,Prion-like protein doppel,18446,1599,1.04 [0.95-1.14],0.3866090149780289
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROC,Vitamin K-dependent protein C,21360,1861,0.83 [0.71-0.98],0.0322630983687405
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROCR,Endothelial protein C receptor,17856,1551,1.05 [0.93-1.17],0.4452415808665588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROK1,Prokineticin-1,21282,1863,1.00 [0.92-1.08],0.923962961491541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROS1,Vitamin K-dependent protein S,18511,1612,1.24 [1.03-1.51],0.0271170574633964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRR4,Proline-rich protein 4,17941,1547,1.06 [1.00-1.14],0.0695065043111755
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRR5,Proline-rich protein 5,17944,1562,1.01 [0.90-1.12],0.9132190945542172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRRT3,Proline-rich transmembrane protein 3,17992,1559,0.99 [0.87-1.13],0.9003183157601153
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS2,Trypsin-2,21393,1864,1.32 [1.24-1.40],1.6156031586843405e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS22,Brain-specific serine protease 4,17944,1562,1.31 [1.18-1.46],8.160083383960934e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS27,Serine protease 27,21214,1853,1.13 [1.02-1.25],0.0199688319384703
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS53,Serine protease 53,18446,1599,0.97 [0.86-1.09],0.5710978031013432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS8,Prostasin,21188,1857,1.96 [1.79-2.15],6.727017956731066e-47
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,20838,1837,1.00 [0.96-1.04],0.9483759970237596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTG,Protogenin,21472,1876,1.15 [0.98-1.35],0.0885488542889762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTN3,Myeloblastin,20770,1811,1.15 [1.06-1.23],0.0002612740101745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRUNE2,Protein prune homolog 2,18165,1571,1.16 [0.98-1.38],0.0785948274180414
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAP,Prosaposin,18332,1593,1.71 [1.45-2.00],5.0258740813664946e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAPL1,Proactivator polypeptide-like 1,18435,1602,0.96 [0.87-1.05],0.3656363742363872
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSCA,Prostate stem cell antigen,18435,1602,1.01 [0.99-1.02],0.4420530092193441
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSG1,Pregnancy-specific beta-1-glycoprotein 1,21104,1848,1.07 [1.03-1.11],0.0005949696437135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSIP1,PC4 and SFRS1-interacting protein,21282,1863,1.06 [1.00-1.12],0.0358428355737745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMA1,Proteasome subunit alpha type-1,20784,1814,0.95 [0.86-1.04],0.2712101505993757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMC3,26S proteasome regulatory subunit 6A,17841,1543,0.76 [0.64-0.92],0.0037097392607613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMD1,26S proteasome non-ATPase regulatory subunit 1,18454,1594,0.93 [0.85-1.03],0.1756164227083196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMD5,26S proteasome non-ATPase regulatory subunit 5,18001,1566,1.01 [0.91-1.12],0.8112129923690669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMD9,26S proteasome non-ATPase regulatory subunit 9,21186,1853,1.05 [0.98-1.13],0.1688224097564352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSME1,Proteasome activator complex subunit 1,21067,1843,1.11 [0.99-1.24],0.0763438643107109
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSME2,Proteasome activator complex subunit 2,21009,1835,1.03 [0.92-1.16],0.6061627966044871
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMG3,Proteasome assembly chaperone 3,21282,1863,1.04 [0.96-1.13],0.3491768600936534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMG4,Proteasome assembly chaperone 4,17944,1562,1.05 [0.97-1.15],0.2442713478444159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSPN,Persephin,21282,1863,1.08 [1.03-1.14],0.0011892462987534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSRC1,Proline/serine-rich coiled-coil protein 1,20784,1814,1.09 [1.02-1.17],0.0110705862025468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,17442,1498,1.01 [0.97-1.06],0.6073508815763456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",20838,1837,0.91 [0.79-1.05],0.1957950365130594
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGDS,Prostaglandin-H2 D-isomerase,21144,1845,1.18 [1.03-1.36],0.0180783137816745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGES2,Prostaglandin E synthase 2,17819,1546,1.06 [0.97-1.16],0.2186779955769081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGR1,Prostaglandin reductase 1,18494,1603,1.08 [1.02-1.14],0.0049935202477276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTH,Parathyroid hormone,18001,1566,1.01 [0.95-1.07],0.7098512864791877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,21282,1863,1.03 [0.93-1.15],0.5660589434235348
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTK7,Inactive tyrosine-protein kinase 7,20838,1837,1.24 [1.11-1.40],0.0002769574577576
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTN,Pleiotrophin,20906,1832,1.16 [1.07-1.26],0.0005016936228252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTP4A3,Protein tyrosine phosphatase type IVA 3,17944,1562,1.14 [1.04-1.25],0.0062163648846978
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,21104,1848,1.07 [1.02-1.13],0.0062926132365338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,21336,1865,1.02 [0.98-1.07],0.3573783248023635
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,17913,1557,1.05 [0.92-1.19],0.4741384838217617
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRB,Receptor-type tyrosine-protein phosphatase beta,18494,1603,1.57 [1.37-1.81],1.9668072911665582e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRC,Receptor-type tyrosine-protein phosphatase C,18498,1605,0.92 [0.75-1.13],0.4352914968606569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRF,Receptor-type tyrosine-protein phosphatase F,21556,1882,0.87 [0.75-1.01],0.0667287852906065
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRH,Receptor-type tyrosine-protein phosphatase H,18435,1602,0.86 [0.78-0.95],0.0025102280797145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,18435,1602,1.30 [1.04-1.61],0.0187062391798945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRM,Receptor-type tyrosine-protein phosphatase mu,21251,1860,0.90 [0.76-1.06],0.1940126292343722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,21035,1839,1.19 [1.05-1.35],0.0054867673280662
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRR,Receptor-type tyrosine-protein phosphatase R,18446,1599,0.92 [0.81-1.05],0.2095154940543175
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRS,Receptor-type tyrosine-protein phosphatase S,21556,1882,0.81 [0.69-0.95],0.0116215315943229
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,18494,1603,1.04 [0.88-1.22],0.6516898842490266
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,18077,1558,0.95 [0.88-1.03],0.2209233789369599
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTS,6-pyruvoyl tetrahydrobiopterin synthase,20738,1830,1.09 [1.01-1.18],0.0204498941064508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTTG1,Securin,18165,1571,1.02 [0.91-1.15],0.7139256987238385
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTX3,Pentraxin-related protein PTX3,21282,1863,1.22 [1.11-1.33],1.3382887952150667e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVALB,Parvalbumin alpha,21388,1869,1.01 [0.97-1.05],0.5817859270760479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVR,Poliovirus receptor,21484,1876,1.60 [1.44-1.76],4.467113503961564e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PXDNL,Peroxidasin-like protein,18419,1587,1.07 [0.99-1.15],0.0795146351147766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PXN,Paxillin,20838,1837,1.07 [0.99-1.16],0.0932470319383055
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PYDC1,Pyrin domain-containing protein 1,17992,1559,0.97 [0.86-1.10],0.6322829738820337
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PYY,Peptide YY,17856,1551,1.09 [1.04-1.14],0.0002516765210645
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PZP,Pregnancy zone protein,18511,1612,1.15 [1.00-1.31],0.0507143982644561
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QDPR,Dihydropteridine reductase,21179,1851,1.10 [1.00-1.21],0.0478728043668741
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QPCT,Glutaminyl-peptide cyclotransferase,21307,1858,1.27 [1.09-1.48],0.0017817369977474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QSOX1,Sulfhydryl oxidase 1,18147,1576,1.28 [1.18-1.39],4.731371734380714e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB10,Ras-related protein Rab-10,18494,1603,1.02 [0.94-1.11],0.6429092118732826
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB11FIP3,Rab11 family-interacting protein 3,18494,1603,1.02 [0.98-1.06],0.3797014700260257
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB27B,Ras-related protein Rab-27B,18494,1603,1.03 [0.98-1.10],0.2563411778161024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB2B,Ras-related protein Rab-2B,18419,1587,0.99 [0.92-1.07],0.835766464315858
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB33A,Ras-related protein Rab-33A,17856,1551,1.02 [0.95-1.09],0.656995418312154
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB37,Ras-related protein Rab-37,20914,1833,0.99 [0.94-1.04],0.7249854325492124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB39B,Ras-related protein Rab-39B,17856,1551,1.01 [0.95-1.06],0.8571949616980835
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,17877,1545,0.96 [0.88-1.05],0.4241550896649108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB44,Ras-related protein Rab-44,18419,1587,1.07 [0.98-1.16],0.1304094047256309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB6A,Ras-related protein Rab-6A,21282,1863,0.93 [0.85-1.02],0.1267033350659451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB6B,Ras-related protein Rab-6B,20838,1837,1.08 [0.99-1.18],0.0904661958005073
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABEP1,Rab GTPase-binding effector protein 1,18077,1558,1.03 [0.97-1.09],0.3734142546612532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABEPK,Rab9 effector protein with kelch motifs,20784,1814,1.04 [0.97-1.12],0.2483213287957701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABGAP1L,Rab GTPase-activating protein 1-like,20914,1833,1.03 [0.97-1.11],0.3272993582845955
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAC3,Ras-related C3 botulinum toxin substrate 3,18001,1566,1.00 [0.94-1.08],0.908359461321428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAD23B,UV excision repair protein RAD23 homolog B,20784,1814,1.06 [0.97-1.17],0.1843659572393479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAD51,DNA repair protein RAD51 homolog 1,18165,1571,1.08 [0.99-1.18],0.074493852166348
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RALB,Ras-related protein Ral-B,17944,1562,0.90 [0.75-1.06],0.2062920576180762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RALY,RNA-binding protein Raly,18419,1587,1.07 [0.98-1.16],0.1293825906022534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RANBP1,Ran-specific GTPase-activating protein,17992,1559,1.02 [0.93-1.12],0.6813521299522467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RANBP2,E3 SUMO-protein ligase RanBP2,17877,1545,0.87 [0.74-1.03],0.1014392051611205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RANGAP1,Ran GTPase-activating protein 1,20784,1814,0.93 [0.84-1.04],0.1933353324504047
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAP1A,Ras-related protein Rap-1A,17944,1562,0.92 [0.85-1.00],0.0403328535660365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAPGEF2,Rap guanine nucleotide exchange factor 2,18165,1571,1.02 [0.93-1.12],0.6509838958630231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES1,Retinoic acid receptor responder protein 1,20784,1814,1.11 [1.00-1.24],0.0606262190592887
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,21427,1865,1.32 [1.22-1.43],1.1459103938782258e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASA1,Ras GTPase-activating protein 1,20838,1837,1.02 [0.89-1.17],0.7636761635236645
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,17841,1543,0.92 [0.82-1.03],0.1535432095144452
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASSF2,Ras association domain-containing protein 2,20784,1814,1.12 [1.06-1.18],0.0001255608116577
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,18454,1594,1.44 [1.29-1.61],5.400093291860273e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBKS,Ribokinase,20798,1818,1.07 [0.99-1.16],0.0956980094335649
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBM17,Splicing factor 45,18454,1594,1.01 [0.95-1.07],0.8038785262085699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBM19,Probable RNA-binding protein 19,17856,1551,1.05 [0.95-1.16],0.363421143546211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBM25,RNA-binding protein 25,17841,1543,1.03 [0.92-1.15],0.6216298803258772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP1,Retinol-binding protein 1,18001,1566,1.00 [0.92-1.08],0.9848328931401836
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP2,Retinol-binding protein 2,21186,1853,1.17 [1.11-1.23],4.947459287813322e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP5,Retinol-binding protein 5,21186,1853,1.32 [1.23-1.42],3.955197199440054e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP7,Retinoid-binding protein 7,18435,1602,1.16 [1.09-1.24],5.683984245114418e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBPMS,RNA-binding protein with multiple splicing,17944,1562,0.97 [0.88-1.06],0.438609742073107
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBPMS2,RNA-binding protein with multiple splicing 2,17992,1559,1.05 [1.00-1.10],0.0348628619451439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RCC1,Regulator of chromosome condensation,18419,1587,1.16 [1.06-1.26],0.0011872483552709
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RCOR1,REST corepressor 1,20906,1832,1.05 [0.96-1.15],0.2645367945528717
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,17992,1559,0.88 [0.70-1.11],0.2828570516533891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REEP4,Receptor expression-enhancing protein 4,18454,1594,1.07 [0.99-1.16],0.0679432330000901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1A,Lithostathine-1-alpha,21181,1846,1.30 [1.21-1.41],3.0412288973010814e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1B,Lithostathine-1-beta,21556,1882,1.24 [1.16-1.32],5.103191731555311e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,21556,1882,1.20 [1.13-1.27],4.665485776730256e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG3G,Regenerating islet-derived protein 3-gamma,18419,1587,1.16 [1.03-1.30],0.0154190668691152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG4,Regenerating islet-derived protein 4,21292,1863,1.40 [1.30-1.52],8.385932744007088e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELB,Transcription factor RelB,17944,1562,1.06 [0.96-1.17],0.2721937891782625
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,21302,1865,1.54 [1.35-1.77],5.002991633911197e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REN,Renin,21289,1860,1.17 [1.11-1.23],1.6119847599191522e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REPS1,RalBP1-associated Eps domain-containing protein 1,17944,1562,0.98 [0.86-1.10],0.697698847823131
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REST,RE1-silencing transcription factor,17841,1543,1.01 [0.87-1.17],0.893283340431678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,21186,1853,0.81 [0.72-0.90],0.0001747154948255
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RETN,Resistin,21254,1859,1.16 [1.06-1.27],0.0018384670767582
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REXO2,"Oligoribonuclease, mitochondrial",17856,1551,1.02 [0.91-1.15],0.6780662382687714
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RFC4,Replication factor C subunit 4,18419,1587,1.12 [0.91-1.37],0.3055384576502457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGCC,Regulator of cell cycle RGCC,18454,1594,1.03 [0.97-1.09],0.3510841665186572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,18165,1571,0.97 [0.90-1.06],0.5281418288884141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGMA,Repulsive guidance molecule A,21484,1876,0.74 [0.65-0.84],4.262568422701298e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGMB,RGM domain family member B,21484,1876,0.90 [0.77-1.05],0.1725534597674154
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGS10,Regulator of G-protein signaling 10,18454,1594,1.01 [0.94-1.09],0.7284721857385514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGS8,Regulator of G-protein signaling 8,20914,1833,0.96 [0.89-1.03],0.2128455853691394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RHOC,Rho-related GTP-binding protein RhoC,20998,1837,1.01 [0.97-1.04],0.7047233847077745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RICTOR,Rapamycin-insensitive companion of mTOR,17944,1562,1.02 [0.93-1.13],0.6285552770196678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,18077,1558,1.16 [1.06-1.27],0.0015738184305159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RILP,Rab-interacting lysosomal protein,21418,1871,1.05 [0.98-1.12],0.192154193375781
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RILPL2,RILP-like protein 2,18494,1603,1.03 [0.98-1.08],0.2636885309293277
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,17856,1551,1.05 [0.98-1.13],0.1390810574402025
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RLN1,Prorelaxin H1,18454,1594,1.03 [0.94-1.13],0.4589224077554719
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RLN2,Prorelaxin H2,18047,1554,0.89 [0.80-0.98],0.02337516212578
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE1,Ribonuclease pancreatic,18509,1603,1.82 [1.50-2.20],7.287844765775495e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE10,Inactive ribonuclease-like protein 10,17992,1559,1.05 [0.95-1.17],0.3091504283663604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE3,Eosinophil cationic protein,21182,1849,1.03 [1.00-1.07],0.0892688479869102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE4,Ribonuclease 4,17924,1555,1.56 [1.31-1.86],6.825904217752372e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE6,Ribonuclease K6,18389,1595,1.48 [1.28-1.71],1.0007096206465525e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASEH2A,Ribonuclease H2 subunit A,18454,1594,0.93 [0.83-1.03],0.1789225974523647
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASET2,Ribonuclease T2,21461,1872,1.50 [1.29-1.74],7.065390320113804e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,17992,1559,1.73 [1.48-2.01],1.876268347551792e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF168,E3 ubiquitin-protein ligase RNF168,17944,1562,0.96 [0.85-1.10],0.5795409443063952
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF31,E3 ubiquitin-protein ligase RNF31,17944,1562,0.85 [0.73-0.99],0.0337756722095396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF4,E3 ubiquitin-protein ligase RNF4,18165,1571,0.95 [0.87-1.03],0.2194339601019281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF41,E3 ubiquitin-protein ligase NRDP1,20784,1814,1.03 [0.97-1.10],0.3411880604694129
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF43,E3 ubiquitin-protein ligase RNF43,18165,1571,1.13 [1.05-1.21],0.0006016184274703
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF5,E3 ubiquitin-protein ligase RNF5,17992,1559,0.94 [0.88-1.01],0.0850848137639671
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO1,Roundabout homolog 1,21292,1863,1.32 [1.11-1.57],0.00164539532788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO2,Roundabout homolog 2,21484,1876,1.08 [0.90-1.30],0.42642295136423
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO4,Roundabout homolog 4,17992,1559,0.82 [0.62-1.08],0.1533483861949746
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,21289,1860,0.89 [0.78-1.01],0.0798628755364831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RP2,Protein XRP2,21186,1853,1.10 [1.00-1.20],0.0443040820961895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPA2,Replication protein A 32 kDa subunit,17944,1562,1.04 [0.88-1.22],0.6370876373030689
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPE,Ribulose-phosphate 3-epimerase,18165,1571,0.97 [0.90-1.04],0.4127472818367945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPGR,X-linked retinitis pigmentosa GTPase regulator,18001,1566,0.99 [0.87-1.12],0.8662165331773819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPL14,60S ribosomal protein L14,17992,1559,1.16 [1.04-1.31],0.0107733968588397
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPS10,40S ribosomal protein S10,17856,1551,1.03 [0.91-1.16],0.6320201136627577
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRAS,Ras-related protein R-Ras,18001,1566,1.02 [0.98-1.06],0.3196222914588278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRM2,Ribonucleoside-diphosphate reductase subunit M2,20784,1814,1.22 [1.13-1.32],2.746498179452663e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,20784,1814,1.05 [0.98-1.11],0.1528562596197145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRP15,RRP15-like protein,17877,1545,1.01 [0.96-1.06],0.6845531342218296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO1,R-spondin-1,21104,1848,1.55 [1.37-1.74],4.406138764404712e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO3,R-spondin-3,21472,1876,1.29 [1.11-1.49],0.0006849275128221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTBDN,Retbindin,21186,1853,1.14 [0.99-1.31],0.0642774185588829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTKN2,Rhotekin-2,17856,1551,1.02 [0.93-1.12],0.6815458200746365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",18454,1594,1.03 [0.98-1.09],0.1874049543185467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTN4R,Reticulon-4 receptor,21472,1876,0.95 [0.85-1.07],0.4269971378024746
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RUVBL1,RuvB-like 1,20784,1814,1.04 [1.00-1.08],0.0558184581434736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RWDD1,RWD domain-containing protein 1,21484,1876,1.03 [0.97-1.10],0.3636245689172204
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RYR1,Ryanodine receptor 1,17856,1551,0.94 [0.81-1.09],0.421558588690373
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A11,Protein S100-A11,21126,1846,1.19 [1.10-1.28],9.662064883635174e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A12,Protein S100-A12,20973,1838,1.09 [1.03-1.15],0.0024426837294333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A13,Protein S100-A13,17944,1562,1.12 [0.97-1.28],0.1291669335885439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A14,Protein S100-A14,18454,1594,1.00 [0.91-1.10],0.9784394777206438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A16,Protein S100-A16,20803,1831,1.07 [1.00-1.15],0.0520884774499216
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A3,Protein S100-A3,18419,1587,1.04 [0.94-1.16],0.447193758741784
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A4,Protein S100-A4,21352,1860,0.97 [0.91-1.05],0.4921737301447623
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100G,Protein S100-G,18454,1594,1.09 [1.00-1.19],0.0466807728166267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100P,Protein S100-P,20906,1832,1.07 [1.00-1.15],0.0546270427708195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAA4,Serum amyloid A-4 protein,18511,1612,1.23 [1.06-1.43],0.0060562041171272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAFB2,Scaffold attachment factor B2,18454,1594,1.03 [0.86-1.22],0.7497608339445911
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAG,S-arrestin,17877,1545,0.97 [0.88-1.07],0.5580029309459267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAMD9L,Sterile alpha motif domain-containing protein 9-like,21282,1863,1.05 [0.99-1.11],0.0820421055241942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAP18,Histone deacetylase complex subunit SAP18,18165,1571,0.97 [0.91-1.04],0.4710335214743613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SARG,Specifically androgen-regulated gene protein,18432,1600,1.04 [1.00-1.09],0.073732154502434
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SART1,U4/U6.U5 tri-snRNP-associated protein 1,17856,1551,1.19 [1.08-1.31],0.0005492357375958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAT1,Diamine acetyltransferase 1,17856,1551,1.00 [0.90-1.11],0.9800823249985308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAT2,Thialysine N-epsilon-acetyltransferase,18165,1571,1.01 [0.94-1.08],0.8000460982808624
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SATB1,DNA-binding protein SATB1,18454,1594,1.07 [0.92-1.25],0.3589989982218283
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SBSN,Suprabasin,18465,1603,1.06 [0.93-1.22],0.3787346344026669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCAMP3,Secretory carrier-associated membrane protein 3,21186,1853,1.05 [1.00-1.10],0.044195871415455
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARA5,Scavenger receptor class A member 5,21484,1876,1.25 [1.08-1.43],0.0019649893964815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB1,Scavenger receptor class B member 1,20838,1837,1.16 [1.07-1.25],0.0001550087775778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB2,Lysosome membrane protein 2,20690,1804,1.60 [1.40-1.82],1.2901904946093113e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF1,Scavenger receptor class F member 1,21556,1882,1.16 [1.05-1.27],0.0028760175743459
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF2,Scavenger receptor class F member 2,21484,1876,1.35 [1.16-1.57],9.05955916905159e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCG2,Secretogranin-2,21385,1868,1.15 [1.01-1.30],0.0302971359643401
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCG3,Secretogranin-3,21292,1863,0.95 [0.84-1.07],0.3636764942833783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB1A1,Uteroglobin,21297,1864,0.81 [0.76-0.86],8.896476802290272e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB2A2,Mammaglobin-A,17856,1551,0.88 [0.75-1.04],0.1443397024093119
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A1,Secretoglobin family 3A member 1,18077,1558,1.81 [1.53-2.15],1.1598180640585199e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A2,Secretoglobin family 3A member 2,21336,1865,1.17 [1.12-1.22],1.7565966855557925e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGN,Secretagogin,20914,1833,1.08 [0.99-1.19],0.0966721734105797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCIN,Adseverin,17877,1545,0.92 [0.86-0.99],0.0316765097596233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCLY,Selenocysteine lyase,21418,1871,1.37 [1.26-1.49],6.753515063294168e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN2A,Sodium channel protein type 2 subunit alpha,17877,1545,1.01 [0.90-1.12],0.8754616122952136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN2B,Sodium channel subunit beta-2,18001,1566,0.92 [0.77-1.10],0.3614590966356639
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN3A,Sodium channel protein type 3 subunit alpha,18001,1566,1.09 [0.94-1.25],0.238948012320622
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN3B,Sodium channel subunit beta-3,17877,1545,0.94 [0.84-1.05],0.2499012853640638
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN4B,Sodium channel subunit beta-4,17992,1559,1.05 [0.94-1.18],0.385655055528371
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCP2,Non-specific lipid-transfer protein,20784,1814,1.06 [1.00-1.12],0.0435694602941832
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCPEP1,Retinoid-inducible serine carboxypeptidase,17930,1557,1.19 [1.08-1.30],0.0003047462997006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRG1,Scrapie-responsive protein 1,18494,1603,1.26 [1.06-1.48],0.0075127608363278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRIB,Protein scribble homolog,17992,1559,1.07 [1.01-1.12],0.0149226545817909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRN1,Secernin-1,21282,1863,1.01 [0.94-1.09],0.816413102810501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCT,Secretin,18001,1566,0.91 [0.82-1.01],0.0677461197288133
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDC1,Syndecan-1,21289,1860,1.22 [1.10-1.35],0.000170000996101
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDC4,Syndecan-4,21289,1860,0.98 [0.90-1.07],0.6566398554405973
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDCCAG8,Serologically defined colon cancer antigen 8,18419,1587,1.03 [0.99-1.08],0.1265610893517409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDHB,Succinate dehydrogenase,18435,1602,1.15 [1.07-1.23],0.0001046545620492
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDK2,Protein sidekick-2,18077,1558,0.98 [0.85-1.12],0.7541861653764586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEC31A,Protein transport protein Sec31A,17992,1559,1.00 [0.94-1.07],0.8799392581742069
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEL1L,Protein sel-1 homolog 1,17992,1559,1.33 [1.14-1.56],0.0004017114019085
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELE,E-selectin,21556,1882,1.36 [1.25-1.48],1.964722415889547e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELENOP,Selenoprotein P,18511,1612,0.54 [0.43-0.67],2.5276546795046948e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELL,L-selectin,18511,1612,0.82 [0.67-1.01],0.0631172048726691
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELP,P-selectin,21393,1864,1.07 [1.00-1.16],0.0564267581125748
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELPLG,P-selectin glycoprotein ligand 1,21282,1863,1.10 [0.96-1.25],0.173026807021401
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA3F,Semaphorin-3F,21289,1860,1.14 [0.98-1.34],0.0955628213350806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA3G,Semaphorin-3G,18077,1558,1.07 [0.96-1.19],0.2289018456471286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA4C,Semaphorin-4C,21186,1853,0.97 [0.83-1.13],0.7076489881527535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA4D,Semaphorin-4D,21484,1876,1.11 [0.98-1.27],0.1107120440424752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA6C,Semaphorin-6C,17944,1562,0.89 [0.73-1.08],0.2453292147346365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA7A,Semaphorin-7A,21480,1875,1.04 [0.90-1.21],0.5554147176952318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN3,Neuronal-specific septin-3,18454,1594,1.14 [1.07-1.22],3.212106336188818e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN7,Septin-7,18165,1571,1.05 [0.96-1.14],0.2728511258924444
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN8,Septin-8,18412,1594,1.59 [1.40-1.80],5.968414602134719e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN9,Septin-9,21186,1853,1.06 [0.92-1.22],0.4163635299333997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA1,Alpha-1-antitrypsin,18177,1582,3.10 [2.06-4.66],5.951301126898096e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA11,Serpin A11,21556,1882,1.25 [1.13-1.38],1.189666685141015e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA12,Serpin A12,20680,1813,1.01 [0.98-1.06],0.4666955615474091
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA3,Alpha-1-antichymotrypsin,18459,1607,2.62 [2.04-3.37],4.0958769402215485e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA4,Kallistatin,18197,1588,0.97 [0.79-1.19],0.7510299781253762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA5,Plasma serine protease inhibitor,18254,1592,0.87 [0.74-1.02],0.0949140149803942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA6,Corticosteroid-binding globulin,18511,1612,2.00 [1.48-2.69],5.122582244602673e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA7,Thyroxine-binding globulin,18511,1612,0.82 [0.63-1.06],0.1267966831325468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA9,Serpin A9,21099,1848,1.11 [1.05-1.17],8.189097319993382e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB1,Leukocyte elastase inhibitor,21232,1863,1.03 [0.98-1.07],0.2212242212598876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB5,Serpin B5,20906,1832,1.00 [0.91-1.09],0.9700506262376256
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB6,Serpin B6,21410,1869,1.06 [0.99-1.13],0.1194732249136319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB8,Serpin B8,21543,1879,1.12 [1.06-1.19],4.4635349792636414e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB9,Serpin B9,21104,1848,1.03 [0.90-1.17],0.6730613697189021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINC1,Antithrombin-III,18483,1611,0.71 [0.51-0.98],0.0364650510650237
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPIND1,Heparin cofactor 2,18483,1611,1.69 [1.43-2.00],7.259146580527672e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINE1,Plasminogen activator inhibitor 1,21556,1882,1.17 [1.10-1.25],3.868761528498425e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINE2,Glia-derived nexin,18494,1603,1.09 [1.02-1.17],0.0169996831509158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINF1,Pigment epithelium-derived factor,18227,1586,1.17 [0.98-1.39],0.0861896131246684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINF2,Alpha-2-antiplasmin,18170,1580,0.51 [0.35-0.74],0.0003172071024252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPING1,Plasma protease C1 inhibitor,18483,1611,2.59 [2.00-3.36],6.578593686675116e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINH1,Serpin H1,18165,1571,1.05 [1.01-1.09],0.0066790991953878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINI1,Neuroserpin,18046,1554,1.06 [0.90-1.24],0.4773185595012758
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINI2,Serpin I2,18435,1602,1.02 [0.94-1.10],0.600761933515432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,20838,1837,1.04 [0.98-1.11],0.1955957067760965
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SETMAR,Histone-lysine N-methyltransferase SETMAR,21027,1843,1.16 [1.02-1.32],0.0200589949179831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6,Seizure protein 6 homolog,18001,1566,0.91 [0.77-1.06],0.219483649930703
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6L,Seizure 6-like protein,21352,1860,0.91 [0.78-1.05],0.1774742186833805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6L2,Seizure 6-like protein 2,21186,1853,1.21 [1.01-1.44],0.0384370305341457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SF3B4,Splicing factor 3B subunit 4,21186,1853,0.99 [0.93-1.05],0.695546443857022
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP1,Secreted frizzled-related protein 1,21024,1837,1.24 [1.13-1.36],3.406159523891633e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP4,Secreted frizzled-related protein 4,18077,1558,0.77 [0.68-0.88],6.729429325454795e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA1,Pulmonary surfactant-associated protein A1,20784,1814,1.19 [1.12-1.27],1.7317785034252263e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA2,Pulmonary surfactant-associated protein A2,20784,1814,1.30 [1.23-1.38],4.157160826761378e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPD,Pulmonary surfactant-associated protein D,21289,1860,1.12 [1.05-1.19],0.0002960162413431
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SGSH,N-sulphoglucosamine sulphohydrolase,18201,1572,1.19 [1.10-1.29],1.2909642570960772e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH2B3,SH2B adapter protein 3,20784,1814,1.03 [0.98-1.07],0.2541589136521104
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH2D1A,SH2 domain-containing protein 1A,21282,1863,1.04 [0.98-1.12],0.2018772386463683
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,17877,1545,0.97 [0.90-1.06],0.5223343938522667
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3BP1,SH3 domain-binding protein 1,18435,1602,0.98 [0.89-1.08],0.690407625209388
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3GL3,Endophilin-A3,18058,1561,0.99 [0.93-1.04],0.6202138389532863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3GLB2,Endophilin-B2,18446,1599,1.07 [0.99-1.15],0.0746700593918079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHBG,Sex hormone-binding globulin,18509,1603,1.12 [1.01-1.25],0.0372181259717956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHC1,SHC-transforming protein 1,17841,1543,0.97 [0.93-1.01],0.1508907831826219
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHD,SH2 domain-containing adapter protein D,17826,1548,1.01 [0.95-1.06],0.8152222610577486
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHH,Sonic hedgehog protein,17944,1562,0.92 [0.81-1.04],0.1783409296808332
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHISA5,Protein shisa-5,18498,1605,1.90 [1.59-2.27],2.560675690885647e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHMT1,"Serine hydroxymethyltransferase, cytosolic",21336,1865,1.05 [1.00-1.10],0.0420221543592528
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHPK,Sedoheptulokinase,18165,1571,1.00 [0.88-1.13],0.9498272818499
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIAE,Sialate O-acetylesterase,21315,1859,1.24 [1.14-1.35],8.782816690675777e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC1,Sialoadhesin,21367,1868,1.41 [1.28-1.55],1.4731789674716045e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,21282,1863,1.37 [1.21-1.54],2.63229348978255e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC15,Sialic acid-binding Ig-like lectin 15,20838,1837,1.04 [0.98-1.09],0.1771455016705478
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC5,Sialic acid-binding Ig-like lectin 5,21302,1865,1.05 [1.01-1.09],0.0226552970686362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC6,Sialic acid-binding Ig-like lectin 6,21472,1876,1.15 [1.02-1.29],0.0204472517521531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,21289,1860,1.98 [1.71-2.29],1.6921629620228718e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC8,Sialic acid-binding Ig-like lectin 8,17992,1559,1.32 [1.18-1.47],9.428619382016736e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC9,Sialic acid-binding Ig-like lectin 9,21442,1872,1.26 [1.10-1.44],0.0008245786007906
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIL1,Nucleotide exchange factor SIL1,17992,1559,1.15 [1.02-1.31],0.0277489553940343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,21347,1863,1.10 [1.02-1.18],0.0139313106605767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,21222,1856,1.19 [1.09-1.29],9.231784643708748e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRT1,NAD-dependent protein deacetylase sirtuin-1,17944,1562,0.98 [0.92-1.06],0.6711425639046456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRT2,NAD-dependent protein deacetylase sirtuin-2,21186,1853,1.02 [0.97-1.07],0.4179927326366434
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",20838,1837,1.04 [0.97-1.12],0.3081557291592014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIT1,Signaling threshold-regulating transmembrane adapter 1,20914,1833,1.14 [1.06-1.22],0.0002324531863354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKAP1,Src kinase-associated phosphoprotein 1,21075,1846,1.07 [1.01-1.13],0.012837937534805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKAP2,Src kinase-associated phosphoprotein 2,21367,1868,1.03 [0.99-1.07],0.115677941951418
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKIV2L,Helicase SKI2W,17856,1551,1.07 [0.94-1.20],0.3102455288128595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLA2,Src-like-adapter 2,18454,1594,1.01 [0.96-1.05],0.8122599452554708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF1,Signaling lymphocytic activation molecule,20914,1833,1.18 [1.10-1.26],5.609704479220261e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF6,SLAM family member 6,20784,1814,1.16 [1.04-1.30],0.0082017775450656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF7,SLAM family member 7,21282,1863,1.21 [1.13-1.28],7.047319169164821e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF8,SLAM family member 8,20784,1814,1.23 [1.13-1.33],1.050502594916358e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC12A2,Solute carrier family 12 member 2,17856,1551,1.14 [0.94-1.37],0.1779798928882103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC13A1,Solute carrier family 13 member 1,18419,1587,1.00 [0.92-1.08],0.9054559612261736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC16A1,Monocarboxylate transporter 1,20838,1837,1.12 [1.05-1.19],0.0007303694351482
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC1A4,Neutral amino acid transporter A,18001,1566,0.99 [0.90-1.10],0.91414304808799
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC27A4,Long-chain fatty acid transport protein 4,20838,1837,1.10 [1.03-1.17],0.0038307142751298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC28A1,Sodium/nucleoside cotransporter 1,17841,1543,1.07 [0.99-1.16],0.0725544793895394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC34A3,Sodium-dependent phosphate transport protein 2C,17841,1543,1.01 [0.90-1.12],0.9178701372722629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC39A14,Zinc transporter ZIP14,20838,1837,1.30 [1.16-1.46],1.2451718700416071e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC39A5,Zinc transporter ZIP5,21282,1863,1.17 [1.08-1.26],8.04450668678147e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC44A4,Choline transporter-like protein 4,18001,1566,1.07 [0.99-1.14],0.0775347063015544
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC4A1,Band 3 anion transport protein,18498,1605,0.94 [0.85-1.04],0.2228397282587654
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC51B,Organic solute transporter subunit beta,17856,1551,1.03 [0.95-1.10],0.491649261734985
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,18077,1558,1.03 [0.97-1.09],0.3247020115881369
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,18435,1602,1.11 [1.01-1.22],0.0251132009284116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",17841,1543,1.11 [1.03-1.20],0.0072186668221491
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLIT2,Slit homolog 2 protein,20838,1837,1.12 [1.04-1.22],0.004779576551489
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK1,SLIT and NTRK-like protein 1,17944,1562,0.65 [0.56-0.76],1.1470407464315564e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,21472,1876,0.73 [0.66-0.81],3.88758871236522e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK6,SLIT and NTRK-like protein 6,20906,1832,1.03 [0.91-1.16],0.6202315790872561
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLK,STE20-like serine/threonine-protein kinase,18165,1571,0.97 [0.91-1.03],0.3108419359676446
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLMAP,Sarcolemmal membrane-associated protein,18435,1602,1.06 [1.00-1.12],0.0407643480223532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLURP1,Secreted Ly-6/uPAR-related protein 1,18371,1593,1.12 [0.98-1.29],0.0960564503505554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD1,Mothers against decapentaplegic homolog 1,20784,1814,1.03 [0.99-1.08],0.1665648829241167
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD2,Mothers against decapentaplegic homolog 2,18419,1587,1.02 [0.95-1.09],0.6139255239822375
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD3,Mothers against decapentaplegic homolog 3,18419,1587,0.99 [0.90-1.08],0.7671924481347224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD5,Mothers against decapentaplegic homolog 5,21186,1853,1.50 [1.21-1.87],0.0002357285522061
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMARCA2,Probable global transcription activator SNF2L2,20838,1837,1.05 [0.99-1.11],0.0822660979492739
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMC3,Structural maintenance of chromosomes protein 3,17841,1543,1.03 [0.94-1.12],0.5844017996776336
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMNDC1,Survival of motor neuron-related-splicing factor 30,18435,1602,1.15 [1.08-1.22],9.72527162102273e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,21472,1876,1.15 [1.03-1.30],0.0160441216115098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,21367,1868,1.13 [1.01-1.26],0.0260325371834286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,21381,1862,1.45 [1.35-1.55],1.0487121896019071e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD3,Sphingomyelin phosphodiesterase 3,17944,1562,0.95 [0.85-1.07],0.3847702005965954
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,21327,1864,1.22 [1.15-1.30],6.093948448714408e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,18419,1587,0.94 [0.88-1.01],0.0733443714844897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMS,Spermine synthase,17877,1545,0.97 [0.90-1.06],0.5280451203351786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMTN,Smoothelin,18409,1596,1.12 [1.06-1.18],1.6850628311044665e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAP23,Synaptosomal-associated protein 23,21289,1860,1.01 [0.97-1.06],0.6157203122067589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAP25,Synaptosomal-associated protein 25,17877,1545,0.97 [0.88-1.07],0.4892504377638098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAP29,Synaptosomal-associated protein 29,21352,1860,1.04 [1.00-1.09],0.0632266622708365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAPIN,SNARE-associated protein Snapin,18454,1594,1.00 [0.92-1.09],0.9916253818237366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNCA,Alpha-synuclein,18077,1558,1.03 [0.99-1.08],0.1114356523790848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNCG,Gamma-synuclein,21104,1848,1.10 [1.03-1.17],0.0031087388132305
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",17992,1559,1.01 [0.86-1.18],0.8986253056069493
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNRPB2,U2 small nuclear ribonucleoprotein B'',18446,1599,1.18 [1.09-1.28],4.947912865673035e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNU13,NHP2-like protein 1,17856,1551,1.05 [0.98-1.13],0.1692530300861787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX15,Sorting nexin-15,18077,1558,1.09 [1.00-1.19],0.0637211929002577
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX18,Sorting nexin-18,18435,1602,1.03 [0.93-1.14],0.565767996947697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX2,Sorting nexin-2,18419,1587,1.01 [0.95-1.07],0.8090797659520033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX5,Sorting nexin-5,17992,1559,0.94 [0.80-1.10],0.4353724459801004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX9,Sorting nexin-9,21289,1860,1.04 [0.98-1.10],0.2467004184657481
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD1,Superoxide dismutase [Cu-Zn],20886,1819,1.06 [0.97-1.15],0.2221129625491658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",21302,1865,1.47 [1.33-1.63],1.354434661920746e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD3,Extracellular superoxide dismutase,18509,1603,1.03 [0.96-1.11],0.355908015161964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORBS1,Sorbin and SH3 domain-containing protein 1,18454,1594,1.09 [0.96-1.24],0.2009116773148458
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,20784,1814,1.23 [1.10-1.37],0.0002725212803414
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORD,Sorbitol dehydrogenase,21386,1868,1.04 [0.98-1.10],0.249543738111008
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORT1,Sortilin,21260,1858,1.27 [1.14-1.41],1.2676275177756334e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOST,Sclerostin,21260,1858,0.99 [0.89-1.10],0.7971401002626376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,18001,1566,0.95 [0.85-1.05],0.3306790421980886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOX2,Transcription factor SOX-2,18415,1592,1.28 [1.03-1.59],0.0258705664876703
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOX9,Transcription factor SOX-9,18001,1566,1.00 [0.83-1.21],0.9839515668764068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,18454,1594,1.18 [1.00-1.40],0.0553935906265024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPAG1,Sperm-associated antigen 1,18454,1594,1.06 [0.98-1.14],0.1276039210035546
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPARC,SPARC,21352,1860,1.11 [1.05-1.18],0.0003779076402361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPARCL1,SPARC-like protein 1,21320,1855,0.95 [0.81-1.12],0.5489748717710852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPART,Spartin,18077,1558,1.06 [1.00-1.13],0.049537258046541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPESP1,Sperm equatorial segment protein 1,18494,1603,1.06 [0.92-1.22],0.4551645596348347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,21302,1865,1.56 [1.42-1.72],5.190459504886741e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK2,Serine protease inhibitor Kazal-type 2,18077,1558,1.32 [1.16-1.51],4.04648600536248e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,21282,1863,1.14 [1.07-1.21],6.353442194662002e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK5,Serine protease inhibitor Kazal-type 5,21302,1865,0.91 [0.81-1.02],0.1188185946711725
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK6,Serine protease inhibitor Kazal-type 6,21472,1876,1.16 [1.07-1.26],0.0002332866870697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK8,Serine protease inhibitor Kazal-type 8,17856,1551,0.97 [0.84-1.12],0.7069800973505971
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,21221,1856,1.84 [1.59-2.13],3.60667352080942e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT2,Kunitz-type protease inhibitor 2,21367,1868,1.20 [1.08-1.33],0.000494541045546
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT3,Kunitz-type protease inhibitor 3,18435,1602,0.97 [0.94-1.00],0.0481049086958276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPOCK1,Testican-1,21104,1848,1.13 [0.96-1.33],0.1357810806975629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON1,Spondin-1,21292,1863,1.73 [1.54-1.93],2.971721036479176e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON2,Spondin-2,21186,1851,1.82 [1.61-2.05],1.0243012219333925e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPP1,Osteopontin,21527,1880,1.26 [1.15-1.37],1.826534502240293e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",17944,1562,1.11 [0.98-1.25],0.0926095968905963
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRING1,SREBP regulating gene protein,17841,1543,0.90 [0.81-1.01],0.0634422465098673
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRR1B,Cornifin-B,18165,1571,1.00 [0.94-1.06],0.8804484971187652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRR3,Small proline-rich protein 3,18446,1599,1.13 [1.04-1.22],0.0028936832434135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRY2,Protein sprouty homolog 2,20914,1833,1.00 [0.95-1.04],0.8500895690712006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",17877,1545,0.88 [0.74-1.06],0.1726597540560887
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPTLC1,Serine palmitoyltransferase 1,18446,1599,1.09 [0.96-1.24],0.203273689037932
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRC,Proto-oncogene tyrosine-protein kinase Src,21318,1855,1.00 [0.97-1.04],0.7741118715585582
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRP14,Signal recognition particle 14 kDa protein,21186,1853,1.09 [1.02-1.16],0.0127970766429139
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRPK2,SRSF protein kinase 2,21282,1863,1.02 [0.98-1.07],0.3326308706694337
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRPX,Sushi repeat-containing protein SRPX,18494,1603,1.17 [1.03-1.34],0.0173240682171397
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSB,Lupus La protein,20838,1837,1.00 [0.94-1.08],0.9378250481558382
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",17944,1562,1.05 [0.93-1.19],0.4418663770769484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,21260,1858,0.84 [0.81-0.87],7.94471309299198e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,21393,1864,1.22 [1.11-1.34],3.6611552056023e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSH3,Protein phosphatase Slingshot homolog 3,17841,1543,1.05 [0.88-1.25],0.6069465274972548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSNA1,Sjoegren syndrome nuclear autoantigen 1,18435,1602,1.09 [0.99-1.19],0.0656582310958474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST13,Hsc70-interacting protein,18077,1558,1.01 [0.92-1.11],0.8194291321304659
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",21186,1853,1.07 [0.98-1.18],0.1208656644055752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",21556,1882,1.69 [1.49-1.91],6.712644133062566e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",17944,1562,0.99 [0.90-1.09],0.8450459256644993
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAB2,Stabilin-2,18498,1605,1.63 [1.38-1.93],8.439924528984384e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAM,Signal transducing adapter molecule 1,18419,1587,1.09 [0.97-1.23],0.1312894635218835
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAMBP,STAM-binding protein,21075,1846,1.02 [0.96-1.09],0.4655044371041942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAT2,Signal transducer and activator of transcription 2,17944,1562,1.08 [1.02-1.15],0.0144544016131376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAT5B,Signal transducer and activator of transcription 5B,21186,1853,0.99 [0.96-1.02],0.581134191357655
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,17841,1543,0.96 [0.88-1.04],0.3253705641819727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STC1,Stanniocalcin-1,21484,1876,1.26 [1.16-1.36],4.035641302572639e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STC2,Stanniocalcin-2,21273,1858,1.13 [0.96-1.35],0.1469072152254389
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STEAP4,Metalloreductase STEAP4,17877,1545,0.95 [0.88-1.02],0.13392304857453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STIP1,Stress-induced-phosphoprotein 1,21260,1863,1.04 [0.97-1.11],0.2450601172013794
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STK11,Serine/threonine-protein kinase STK11,20906,1832,1.03 [0.97-1.09],0.3766890453257216
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STK24,Serine/threonine-protein kinase 24,20838,1837,1.00 [0.93-1.07],0.9689668615314274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STK4,Serine/threonine-protein kinase 4,21289,1860,1.01 [0.97-1.06],0.6091071284391534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STOML2,"Stomatin-like protein 2, mitochondrial",17841,1543,0.94 [0.89-1.00],0.0413285799554021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX16,Syntaxin-16,20784,1814,1.06 [0.98-1.14],0.1532458191786905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX1B,Syntaxin-1B,18001,1566,0.98 [0.87-1.11],0.7910419772347823
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX3,Syntaxin-3,18446,1599,0.95 [0.82-1.09],0.4352071836826223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX4,Syntaxin-4,21186,1853,1.10 [1.03-1.18],0.002821557219936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX5,Syntaxin-5,17944,1562,0.97 [0.86-1.10],0.6888626972679497
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX6,Syntaxin-6,20784,1814,1.04 [0.97-1.12],0.2371296003022868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX7,Syntaxin-7,17944,1562,1.05 [0.94-1.16],0.3867047643338996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX8,Syntaxin-8,21282,1863,1.15 [1.06-1.25],0.0006858954056522
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STXBP1,Syntaxin-binding protein 1,18454,1594,0.99 [0.94-1.06],0.867379032713011
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STXBP3,Syntaxin-binding protein 3,20784,1814,1.01 [0.91-1.11],0.9189429679299376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUGP1,SURP and G-patch domain-containing protein 1,18435,1602,1.07 [0.96-1.19],0.2202134655369267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUGT1,Protein SGT1 homolog,20784,1814,1.03 [0.98-1.09],0.2268539043754502
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT1A1,Sulfotransferase 1A1,21484,1876,0.99 [0.96-1.03],0.7250539605692405
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT2A1,Bile salt sulfotransferase,21282,1863,1.27 [1.20-1.34],1.4164958219169914e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUMF1,Formylglycine-generating enzyme,17944,1562,1.05 [0.97-1.13],0.1954094121279844
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,21484,1876,1.14 [1.05-1.23],0.0017999712512628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUOX,"Sulfite oxidase, mitochondrial",18454,1594,1.08 [1.00-1.17],0.0419805340242413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD1,Sushi domain-containing protein 1,20906,1832,1.03 [0.95-1.13],0.4799687096363201
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD2,Sushi domain-containing protein 2,21302,1865,1.65 [1.47-1.85],2.5135439703454328e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD4,Sushi domain-containing protein 4,18419,1587,0.92 [0.82-1.04],0.1985548800488717
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD5,Sushi domain-containing protein 5,17994,1552,0.74 [0.65-0.85],1.3486152213325671e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SV2A,Synaptic vesicle glycoprotein 2A,18001,1566,1.03 [0.96-1.11],0.4167204473258954
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SWAP70,Switch-associated protein 70,18435,1602,1.15 [1.02-1.30],0.0229599950323654
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYAP1,Synapse-associated protein 1,18077,1558,1.03 [0.95-1.12],0.4076169951340983
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,17877,1545,1.01 [0.93-1.09],0.8068467533494577
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYT1,Synaptotagmin-1,18446,1599,1.18 [1.04-1.34],0.0104862381063995
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYTL4,Synaptotagmin-like protein 4,18494,1603,1.03 [0.97-1.10],0.3051584137990549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,18165,1571,1.01 [0.97-1.06],0.6142385992828299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TACC3,Transforming acidic coiled-coil-containing protein 3,21186,1853,1.00 [0.96-1.03],0.8321241231297068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TACSTD2,Tumor-associated calcium signal transducer 2,18848,1635,1.30 [1.11-1.51],0.0008185460598615
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TADA3,Transcriptional adapter 3,18419,1587,1.10 [0.98-1.24],0.0963513759649142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,21186,1853,1.35 [1.21-1.51],7.568066378900482e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAGLN3,Transgelin-3,17841,1543,0.98 [0.90-1.07],0.604968835847179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TALDO1,Transaldolase,18439,1602,1.14 [1.03-1.26],0.0094536354810435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TANK,TRAF family member-associated NF-kappa-B activator,20914,1833,0.99 [0.94-1.05],0.7627424253841855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAP1,Antigen peptide transporter 1,18165,1571,1.06 [0.98-1.14],0.1589803955087804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TARBP2,RISC-loading complex subunit TARBP2,20838,1837,1.05 [1.00-1.11],0.0753187823548736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",18001,1566,0.98 [0.92-1.05],0.63775300052236
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",18419,1587,0.93 [0.82-1.07],0.3238520161741172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAX1BP1,Tax1-binding protein 1,18446,1599,1.14 [1.06-1.23],0.0005961926834385
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBC1D17,TBC1 domain family member 17,20838,1837,1.06 [0.96-1.16],0.2576769501398007
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBC1D23,TBC1 domain family member 23,21186,1853,1.02 [0.97-1.07],0.3984774239241905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBC1D5,TBC1 domain family member 5,21282,1863,1.06 [1.01-1.11],0.0288834025901007
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBCA,Tubulin-specific chaperone A,18077,1558,1.01 [0.95-1.07],0.771689029236959
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBCB,Tubulin-folding cofactor B,21104,1848,1.02 [0.98-1.06],0.4424905120738839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBCC,Tubulin-specific chaperone C,21104,1848,1.03 [0.98-1.08],0.2253622130176544
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBL1X,F-box-like/WD repeat-containing protein TBL1X,20784,1814,1.03 [0.98-1.08],0.2751726251813065
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBR1,T-box brain protein 1,18001,1566,0.99 [0.90-1.10],0.8780332251891598
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCL1A,T-cell leukemia/lymphoma protein 1A,21077,1846,1.00 [0.96-1.04],0.8859101430872595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCL1B,T-cell leukemia/lymphoma protein 1B,20906,1832,0.98 [0.93-1.03],0.4409062518688911
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN1,Transcobalamin-1,18153,1573,1.24 [1.08-1.43],0.0023555582001218
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN2,Transcobalamin-2,21527,1880,1.45 [1.27-1.66],5.4533356516302074e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCOF1,Treacle protein,18494,1603,1.27 [1.13-1.44],9.44194521039537e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCP11,T-complex protein 11 homolog,18165,1571,1.00 [0.93-1.09],0.911058348425472
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCTN3,Tectonic-3,18494,1603,1.63 [1.40-1.89],1.6395091541524268e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDGF1,Teratocarcinoma-derived growth factor 1,20838,1837,1.02 [0.99-1.05],0.1888996638032008
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDO2,"Tryptophan 2,3-dioxygenase",18001,1566,1.16 [1.03-1.30],0.0119242537741206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDP1,Tyrosyl-DNA phosphodiesterase 1,18419,1587,0.99 [0.92-1.07],0.8344747510250682
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDRKH,Tudor and KH domain-containing protein,20838,1837,1.04 [0.99-1.10],0.1017021118802933
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEF,Thyrotroph embryonic factor,17856,1551,1.06 [0.95-1.18],0.333195610048575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEK,Angiopoietin-1 receptor,21352,1860,1.36 [1.13-1.63],0.001244192628552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TERF1,Telomeric repeat-binding factor 1,17944,1562,1.03 [0.87-1.22],0.7464867782186231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TET2,Methylcytosine dioxygenase TET2,18132,1568,1.03 [0.98-1.08],0.2149649989651954
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEX101,Testis-expressed protein 101,18001,1566,1.06 [0.98-1.15],0.124560001548542
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEX33,Testis-expressed protein 33,18165,1571,0.92 [0.82-1.03],0.1422918224824072
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TF,Serotransferrin,18511,1612,1.48 [1.18-1.86],0.0006460163934589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFAP2A,Transcription factor AP-2-alpha,17877,1545,0.95 [0.87-1.03],0.2006960589885122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF1,Trefoil factor 1,21207,1860,1.23 [1.18-1.29],3.576823880841489e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF2,Trefoil factor 2,21336,1865,1.50 [1.41-1.59],3.26981139871573e-38
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF3,Trefoil factor 3,21286,1847,1.46 [1.33-1.60],5.160589228283567e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI,Tissue factor pathway inhibitor,21250,1853,1.35 [1.19-1.53],3.726061349929068e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,21294,1853,1.27 [1.18-1.37],4.643913149944e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFRC,Transferrin receptor protein 1,21391,1862,1.04 [0.93-1.17],0.4658709534472294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TG,Thyroglobulin,18419,1587,0.95 [0.90-1.00],0.0320047880471403
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFA,Protransforming growth factor alpha,21282,1863,1.41 [1.31-1.51],2.474243860196751e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,21507,1876,1.36 [1.23-1.50],2.080959967188673e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB2,Transforming growth factor beta-2 proprotein,18419,1587,1.11 [1.02-1.22],0.021951767903969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBI,Transforming growth factor-beta-induced protein ig-h3,21182,1846,1.45 [1.24-1.70],2.753678780751186e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR1,TGF-beta receptor type-1,17944,1562,1.37 [1.08-1.74],0.0098363227927809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR2,TGF-beta receptor type-2,21352,1860,1.35 [1.20-1.52],6.380882266960723e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR3,Transforming growth factor beta receptor type 3,21556,1882,1.11 [0.97-1.28],0.1222744142292504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGM2,Protein-glutamine gamma-glutamyltransferase 2,21252,1854,1.00 [0.95-1.06],0.9215603064936596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGOLN2,Trans-Golgi network integral membrane protein 2,18509,1603,1.17 [0.97-1.42],0.0984999044212479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THAP12,52 kDa repressor of the inhibitor of the protein kinase,17810,1538,1.06 [1.00-1.12],0.063790742320314
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBD,Thrombomodulin,21289,1860,1.03 [0.89-1.19],0.661699311856299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS2,Thrombospondin-2,21302,1865,1.68 [1.51-1.87],1.1433014270253737e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS4,Thrombospondin-4,21325,1860,1.03 [0.95-1.13],0.471346387998263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THOP1,Thimet oligopeptidase,21189,1855,1.39 [1.23-1.57],2.255437928890863e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THPO,Thrombopoietin,20906,1832,1.03 [0.92-1.14],0.6028440791310214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THRAP3,Thyroid hormone receptor-associated protein 3,17856,1551,0.99 [0.95-1.04],0.6854877040783951
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THSD1,Thrombospondin type-1 domain-containing protein 1,17816,1550,0.93 [0.80-1.07],0.3146244758053927
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THTPA,Thiamine-triphosphatase,18375,1585,1.02 [0.96-1.07],0.5525330157107238
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THY1,Thy-1 membrane glycoprotein,21484,1876,1.17 [1.01-1.35],0.0348315182699075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIA1,Nucleolysin TIA-1 isoform p40,20681,1811,1.01 [0.98-1.04],0.6010244997481419
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIE1,Tyrosine-protein kinase receptor Tie-1,21556,1882,1.14 [1.03-1.27],0.0109074737028723
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",20809,1835,1.12 [1.03-1.22],0.0089995404106705
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,18165,1571,1.21 [1.07-1.37],0.0022664991134241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,21393,1864,1.18 [1.07-1.29],0.0005728723655837
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,18494,1603,1.05 [0.94-1.18],0.3912169429443298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,18446,1599,1.02 [0.96-1.08],0.5193537211807693
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,21081,1833,1.96 [1.70-2.26],3.1740637026039764e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP2,Metalloproteinase inhibitor 2,18494,1603,0.92 [0.77-1.11],0.3908116932412654
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP3,Metalloproteinase inhibitor 3,21367,1868,1.05 [1.02-1.08],0.0024490244472174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,21302,1865,1.75 [1.60-1.91],4.2331322628680515e-35
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TINAGL1,Tubulointerstitial nephritis antigen-like,21226,1856,0.93 [0.77-1.12],0.4225736670273993
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TJAP1,Tight junction-associated protein 1,21352,1860,1.02 [0.97-1.07],0.4743407763225777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TJP3,Tight junction protein ZO-3,17877,1545,0.97 [0.85-1.09],0.5984208198987457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TK1,"Thymidine kinase, cytosolic",18165,1571,1.03 [0.93-1.14],0.6260396736060538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR1,Toll-like receptor 1,17944,1562,1.22 [1.01-1.49],0.0430656859922658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR2,Toll-like receptor 2,18165,1571,1.32 [1.07-1.63],0.009774689637092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR3,Toll-like receptor 3,21543,1879,1.05 [0.99-1.13],0.1119490650355998
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR4,Toll-like receptor 4,17944,1562,1.03 [0.87-1.21],0.7242193318847621
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,18001,1566,1.00 [0.92-1.10],0.9367465113094868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED1,Transmembrane emp24 domain-containing protein 1,18165,1571,1.04 [0.95-1.14],0.3983934318229087
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED10,Transmembrane emp24 domain-containing protein 10,17856,1551,1.02 [0.92-1.13],0.7036828000794629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED4,Transmembrane emp24 domain-containing protein 4,17856,1551,1.03 [0.94-1.12],0.5102449881240074
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED8,Protein TMED8,18435,1602,1.02 [0.97-1.06],0.5014468494680995
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMEM106A,Transmembrane protein 106A,18419,1587,1.02 [0.95-1.09],0.5882275158571418
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMEM132A,Transmembrane protein 132A,17992,1559,1.02 [0.94-1.10],0.7050594506974239
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMEM25,Transmembrane protein 25,18454,1594,1.05 [0.95-1.16],0.304540049986448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMOD4,Tropomodulin-4,17841,1543,1.01 [0.88-1.15],0.9123923595865444
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS11B,Transmembrane protease serine 11B,17877,1545,0.96 [0.90-1.03],0.2370007441384123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS11D,Transmembrane protease serine 11D,18412,1594,1.39 [1.23-1.57],1.579110135152627e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS15,Enteropeptidase,21186,1853,0.99 [0.94-1.04],0.6177116058290907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS5,Transmembrane protease serine 5,21002,1837,0.87 [0.78-0.96],0.0061761701520193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMSB10,Thymosin beta-10,21302,1865,1.11 [1.06-1.17],8.410459932828322e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNC,Tenascin,21393,1864,1.25 [1.15-1.36],4.180220706058246e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNF,Tumor necrosis factor,20880,1828,1.26 [1.12-1.40],5.240357787964952e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,18435,1602,1.14 [1.05-1.24],0.0010928857879334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,20914,1833,1.03 [0.92-1.16],0.623401016096143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,18077,1558,1.00 [0.93-1.08],0.953528939253688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,21104,1848,1.83 [1.62-2.06],1.3470983204878608e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,21104,1848,1.70 [1.66-1.75],0.0
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,21361,1863,1.18 [1.09-1.29],0.0001115175825211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,21543,1879,1.30 [1.17-1.44],5.197739089332935e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,21262,1860,1.93 [1.72-2.16],7.575504619659171e-30
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,21352,1860,1.66 [1.48-1.85],1.5800169478525725e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,21292,1863,1.28 [1.16-1.43],3.386681838965541e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,20914,1833,0.88 [0.80-0.97],0.0086175973338399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,21292,1863,1.40 [1.23-1.60],3.993093861720141e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,18077,1558,1.17 [1.04-1.32],0.0077871022572616
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,21472,1876,1.19 [1.05-1.35],0.0082245652624698
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,21302,1865,1.78 [1.57-2.03],1.88126659514338e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,21302,1865,1.44 [1.31-1.59],5.04389880500512e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,21484,1876,1.35 [1.17-1.56],2.9594094423276898e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,21507,1876,1.18 [1.06-1.31],0.0033838259437699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,21104,1848,1.40 [1.31-1.49],2.6946268776999744e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,21484,1876,1.15 [1.05-1.26],0.0021614712014724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,21104,1848,1.27 [1.16-1.39],2.650801740418938e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF10,Tumor necrosis factor ligand superfamily member 10,21543,1879,0.76 [0.65-0.89],0.0004847784725407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF11,Tumor necrosis factor ligand superfamily member 11,21282,1863,0.81 [0.76-0.86],3.420385061620471e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF12,Tumor necrosis factor ligand superfamily member 12,21543,1879,0.67 [0.58-0.77],2.5778532302242136e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,21367,1868,1.63 [1.41-1.88],5.2330831824955e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,21521,1879,1.88 [1.64-2.16],1.0983267168053396e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF14,Tumor necrosis factor ligand superfamily member 14,21104,1848,1.10 [1.03-1.17],0.0060919991433987
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF8,Tumor necrosis factor ligand superfamily member 8,18498,1605,1.03 [0.91-1.17],0.6497045280382889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNIP1,TNFAIP3-interacting protein 1,18446,1599,1.07 [1.01-1.13],0.014771884695867
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNN,Tenascin-N,18498,1605,0.86 [0.77-0.96],0.0078047684975051
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNNI3,"Troponin I, cardiac muscle",20906,1832,1.02 [0.97-1.07],0.546887221051501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNPO1,Transportin-1,18165,1571,0.89 [0.78-1.03],0.1171514658640406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNR,Tenascin-R,21104,1848,0.67 [0.61-0.74],4.123554645436096e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNXB,Tenascin-X,21302,1865,1.15 [0.98-1.35],0.0772853786079256
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,18494,1603,1.08 [1.02-1.15],0.0103447228127712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP1,DNA topoisomerase 1,18435,1602,0.94 [0.90-0.98],0.0027988579864224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP1MT,"DNA topoisomerase I, mitochondrial",17841,1543,1.06 [0.95-1.18],0.2986496608378397
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP2B,DNA topoisomerase 2-beta,17944,1562,1.06 [1.00-1.13],0.0402223332976369
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOR1AIP1,Torsin-1A-interacting protein 1,17992,1559,1.06 [0.98-1.15],0.1464520288574923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53,Cellular tumor antigen p53,20784,1814,1.02 [0.93-1.12],0.6894529963199236
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53BP1,TP53-binding protein 1,17944,1562,0.97 [0.91-1.03],0.2985112799080545
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53I3,Quinone oxidoreductase PIG3,17689,1528,1.10 [1.00-1.20],0.0392410864621728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53INP1,Tumor protein p53-inducible nuclear protein 1,20906,1832,1.02 [0.89-1.17],0.7608902824806211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP73,Tumor protein p73,18001,1566,1.04 [0.90-1.21],0.5988638552431403
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPBGL,Trophoblast glycoprotein-like,18001,1566,0.91 [0.80-1.03],0.1425395163199179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPD52L2,Tumor protein D54,18077,1558,1.01 [0.97-1.06],0.5977067593038512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPK1,Thiamin pyrophosphokinase 1,18494,1603,1.10 [0.95-1.29],0.2105846158917055
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPM3,Tropomyosin alpha-3 chain,17856,1551,0.94 [0.84-1.05],0.2523961449345244
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPMT,Thiopurine S-methyltransferase,20784,1814,1.03 [0.97-1.09],0.3704129056475627
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPP1,Tripeptidyl-peptidase 1,21124,1852,1.50 [1.40-1.61],4.687438749375709e-31
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPPP2,Tubulin polymerization-promoting protein family member 2,18165,1571,0.99 [0.93-1.06],0.8327089304646144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPPP3,Tubulin polymerization-promoting protein family member 3,20838,1837,1.04 [0.93-1.16],0.4731185808930077
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPR,Nucleoprotein TPR,17856,1551,1.10 [1.02-1.19],0.0180403580748548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPRKB,EKC/KEOPS complex subunit TPRKB,17841,1543,0.99 [0.91-1.07],0.7402407084553391
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPSAB1,Tryptase alpha/beta-1,21508,1876,1.01 [0.93-1.09],0.8965948936731813
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPSD1,Tryptase delta,18454,1594,1.02 [0.89-1.17],0.787328379996415
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPSG1,Tryptase gamma,17944,1562,0.99 [0.82-1.19],0.912144946348768
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPT1,Translationally-controlled tumor protein,20914,1833,0.98 [0.92-1.05],0.5984451543025651
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRAF2,TNF receptor-associated factor 2,21282,1863,0.97 [0.91-1.03],0.2762948980819777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRAF3,"TNF receptor-associated factor 3, Isoform 2",17944,1562,0.99 [0.87-1.12],0.8597596690258991
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,17856,1551,1.05 [0.95-1.15],0.3378186775789072
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,18165,1571,1.03 [0.97-1.08],0.3390974570779931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREH,Trehalase,18498,1605,0.92 [0.86-0.98],0.0060817546186982
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,21262,1860,1.47 [1.37-1.58],9.029777978915578e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREML1,Trem-like transcript 1 protein,18509,1603,1.01 [0.92-1.10],0.8280057051460084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREML2,Trem-like transcript 2 protein,21302,1865,0.93 [0.82-1.04],0.2099114893289198
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIAP1,TP53-regulated inhibitor of apoptosis 1,21472,1876,1.12 [1.05-1.20],0.000386514151193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM21,E3 ubiquitin-protein ligase TRIM21,21282,1863,0.96 [0.91-1.01],0.1469939862598409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM24,Transcription intermediary factor 1-alpha,18133,1566,1.00 [0.93-1.08],0.9806878499566676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,18435,1602,1.03 [0.99-1.08],0.1221873995441933
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM26,Tripartite motif-containing protein 26,17841,1543,0.99 [0.92-1.08],0.8964540473372633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM40,E3 ubiquitin ligase TRIM40,18001,1566,1.02 [0.95-1.09],0.6457287362251253
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM5,Tripartite motif-containing protein 5,21282,1863,1.01 [0.97-1.06],0.640809647802087
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM58,E3 ubiquitin-protein ligase TRIM58,18419,1587,1.00 [0.95-1.06],0.9952350045808708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRPV3,Transient receptor potential cation channel subfamily V member 3,17856,1551,0.98 [0.87-1.09],0.6694699895806242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSC1,Hamartin,17944,1562,0.97 [0.89-1.05],0.430709177383229
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSC22D1,TSC22 domain family protein 1,18454,1594,0.98 [0.91-1.05],0.5713263642997738
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSHB,Thyrotropin subunit beta,21289,1860,0.93 [0.87-0.98],0.0139848501100697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSLP,Thymic stromal lymphopoietin,20906,1832,1.00 [0.93-1.07],0.988865010354964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSNAX,Translin-associated protein X,17856,1551,0.96 [0.85-1.10],0.5773104075340996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN1,Tetraspanin-1,20906,1832,0.98 [0.93-1.04],0.5370749413475248
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN15,Tetraspanin-15,17856,1551,1.04 [0.94-1.14],0.4582823458075838
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN7,Tetraspanin-7,17877,1545,0.88 [0.83-0.94],6.55606874113328e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN8,Tetraspanin-8,18435,1602,1.13 [1.08-1.19],1.2801624781272986e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPYL1,Testis-specific Y-encoded-like protein 1,17944,1562,1.03 [0.91-1.17],0.6189023369818184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TST,Thiosulfate sulfurtransferase,20803,1837,1.02 [0.97-1.08],0.4781314111592895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTF2,Transcription termination factor 2,18001,1566,0.91 [0.82-1.00],0.0502879719043873
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTN,Titin,17856,1551,0.94 [0.86-1.03],0.2030233698115565
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTR,Transthyretin,18325,1596,0.75 [0.61-0.91],0.0031556063573938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TUBB3,Tubulin beta-3 chain,17877,1545,1.06 [0.90-1.25],0.4591560882732709
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TWF2,Twinfilin-2,18498,1605,1.03 [0.97-1.08],0.3499538698800901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXK,Tyrosine-protein kinase TXK,18165,1571,0.98 [0.91-1.05],0.5325392375484979
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXLNA,Alpha-taxilin,21104,1848,1.03 [0.98-1.08],0.2176361384009351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXN,Thioredoxin,18223,1585,1.11 [1.00-1.23],0.0578679079253936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC15,Thioredoxin domain-containing protein 15,21352,1860,1.60 [1.38-1.86],2.874130623493106e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC5,Thioredoxin domain-containing protein 5,21484,1876,1.11 [1.05-1.18],0.0003046331424462
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC9,Thioredoxin domain-containing protein 9,18446,1599,1.02 [0.93-1.11],0.7096315700620743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNL1,Thioredoxin-like protein 1,17845,1543,0.93 [0.88-0.98],0.0033794055611399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",21302,1865,1.10 [1.01-1.20],0.0301668194163192
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYMP,Thymidine phosphorylase,21159,1850,1.13 [1.07-1.21],5.821177532079018e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYRO3,Tyrosine-protein kinase receptor TYRO3,21289,1860,1.06 [0.91-1.22],0.4606162204886507
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",17944,1562,1.11 [1.02-1.20],0.0106255604944069
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBAC1,Ubiquitin-associated domain-containing protein 1,21186,1853,1.05 [0.93-1.19],0.4152295113172837
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2B,Ubiquitin-conjugating enzyme E2 B,18419,1587,0.97 [0.81-1.15],0.7055500505427315
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,18494,1603,1.10 [1.02-1.19],0.0132164903617525
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,17944,1562,0.99 [0.90-1.09],0.8483432849061299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBQLN3,Ubiquilin-3,17856,1551,1.04 [0.94-1.15],0.4239328358378762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBXN1,UBX domain-containing protein 1,18077,1558,1.02 [0.95-1.09],0.5859948919691753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,18435,1602,1.00 [0.97-1.04],0.7963903926815319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UGDH,UDP-glucose 6-dehydrogenase,17856,1551,0.97 [0.92-1.04],0.4096702667930227
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UHRF2,E3 ubiquitin-protein ligase UHRF2,17856,1551,0.94 [0.81-1.09],0.4395720731025483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ULBP2,UL16-binding protein 2,21104,1848,1.37 [1.23-1.52],2.8019199337345704e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UMOD,Uromodulin,21479,1874,0.82 [0.76-0.88],5.0490778235060266e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UNC5D,Netrin receptor UNC5D,17944,1562,0.84 [0.70-1.01],0.0634034028591547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UNC79,Protein unc-79 homolog,17841,1543,0.98 [0.89-1.07],0.5765778817232701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UNG,Uracil-DNA glycosylase,18419,1587,1.08 [0.94-1.24],0.2591838591764658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPB1,Beta-ureidopropionase,18494,1603,1.08 [1.03-1.13],0.0023750832737227
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPK3A,Uroplakin-3a,17877,1545,1.07 [0.97-1.17],0.1802040270572859
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPK3BL1,Uroplakin-3b-like protein 1,18126,1569,0.96 [0.87-1.05],0.3563385622440589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UROD,Uroporphyrinogen decarboxylase,18077,1558,0.97 [0.90-1.04],0.3812237962308105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UROS,Uroporphyrinogen-III synthase,18001,1566,0.94 [0.87-1.02],0.1468932490449424
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USO1,General vesicular transport factor p115,21186,1853,1.03 [0.98-1.07],0.2738280495366152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP25,Ubiquitin carboxyl-terminal hydrolase 25,18419,1587,1.05 [0.98-1.12],0.1584531886132324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP28,Ubiquitin carboxyl-terminal hydrolase 28,18446,1599,1.26 [1.12-1.41],0.0001094064938969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP47,Ubiquitin carboxyl-terminal hydrolase 47,17856,1551,1.03 [0.97-1.09],0.3273455062316132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP8,Ubiquitin carboxyl-terminal hydrolase 8,20906,1832,1.00 [0.96-1.05],0.8533751955070545
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UXS1,UDP-glucuronic acid decarboxylase 1,20784,1814,1.09 [1.01-1.19],0.0358971297750439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP5,Vesicle-associated membrane protein 5,20906,1832,1.29 [1.20-1.39],1.1318753353455425e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP8,Vesicle-associated membrane protein 8,17944,1562,1.06 [1.01-1.12],0.0263374414830367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VASH1,Tubulinyl-Tyr carboxypeptidase 1,21282,1863,0.99 [0.95-1.05],0.8353491499011635
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VASN,Vasorin,20970,1831,0.82 [0.70-0.96],0.0127550757244404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VASP,Vasodilator-stimulated phosphoprotein,18509,1603,1.02 [0.96-1.09],0.5204564416090991
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,21186,1853,0.77 [0.62-0.94],0.0126612431564081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAV3,Guanine nucleotide exchange factor VAV3,17877,1545,1.01 [0.96-1.06],0.6583423091627458
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAM1,Vascular cell adhesion protein 1,21360,1861,1.20 [1.03-1.39],0.0224275899192516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAN,Versican core protein,21484,1876,1.31 [1.15-1.49],5.589054371550472e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCPKMT,Protein-lysine methyltransferase METTL21D,17841,1543,1.05 [0.99-1.12],0.0760147620073223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFA,Vascular endothelial growth factor A,21472,1872,1.21 [1.13-1.30],2.7731502468053886e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFB,Vascular endothelial growth factor B,17944,1562,1.32 [1.11-1.56],0.0016819843061925
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFC,Vascular endothelial growth factor C,21352,1860,1.08 [1.01-1.16],0.0322226587164531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFD,Vascular endothelial growth factor D,21512,1876,1.26 [1.12-1.40],6.722625384685252e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VGF,Neurosecretory protein VGF,18454,1594,0.99 [0.84-1.17],0.8918649499797665
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIM,Vimentin,20906,1832,1.00 [0.96-1.04],0.9367948010215308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIPR1,Vasoactive intestinal polypeptide receptor 1,17992,1559,0.88 [0.70-1.10],0.2676482104031974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIT,Vitrin,18494,1603,1.23 [1.08-1.40],0.0012844057989684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VMO1,Vitelline membrane outer layer protein 1 homolog,21186,1853,1.08 [1.02-1.15],0.0122622059239022
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VNN1,Pantetheinase,18509,1603,1.08 [1.02-1.16],0.016104336927108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VNN2,Vascular non-inflammatory molecule 2,21186,1853,1.21 [1.11-1.32],2.0345590895490943e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS28,Vacuolar protein sorting-associated protein 28 homolog,18165,1571,1.04 [0.97-1.12],0.2202235289384151
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS37A,Vacuolar protein sorting-associated protein 37A,21186,1853,1.01 [0.96-1.06],0.7669500270777634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS4B,Vacuolar protein sorting-associated protein 4B,18419,1587,1.02 [0.97-1.07],0.4801441043815586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS53,Vacuolar protein sorting-associated protein 53 homolog,21186,1853,1.01 [0.96-1.06],0.7351628676263915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG10,V-set and immunoglobulin domain-containing protein 10,18419,1587,0.92 [0.80-1.05],0.217944138372591
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,17856,1551,1.34 [1.18-1.53],1.2678580842244315e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,18419,1587,1.28 [1.19-1.37],3.6313826250368857e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,21273,1858,1.55 [1.40-1.71],5.794145320740927e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,21257,1856,1.06 [1.00-1.14],0.0629780889759234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSNL1,Visinin-like protein 1,18446,1599,1.26 [1.14-1.39],6.701430506236496e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM1,V-set and transmembrane domain-containing protein 1,20838,1837,1.12 [1.03-1.21],0.0067736087483794
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM2B,V-set and transmembrane domain-containing protein 2B,18165,1571,0.95 [0.82-1.09],0.4335470836958186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,20906,1832,1.10 [1.02-1.17],0.0079954399763124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,21484,1876,1.03 [0.98-1.09],0.2793750492824607
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTCN1,V-set domain-containing T-cell activation inhibitor 1,20784,1814,1.12 [0.98-1.29],0.0970776893012885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,18077,1558,1.10 [1.02-1.19],0.0142604084709079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,21448,1875,1.63 [1.50-1.78],3.287985869851629e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA5A,von Willebrand factor A domain-containing protein 5A,17841,1543,0.94 [0.88-1.01],0.0748777690143497
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWC2,Brorin,21035,1842,1.24 [1.12-1.37],2.1674970608737903e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWC2L,von Willebrand factor C domain-containing protein 2-like,18454,1594,0.95 [0.84-1.06],0.3541580382661883
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWF,von Willebrand factor,21556,1882,1.05 [0.99-1.10],0.1070126291222697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WARS,"Tryptophan--tRNA ligase, cytoplasmic",21302,1865,1.30 [1.16-1.45],4.855530969319645e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WAS,Wiskott-Aldrich syndrome protein,20914,1833,1.02 [0.96-1.09],0.4984275676635434
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASF1,Wiskott-Aldrich syndrome protein family member 1,20906,1832,1.02 [0.98-1.07],0.3682119259604376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASF3,Wiskott-Aldrich syndrome protein family member 3,20838,1837,0.98 [0.93-1.03],0.3921437342955323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASHC3,WASH complex subunit 3,18446,1599,1.06 [1.00-1.13],0.0645279747425213
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASL,Neural Wiskott-Aldrich syndrome protein,17944,1562,0.88 [0.80-0.96],0.0066813584018471
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WDR46,WD repeat-containing protein 46,18419,1587,1.15 [1.02-1.29],0.0243861753920903
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC1,WAP four-disulfide core domain protein 1,18040,1552,1.08 [0.99-1.17],0.1007508549932289
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,21428,1871,1.19 [1.12-1.27],3.806290206765087e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,20247,1746,1.93 [1.78-2.10],2.488928804817489e-53
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",21027,1843,0.64 [0.58-0.71],1.618368323592654e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",21292,1863,0.89 [0.79-1.01],0.0686576792390172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WIF1,Wnt inhibitory factor 1,21472,1876,1.36 [1.21-1.52],1.5753661791989017e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WNT9A,Protein Wnt-9a,20914,1833,1.34 [1.16-1.55],9.526035795140074e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,21104,1848,0.98 [0.90-1.06],0.5790462821018627
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XCL1,Lymphotactin,21472,1876,1.13 [1.05-1.23],0.0014014251260866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XG,Glycoprotein Xg,21456,1874,1.08 [0.94-1.23],0.277897612863684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XIAP,E3 ubiquitin-protein ligase XIAP,17944,1562,1.02 [0.94-1.11],0.562234583034694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XPNPEP2,Xaa-Pro aminopeptidase 2,21352,1860,0.97 [0.93-1.00],0.0640857858873508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XRCC4,DNA repair protein XRCC4,20838,1837,1.14 [1.01-1.28],0.0274855797362294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YAP1,Transcriptional coactivator YAP1,18446,1599,1.73 [1.45-2.06],6.019736290344794e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",18435,1602,1.03 [1.00-1.06],0.0677400626469212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YES1,Tyrosine-protein kinase Yes,21186,1853,1.03 [0.99-1.07],0.0933821998503871
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YJU2,Splicing factor YJU2,18419,1587,1.03 [0.89-1.19],0.6874128641738384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YOD1,Ubiquitin thioesterase OTU1,17856,1551,0.98 [0.90-1.06],0.631321456250015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YTHDF3,YTH domain-containing family protein 3,20914,1833,1.04 [0.99-1.09],0.1116543537284385
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YWHAQ,14-3-3 protein theta,18077,1558,1.01 [0.95-1.07],0.7977882529165194
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YY1,Transcriptional repressor protein YY1,17944,1562,0.99 [0.84-1.16],0.8806365689795803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBP1,Z-DNA-binding protein 1,17944,1562,1.07 [0.95-1.20],0.2574872522643273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB16,Zinc finger and BTB domain-containing protein 16,20784,1814,1.01 [0.95-1.07],0.7412340131248619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,20906,1832,1.22 [1.12-1.33],3.6425977263754415e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZCCHC8,Zinc finger CCHC domain-containing protein 8,17856,1551,1.05 [0.97-1.14],0.2576020243779138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZFYVE19,Abscission/NoCut checkpoint regulator,18435,1602,1.00 [0.95-1.06],0.8557527202093129
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZHX2,Zinc fingers and homeoboxes protein 2,18446,1599,1.19 [1.06-1.34],0.00402050483458
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNF174,Zinc finger protein 174,17944,1562,1.03 [0.90-1.17],0.657813226422745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNF75D,Zinc finger protein 75D,18165,1571,1.04 [0.96-1.12],0.3771210198552129
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNF830,Zinc finger protein 830,18419,1587,1.00 [0.94-1.06],0.938982340135265
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNRD2,Protein ZNRD2,18435,1602,1.07 [1.00-1.14],0.0509840643158145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,18419,1587,0.98 [0.90-1.06],0.5902859461806124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZP3,Zona pellucida sperm-binding protein 3,17992,1559,0.99 [0.98-1.01],0.5016789040135925
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZP4,Zona pellucida sperm-binding protein 4,17841,1543,1.05 [0.91-1.21],0.496788026506533
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZPR1,Zinc finger protein ZPR1,17877,1545,1.02 [0.98-1.08],0.3275267634536829
